Development and regulation of body weight: A genetic, behavioral and neuro-endocrinological approach by Rutters, F.
  
 
Development and regulation of body weight: A
genetic, behavioral and neuro-endocrinological
approach
Citation for published version (APA):
Rutters, F. (2009). Development and regulation of body weight: A genetic, behavioral and neuro-
endocrinological approach. Maastricht: Maastricht University.
Document status and date:
Published: 01/01/2009
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
  
 
 
 
 
 
 
Development and regulation of body weight 
A genetic, behavioral and neuro-endocrinological approach 
 
Thesis_Rutters_v10.pdf   1 2-7-2009   14:50:33
The studies presented in this thesis were performed at the Nutrition and Toxicology 
Research Institute Maastricht (NUTRIM), which participates in the graduate school VLAG 
(Food Technology, Agro biotechnology, Nutrition and Health Sciences), accredited by the 
Royal Netherlands Academy of Arts and Sciences. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Printing of this thesis was financially supported by the J.E. Jurriaanse stichting. 
 
 
 
 
Cover design: Femke Rutters and Jurriaan Born 
Cover: Jurriaan Born 
Layout: Femke Rutters and Datawyse 
Printed by: Datawyse, Universitaire Pers Maastricht  
 
 
© F. Rutters, Maastricht 2009 
ISBN: 978 90 5278 852 4 
Thesis_Rutters_v10.pdf   2 2-7-2009   14:50:34
  
 
 
 
 
 
 
Development and regulation of body weight 
A genetic, behavioral and neuro-endocrinological approach 
 
 
 
 
 
 
 
Proefschrift 
 
Ter verkrijging van de graad van doctor 
aan de universiteit Maastricht, 
op gezag van de Rector Magnificus, 
Prof. mr. G.P.M.F. Mols, 
volgens het besluit van het College van Decanen, 
in het openbaar te verdedigen 
op vrijdag 4 september 2009 om 14.00 uur 
 
door 
 
 
Femke Rutters 
 
Geboren te Waalwijk op 1 september 1982 
Thesis_Rutters_v10.pdf   3 2-7-2009   14:50:34
UNIVERSITAIRE
PERS MAASTRICHT
P
M
 Promotor 
 Prof. dr. M.S. Westerterp-Plantenga 
 
Copromotor 
 Dr. A.G. Nieuwenhuizen 
 
Beoordelingscommissie 
 Prof. dr. K.R. Westerterp (voorzitter) 
 Dr. W.J. Gerver 
 Dr. S.E. La Fleur (Universiteit Amsterdam) 
 Prof. dr. N. Schaper 
 Prof. dr. J. Wardle (University College London)  
Thesis_Rutters_v10.pdf   4 2-7-2009   14:50:34
  
Content 
 
Chapter 1 7 
General introduction 
 
Chapter 2 19 
Associations between the FTO gene (rs9939609) and development of obesity related 
characteristics over time in a Dutch children cohort 
 
Chapter 3 29 
Leptin-adiposity relationship changes, plus behavioral and parental factors,  
are involved in the development of body weight in a Dutch children cohort 
 
Chapter 4 41 
Sleep duration and body-weight development during puberty in a Dutch  
children cohort  
 
Chapter 5 49 
The relationship between leptin concentrations, gonadotrophic hormones, and body 
composition during puberty in a Dutch children cohort 
 
Chapter 6  59 
The hypothalamic-pituitary-adrenal-axis in the regulation of energy balance  
 
Chapter 7 75 
Sex specific associations between the BclI polymorphism in the glucocorticoid receptor 
gene and HPA axis exposure as well as feedback sensitivity  
 
Chapter 8 85 
Hypothalamus/Pituitary/Adrenal (HPA) axis functioning in relation to body fat  
distribution 
 
Chapter 9 95 
Acute stress-related changes in eating in the absence of hunger 
 
Chapter 10 107 
Hyperactivity of the HPA axis is related to dietary restraint in normal weight women 
 
Chapter 11  117 
General discussion 
 
Summary 131 
 
Samenvatting 133 
 
Dankwoord 135 
 
List of publications 137 
 
Curriculum Vitae 139 
Thesis_Rutters_v10.pdf   5 2-7-2009   14:50:34
 Thesis_Rutters_v10.pdf   6 2-7-2009   14:50:34
 7 
Chapter 1 
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General 
In healthy adults, body weight normally 
fluctuates around a relatively constant 
value, and therefore appears to be 
regulated with remarkable precision [1]. A 
stable body weight is a reflection of a 
balance between energy intake and 
energy expenditure.  A chronic 
deregulation of energy balance, with 
energy intake exceeding energy 
expenditure, leads to the storage of the 
excessive energy as fat, a characteristic 
feature of overweight and obesity [2]. 
Overweight and obesity are classified by 
the body mass index (BMI) and body 
composition. According to the World 
Health Organization, adults with a BMI 
between 20 and 24.9 kg/m2 and body fat 
percentage of 10-15% in men and 20-
25% in women are defined as normal 
weight, with a BMI between 25.0 and 29.9 
kg/m2 and body fat percentage of > 15% 
in men and >25% in women as 
overweight, and with a BMI between 30.0 
and 34.9 kg/m2 as obese [3]. In children 
BMI changes substantially with age, 
therefore Cole et al. (2000) [4] recently 
developed age and sex specific cut off 
points for BMI to be able to define 
overweight and obesity during childhood. 
Chronic deregulation of body weight, as 
seen in obesity, reflects a multi-factorial 
disorder [4]. Development and regulation 
of body weight are determined by a 
number of factors namely genetic, 
parental, behavioral, endocrine, and the 
interaction between these factors.  
The first part of this thesis elaborates on 
the factors involved in body-weight 
development during childhood and 
puberty. Thereafter, the second part of 
this thesis elaborates on the role of the 
neuro-endocrine system of the 
hypothalamus/pituitary/adrenal (HPA) 
axis in body-weight regulation in adults.  
 
Body-weight development during 
childhood and puberty 
First, relevant genetic factors involved in 
development of body weight during 
childhood and puberty will be dealt with. 
The interaction between genetic factors 
and body-weight development is typically 
studied by means of twin studies, 
adoption studies and/or single nucleotide 
polymorphism (SNP) association studies 
[5].  
In this thesis, we focus on polymorphisms 
that previously have been related to 
variation in body weight, body 
composition and/or energy intake such as 
the ciliary neurotrophic factor (CNTF) 
gene [6, 7], the peroxisome proliferated-
activated receptor γ2 (PPARγ2) gene [8], 
and the fat mass and obesity-associated 
gene (FTO) [9-11].  
CNTF is a neurocytokine that is involved in 
control of energy balance, as 
administration of CNTF leads to weight 
loss in humans [12]. The null mutation G 
> A of the CNTF gene leads to an inactive 
CNTF protein, and is related to a higher 
BMI [7], lower leptin concentrations, and 
a smaller decrease in leptin concentrations 
during weight loss in adults [6]. In 
children, the CNTF G > A null mutation 
has not been related to obesity yet.  
PPARγ is nuclear receptor protein that 
functions as a transcription factor in the 
regulation of adipocyte differentiation 
[13]. The PPARy polymorphism Pro12Ala 
represents a substitution of proline to 
alanine in exon B, and leads to decreased 
transcriptional activity [14]. In children, 
the PPARy polymorphism Pro12Ala is 
related to deficiency in energy storage 
and utilization, which leads to reduced 
growth [13, 15], increased obesity risk 
[16], increased adiposity [17], and insulin 
resistance [18, 19].  
The FTO gene is involved in the control of 
energy balance, as FTO expression is 
decreased in the hypothalamus in fasted 
mice, when compared to fed mice [20]. In 
children, the A allele of the FTO gene 
(rs9939609) is related to a number of 
obesity related characteristics, such as an 
increased BMI [11, 21], increased hip 
circumference [22], increased adiposity 
[9], increased leptin levels [23, 24], 
increased energy intake [25, 26], and 
reduced satiety responsiveness [27]. The 
influence of these SNP’s may change over 
time as gene expression changes over 
time [28]. The effects of the SNP’s during 
body-weight development therefore need 
to be assessed over time.  
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Parental factors 
Parental factors are also important in 
body-weight development during 
childhood. Parental factors are a 
combination of genetic and behavioral 
factors, and for instance, parental obesity 
is an important parental factor [29], as 
the BMI of the child is positively related to 
the BMI of the parent [29, 30]. Also 
parents’ restrained eating behavior affects 
children’s body-weight development, since 
the child’s body weight at age 12y has 
been shown to be positively related to the 
restraint score of the mother [30]. The 
parental association is due to genetic and 
environmental factors, such as shared 
lifestyles (i.e. diets, feeding practices and 
food choices) and patterns of activity 
[29].  
 
Behavioral factors 
Behavioral factors, such as eating 
behavior and sleep duration are involved 
in body-weight development during 
childhood as well. Eating behavior in 
general can be analyzed using the Three 
Factor Eating Questionnaire (TFEQ) [31]. 
The TFEQ assesses three factors involved 
in eating behavior: dietary restraint, 
disinhibition and feeling of hunger. Dietary 
restraint refers to conscious restriction of 
food intake to achieve or maintain a 
preferred body weight. Disinhibition 
reflects individual differences in the extent 
to which release from the cognitive 
suppression of eating occurs in response 
to the presence of palatable food or other 
disinhibiting stimuli, such as emotional 
distress. The third factor refers to the 
general feeling of hunger [31]. In 11-12 y 
old children dietary restraint only occurs 
in the overweight children [30], while in 
adults dietary restraint also occurs in lean 
people who are called ‘successfully dietary 
restrained eaters’ [32]. The development 
of dietary restraint in lean people may 
start during puberty.  
In children an inverse relationship 
between the behavioral factor sleep 
duration and BMI has been observed [36-
38], which suggests that short sleep has 
an effect on body-weight development. 
Sleep duration could affect body-weight 
development [33, 34], as short sleep 
duration is already present from a very 
young age onwards [35]. Some studies 
even observed a curvilinear relationship 
between sleep duration and BMI [39, 40], 
which suggests that sleeping too short 
and too long have a negative effect on 
body-weight development. Also, negative 
relationships have been observed between 
sleep duration and body fat percentage 
[41, 42], waist circumference [36], leptin 
levels [42], as well as insulin resistance 
[42, 43].  
Sleep duration during childhood is 
however subjected to developmental 
changes, in particular during puberty 
when a significant decrease in sleep 
duration has been observed [35, 44]. 
Previous longitudinal studies on sleep 
duration and BMI in children have 
observed a consistent negative linear 
association between habitual sleep 
duration and later obesity [44-47]. 
However they have not investigated 
whether changes in sleep duration are 
associated with changes in BMI. 
 
Endocrine factors 
Furthermore, the endocrine factor leptin 
appears to play a remarkable role in body-
weight development during childhood, 
especially during puberty [48, 49], as 
leptin is thought to affect development of 
body weight as well as body composition 
during puberty [50]. In children and 
adults, concentrations of the hormone 
leptin are directly related to the amount of 
adiposity, since leptin is derived from the 
adipocytes [51, 52]. Leptin is thought to 
be a permissive factor for the start of 
puberty, since puberty is suggested to 
start when a critical amount of body 
weight or fat mass is achieved [51-53]. 
Until children reach puberty, body 
composition in boys and girls are similar, 
however, during puberty the percentage 
of fat mass in girls increases when 
compared to boys [50]. During puberty 
and adulthood, a ‘healthy’ body 
composition beholds a body fat 
percentage of 10-15% in boys/men and 
20-25% in girls/women [50]. The 
proposed mechanism behind leptin as a 
permissive factor for the start of puberty, 
beholds that leptin independently of fat 
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mass acts on the hypothalamic luteinizing 
hormone-releasing hormone (LHRH) pulse 
generator, which stimulates the release of 
luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) from the 
pituitary [54-56]. LH and FSH in turn 
stimulate the gonads to release 
testosterone and estradiol that will form a 
negative feedback loop, which will inhibit 
the secretion of LH and FSH [55, 56]. 
Moreover, testosterone alone will form a 
negative feedback loop that will inhibit 
leptin secretion from the adipocytes, and 
estradiol will form a positive feedback 
loop, which stimulates leptin secretion 
from the adipocytes [56-58]. This 
suggests that leptin, gonadotrophic 
hormones, and gonadal hormones are 
temporarily related during puberty and 
this may alter the relationship between 
leptin concentrations and body fat during 
puberty. The role of leptin during puberty 
is an interesting issue, which deserves 
more research. 
 
During adulthood genetic, parental, 
behavioral, physiological i.e. mainly 
endocrine factors are also involved in 
body-weight regulation, however it is 
suggested that the magnitude of 
involvement of the factors is different. 
Body-weight regulation during adulthood 
is for example affected by behavioral and 
endocrine factors, such as stress and 
cortisol concentrations [59].  The 
hypothalamus/pituitary/adrenal (HPA) 
axis is involved in the stress-response and 
secretion of cortisol. The second part of 
this thesis elaborates on the role of the 
neuro-endocrine system of the HPA axis in 
the regulation of body weight in adults.  
 
Hypothalamus/pituitary/adrenal 
(HPA) axis and body-weight 
regulation 
The second part of this thesis elaborates 
on the role of the neuro-endocrine system 
of the HPA axis in body-weight regulation 
in adults. The HPA axis is involved in the 
stress-response through regulating the 
physical and behavioral adaptations to 
stressors [60]. The cascade of the HPA 
axis beholds that the hypothalamus 
produces corticotropin-releasing hormone 
(CRH), which subsequently stimulates the 
production of adrenocortiocotropin (ATCH) 
from the anterior pituitary, which in turn 
will stimulate the synthesis and release of 
cortisol by the adrenal cortex. Cortisol 
exerts its actions through binding to and 
activation of two types of intracellular 
receptors, the low affinity glucocorticoid 
receptor (GR) and the high affinity 
mineralocorticoid receptor. The GR 
induces negative feedback of the HPA axis 
through GRs on the hypothalamus and 
pituitary. The mineralocorticoid receptor is 
supposed to regulate basal activity of the 
HPA axis [60]. Support for the 
involvement of the HPA axis in body-
weight regulation is found in two extremes 
of plasma cortisol levels in humans; 
Addison’s disease (hypocortisolism) that 
has been related to weight loss, and 
Cushing’s syndrome (hypercortisolism) 
that has been related to rapid weight gain, 
particularly of the trunk and face with 
sparing of the limbs [61].  
 
Genetic factors 
Support for the involvement of the HPA 
axis in body-weight regulation is also 
derived from genetic studies. In this thesis 
we focus on the BclI (rs41423247) 
polymorphism of the GR gene, which has 
been related to disturbed body-weight 
regulation and obesity-related 
characteristics [62]. The BclI G/G 
genotype has been related to an increased 
BMI [63, 64], more visceral fat deposition 
[63], insulin resistance [65], increased 
blood pressure and cholesterol levels [66, 
67], and larger weight loss during a very 
low calorie diet [6, 67].  
With respect to HPA axis functioning, the 
BclI polymorphism results in decreased 
GR density, possibly resulting in altered 
cortisol sensitivity [62]. Consequently, the 
BclI G/G genotype is related to variation 
in HPA axis functioning, such as increased 
salivary cortisol concentrations [68, 69] 
and increased cortisol concentrations after 
a dexamethasone suppression test [69-
71]. Remarkably, sex differences were 
shown in the cortisol response to stress, 
as men with the BclI G/G genotype show 
a diminished cortisol response to 
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psychosocial stress [72], while women 
show an increased cortisol response. This 
inconsistency may either be explained by 
different research protocols, or may 
suggest a sex specific association between 
the BclI genotype and HPA axis 
functioning, which has not been 
investigated before. 
 
Endocrine factors 
Additional support for the involvement of 
the HPA axis in body-weight regulation is 
found in humans with visceral fat 
accumulation. Visceral fat accumulation in 
obese subjects is related to altered HPA 
axis functioning, such as decreased 
salivary and serum cortisol levels [73-78], 
increased urinary secretion of cortisol [76, 
79], decreased cortisol variability [73, 74, 
80-82], and enhanced cortisol awakening 
response [83]. In both lean and obese 
subjects, visceral fat distribution has been 
associated with increased cortisol 
secretion after physical and psychological 
stressors [73-76, 79, 84]. However 
studies on the relationship between 
negative feedback of the HPA axis and 
body fat distribution have yielded 
inconclusive results.  Some studies find an 
increased capacity of dexamethasone (a 
GR agonist) to suppress plasma cortisol 
concentrations [74, 85], while some 
studies find no differences in the capacity 
of dexamethasone to suppress plasma 
cortisol concentrations [73, 75, 76, 80], or 
some find even a decreased capacity [86]. 
This inconclusiveness possibly results from 
differences in techniques to test HPA 
feedback functioning. Previously, Petrides 
et al. (1997)[87] developed a technique 
to test HPA axis feedback functioning 
under a physical stressor. Using this 
technique they observed, even in a 
relatively homogenous population of 
young men, a large inter-individual 
variance in HPA axis feedback functioning 
[87]. It however remains unknown 
whether intra-individual variation in HPA 
axis functioning can be related to fat 
distribution in a normal-weight to obese 
population, and whether HPA axis 
feedback functioning tested under a 
physical stressor is related to fat 
distribution. 
Behavioral factors 
Final support for the involvement of the 
HPA axis in body-weight regulation is 
found in the involvement of the HPA axis 
in energy intake. Most of the data directly 
indicating a crucial role of the HPA axis in 
the regulation in food intake are derived 
from animal studies, showing that the 
anorectic effects of adrenalectomy can be 
reversed by corticosterone replacement 
[88, 89]. Human studies support the 
orexigenic effect of cortisol, as cortisol 
administration stimulates food intake 
[90]. The orexigenic effect of cortisol may 
underlie the reported increase of energy 
intake after stress, as psychological stress 
seems to increase the intake frequency, 
increase the amount of food taken in [91-
93], and alter food preference towards 
intake of sweet and fat foods [94]. The 
alterations in energy intake during 
psychological stress have been suggested 
to relate to non-homeostatic regulatory 
mechanisms involved in eating behavior, 
such as reward [95].  Dallman and 
colleagues [96] even introduced the term 
‘comfort foods’ to emphasize the fact that 
the drive behind stress-induced eating is 
not necessarily a homeostatic need for 
calories, translated into feelings of 
hunger. 
Reward is defined by two distinct 
processes namely ‘liking’ and ‘wanting’ 
[97], and involves the neural networks of 
the opioid and dopamineric system [97, 
98]. Disturbance of these neural networks 
is thought to underlie stress-induced 
eating, as HPA axis activation leads to a 
decrease in opioid sensitivity in rats [99], 
and increased dopamine levels in rats 
[100]. Altered levels through 
administration of antagonists of opioid and 
dopamine lead to a reduction of food 
intake and reduced pleasantness of food 
in humans [101, 102]. The involvement of 
non-homeostatic regulatory mechanisms, 
such as reward, in stress-induced eating 
has however never been directly 
demonstrated in humans. Moreover, 
previous studies in humans could not 
exclude a role for hunger [103].  
 
In humans, stress affects eating in a 
bidirectional way; in a subgroup of about 
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30% stress decreases food intake, 
indicating that large inter-individual 
differences are present. These individual 
differences in response to stress may 
relate to eating behavior characteristics 
[92-94, 104], as these are determined 
using the Three Factor Eating 
Questionnaire (TFEQ) [31]. An increase in 
energy intake during stress has been 
found in individuals with high scores on 
dietary restraint and/or disinhibition [92-
94, 104]. Moreover, subjects that have a 
high cortisol response to a laboratory 
stressor have a larger energy intake after 
the stressor when compared to subjects 
with a low cortisol response [92]. These 
data suggest that there may be a link 
between cortisol response and eating 
behavior characteristics. For instance 
weight loss and/or weight maintenance 
are experienced as demanding tests, and 
can therefore be perceived as stressors, 
even in normal weight women [105-107]. 
Several studies have shown increased 
cortisol concentrations (86-88), in normal 
weight women who attempt to cognitively 
control their food intake (high dietary 
restraint score) when compared to those 
who do not (low dietary restraint score). 
When dietary restraint is considered as a 
chronic physiological stressor, it may lead 
to alterations in HPA axis functioning, 
such as a decreased sensitivity of the GR 
to cortisol, which results in decreased 
negative feedback of the HPA axis [59]. It 
remains unknown however, whether 
dietary restraint affects cortisol feedback 
functioning. 
 
Outline of this thesis 
A stable body weight reflects a balance 
between energy intake and energy 
expenditure. This thesis encompasses 
genetic, parental, behavioral, 
physiological i.e. mainly endocrine factors 
involved in body-weight development and 
regulation during childhood, puberty and 
adulthood.  
From a large cohort of Dutch children born 
between 1990 and 1993 valuable 
anthropometrical data from birth till age 
7y are available. To study body-weight 
development during puberty, follow-up 
studies were performed yearly between 
2004 and 2008, when the children had a 
mean age of 12 to 16y. The roles of 
relevant genetic factors, such as the FTO 
gene, in body-weight development are 
described in chapter 2. Subsequently, 
the assessment of the roles of parental, 
behavioral, and physiological i.e. mainly 
endocrine factors in body-weight 
development during puberty are dealt 
with in chapter 3 and 4.  
The amount of adiposity is directly related 
to leptin concentrations, which is thought 
to be a permissive factor for the start of 
puberty, since puberty starts when a 
critical amount of body weight or fat mass 
is achieved. The changing relationship 
between leptin and gonadotropic 
hormones during puberty is described in 
chapter 5.  
During adulthood it is suggested that the 
magnitude of effect of the factors involved 
in body-weight regulation is different. 
Body-weight regulation is for example 
affected by behavioral and endocrine 
factors, such as stress and cortisol 
concentrations. Through the secretion of 
cortisol, the HPA axis plays an important 
role in the regulation of the stress 
response. The present knowledge of the 
role of the HPA axis in the body-weight 
regulation in adults is described in 
chapter 6. Subsequently, the role of 
genetic factors, such as the BclI 
polymorphism, and physiological factors, 
such as body composition, in HPA axis 
functioning are dealt with in chapter 7 
and 8.  
Stress has been related to alterations in 
eating behavior, such as an increase or 
decrease in energy intake. Assessment of 
food intake in the absence of hunger after 
psychological stress exposure is given in 
chapter 9. The intra-individual 
differences in the effect of stress on food 
intake may relate to eating behavior 
characteristics, such as dietary restraint, 
which in turn is related to alterations in 
HPA axis functioning. Weight loss and/or 
weight maintenance can be perceived as a 
stressor, even in normal weight women, 
and therefore dietary restraint may lead 
to alterations in HPA axis functioning as 
dealt with in chapter 10.  
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Finally in chapter 11, the results and 
interpretations of the previous described 
studies are discussed and put into a 
broader perspective. 
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Abstract 
Objective: to replicate earlier findings on the relationship between FTO and obesity 
related characteristics, as well as investigate the effect of FTO on BMI, body composition, 
leptin concentrations, and physical activity longitudinally. 
Subjects and measurements: FTO (rs9939609) was genotyped in 101 children, from 
whom we have collected anthropometric measurements from birth to age 15y, as well as 
body composition, leptin concentrations, and physical activity (Baecke questionnaire) 
yearly from age 12 to 15y.  
Results: children with the A/A and A/T genotype had a higher BMI at age 12, 13, 14, 15y 
(19.5±2.9 vs. 18.3±1.9, 20.2±3.3 vs. 18.6±2.0, 21.0±3.2 vs. 20.0±2.1, 21.9±3.6 vs. 
20.8±2.2 kg/m2, p<0.05), and a larger increase in BMI from age 7-15y (6.3±2.9 vs. 
5.4±1.6 kg/m2, p<0.05), when compared to children with the T/T genotype. Additionally, 
children with the A/A and A/T genotype had a higher fat mass index (FMI) at age 12 and 
13y (4.2±2.1 vs. 3.4±1.5 kg/m2 and 4.3±2.3 vs. 3.4±1.5 kg/m2, p<0.03), a lower 
Baecke score at age 13y (7.8±0.8 vs. 8.2±0.8, p<0.03), higher leptin concentrations at 
age 12 and 13y (8.7±7.3 vs. 5.9±4.5 ng/ml, p<0.02 and 6.8±6.1 vs. 4.5±3.8 ng/ml, 
p<0.05), as well as a larger leptin peak at age 12y, when compared to children with the 
T/T genotype. At age 13y, an association was observed between BMI and leptin 
concentrations (ng/ml), Baecke scores, and the FTO A allele (R2=0.523, p<0.001).  
Conclusion: the FTO A allele (rs9939609) is associated with higher BMI, FMI, leptin 
concentrations, and lower activity scores from childhood to puberty; these associations 
are independent and change in strength over time. 
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Introduction 
The prevalence of obesity is emerging as 
a major health problem [1] and is 
associated with several risk factors, such 
as an increased risk on cardiovascular 
disease and type 2 diabetes [2, 3]. 
Individual susceptibility to obesity is 
determined by interactions between 
genetic, behavioral, and environmental 
factors [4]. To study the interaction 
between genetics and obesity often single 
nucleotide polymorphism (SNP) 
association studies are used [5]. Recent 
SNP association studies identified a 
relationship between the FTO (fat mass 
and obesity associated) gene (rs9939609) 
and the control of energy balance, since 
FTO expression is decreased in the 
hypothalamus in fasted mice, when 
compared to fed mice [6].   
SNP association studies have linked the A 
allele of the FTO gene (rs9939609) to a 
number of obesity related characteristics, 
such as an increased BMI [7-10], 
increased hip circumference [11], 
increased adiposity [5, 7, 8], increased 
leptin levels [12, 13], increased C-reactive 
protein levels [14], elevated dietary fat 
intake [15, 16], increased energy intake 
[17, 18], and reduced satiety 
responsiveness [19]. Additionally, 
Andreasen et al. observed an interaction 
between the FTO genotype and physical 
activity, where physically inactive subjects 
with the AA genotype had a higher BMI 
when compared to T/T genotype [7]. 
Previous studies, however, only assessed 
the effect of FTO polymorphisms in one 
single population at one time point [7, 8, 
14-17, 19], or assessed only BMI 
longitudinally [9, 12, 20, 21]. Gene 
expression however changes 
developmentally [22], and so the 
influence of FTO may change over time. It 
therefore remains unknown whether the 
effect of FTO is stable during life on other 
obesity related characteristics, such as 
body composition, leptin concentrations, 
as well as physical activity, and whether 
FTO influences the obesity related 
characteristics independently. 
Consequently, the objective of our study 
was to replicate earlier findings on the 
relationship between FTO and obesity 
related characteristics, as well as 
investigate the effect of FTO (rs9939609) 
on BMI, body composition, leptin 
concentrations, and physical activity 
longitudinally. Therefore, we determined 
in 101 children anthropometric 
measurements yearly from birth to age 
15y, as well as body composition, leptin 
concentrations, and physical activity 
yearly from age 12 to 15y.  
 
Subjects and methods 
Subjects 
Subjects were recruited from a Dutch 
Caucasian cohort of children born between 
1990 and 1993 [23, 24]. Anthropometric 
data were available from these children, 
no interventions were executed, and 
follow-up studies were performed with 58 
boys and 43 girls. Each child and their 
parents gave written informed consent to 
participate in the study, which was 
approved by the Central Committee 
Human Research and by the Medical 
Ethical Committee of Maastricht 
University.  
 
Study design 
Children’s body weight (BW), height, body 
mass index (BMI), waist circumference, 
body composition [24, 25], leptin 
concentrations, as well as physical activity 
were determined in the afternoon after a 
3-hour fast.  
 
Measurements 
Anthropometry 
The children’s BW was determined using a 
digital balance accurate to 0.1 kg (Sauter 
D7470, Ebingen, Germany) and their 
height was determined using a wall-
mounted stadiometer (Seca, model 220, 
Hamburg, Germany). Measurements were 
executed in underwear, after a 3-hour 
fast, and after voiding the bladder. BMI 
was calculated by BW/height2 (kg/m2) and 
BMI changed substantially with age in 
childhood. To define normal weight, 
overweight and obesity in children, we 
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used the specific cut off points described 
by Cole et al. 2000 [2]. The waist 
circumference was measured at the site of 
the smallest circumference between the 
rib cage and the ileac crest, with the 
subjects in standing position. The pubertal 
stage (development of breast, genitalia, 
and pubic hair) was determined in all 
children, according to the classification by 
Tanner [26]. Anthropometric 
measurements were determined at age 7, 
12, 13, 14 and 15y. 
 
Body composition 
Body composition was measured using the 
deuterium dilution technique (D2O). D2O 
dilution was used to measure total body 
water (TBW). Subjects were asked to 
collect a urine sample in the evening just 
before drinking the deuterium-enriched 
water solution. After ingestion of this 
solution, no further consumption was 
allowed. Ten hours after drinking the 
water solution, another urine sample was 
collected. The dilution of the deuterium 
isotope is a measure of the TBW of the 
subject. Deuterium was measured in the 
urine samples with an isotope ratio mass 
spectrometer (VG-Isogas Aqua Sira, VG 
Isogas, Middlewich, Cheshire, England).  
TBW was obtained by dividing the 
measured deuterium dilution space by 
1.04. Fat free mass (FFM) was calculated 
by dividing TBW by the hydration factor 
0.73 [27-29].  Fat mass (FM) was 
determined as BW-FFM. Fat mass index 
(FMI) was calculated by fat mass/height2 
(kg/m2) and fat free mass index (FFMI) 
was calculated by fat free mass/height2 
(kg/m2). Body composition was measured 
at age 12,13,14 and 15y. 
 
Leptin 
Plasma leptin concentrations were 
measured with a double-antibody, 
sandwich-type enzyme-linked 
immunosorbent assay that used a 
monoclonal antibody specific for human 
leptin. The lower and upper limits of 
detection were 0.5 μg/L and 50 μg/L 
respectively. The intra- and inter assay 
CVs were 9% and 12%, respectively. The 
leptin concentrations of normal-weight 
subject’s range from 2 to 12 μg/L. Plasma 
leptin concentrations were measured at 
age 7, 12, 13, 14 and 15y. 
 
Physical activity  
Physical activity was measured with the 
Baecke questionnaire. The Baecke 
questionnaire consists of three 
components: work activity, sports activity 
and leisure activity, and has been 
validated using doubly labeled water [30]. 
For the children, the work index was 
replaced by a school index with similar 
questions (e.g. ‘When I am at school, I 
walk: never/seldom/sometimes/often/all 
the time?’). The Baecke questionnaire for 
children was validated by Vogels et al. 
2007 [31]. Physical activity was 
determined at age 12, 13, 14 and 15y. 
 
Determination of FTO genotypes 
The genomic DNAs of 101 participants 
were isolated from peripheral blood 
leukocytes using a QIAamp kit (QIAgen, 
Germany). FTO (rs9939609) genotypes 
were determined using Taqman allelic 
discrimination (AB, Applied Biosystems).  
 
Statistical analysis 
Student t-tests (for continuous variables) 
and chi-square tests (for the nominal 
variables) were executed to determine 
differences in single variables between 
groups. Differences over time and 
between conditions were determined 
using two-factor ANOVA with repeated 
measures. Relationships between 
dependent and independent variables 
were determined using simple linear 
regression and multiple regression 
models.  
The genotypic and allelic distributions of 
the FTO polymorphism are provided in 
table 1.  
 
Table 1: FTO genotype frequencies and the frequency 
of the A allele in the study sample (n = 101) 
Poly-morphism Genotype F (n) F (%) Allele F (%) HWEa  
Rs9939609 TT 45 44.6 T 67.8 0.93 
T > A TA 47 45.5 A 32.1  
 AA 9 8.9    
F, Frequency, either absolute (n) or relative (%);          
a P-values obtained from the Chi-square test of Hardy 
Weinberg Equilibrium (HWE) 
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The genotype frequencies were in Hardy 
Weinberg Equilibrium. Because of the 
small study population and since the data 
of the homozygotes for the minor allele 
(A/A) did not differ significantly from the 
heterozygotes (A/T), they were taken 
together in the analysis and compared to 
the homozygotes for the major allele 
(T/T).  
All tests were two-sided and differences 
were considered significant at P<0.05. 
Values are expressed as mean ± standard 
deviation (s.d.).  
 
Results 
Data on height, BW, BMI, waist 
circumference, body composition, leptin 
concentrations, and Baecke scores were 
collected at age 7 to 15y from 58 boys 
and 43 girls. The subject characteristics at 
age 15y are presented in table 2. At age 
15y most children were at Tanner stage 3 
of the pubertal development, and 11% of 
the children were overweight. Overweight 
status measured as BMI and body fat 
percentage, was defined on the basis of 
age- and sex-appropriate international 
standards [2]. With respect to genotypic 
distribution of the FTO polymorphism 
more overweight and obese children had 
the A/A and T/A genotype when compared 
to the T/T genotype at age 12 (14.3 and 
31.4 vs. 4.9%) and 15y (28.6 and 31.3 
vs. 5.1%). 
 
Table 2: Characteristics of the boys (n = 58) and girls 
(n = 43) at the mean age of 15y 
 Boys Girls  P-value 
Body weight (kg)  65.4 ± 10.8 60.5 ± 10.8 0.02 
Height (cm) 176.1 ± 7.2 165.8 ± 6.8 0.01 
Body mass index (kg/m2) 20.9 ± 2.7 21.9 ± 3.5 0.18 
Waist (cm) 73.4 ± 6.1 70.4 ± 7.4 0.01 
Body fat (%) 15.9 ± 6.0  27.5 ± 5.7 0.01 
Leptin (μg/L)  2.2 ± 1.9 9.8 ± 6.5 0.01 
Baecke score 8.3 ± 0.9 8.1 ± 1.0 0.25 
 
BMI  
Figure 1 depicts the development of the 
BMI (kg/m2) of children with the A/A and 
A/T genotype versus the T/T genotype 
over time. BMI was not different between 
birth and age 7, however BMI was 
significantly higher at age 12, 13, 14, and 
15y in children with the A/A and A/T 
genotype, when compared to children with 
the T/T genotype. Over time, a significant 
increase in BMI was seen in all groups 
from age 7 to 15y, and in children with 
the A/A and A/T genotype a stronger 
increase was observed, when compared to 
children with the T/T genotype (6.3±2.9 
vs. 5.4±1.6 kg/m2, p<0.05).  
 
Figure 1: Development of body mass index (kg/m2) in 
children with the A/A and A/T genotype (n = 56) versus 
the T/T genotype (n = 45). Values are means. 
 
# P < 0.05 overall group x time interaction between A/A 
and A/T genotype vs. T/T genoype (2- factor ANOVA 
repeated measures) 
* P < 0.05 for differences in children with the A/A and 
A/T genotype vs. T/T genoype (2- factor ANOVA 
repeated measures) 
 
Figure 2: Development of fat mass index (FMI)(kg/m2) 
in children with the A/A and A/T genotype (n = 56) 
versus the T/T genotype (n = 45). Values are means.  
 
* P < 0.05 for differences in children with the A/A and 
A/T genotype vs. T/T genoype (2- factor ANOVA 
repeated measures) 
 
Fat Mass Index (FMI) 
Fat mass index (FMI) was calculated by 
fat mass/height2 (kg/m2). Figure 2 
depicts the development of the FMI 
(kg/m2) of children with the A/A and A/T 
genotype versus the T/T genotype over 
time. FMI was significantly higher at age 
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12 and 13y in children with the A/A and 
A/T genotype, when compared to children 
with the T/T genotype. Over time no 
significant changes in FMI were present. 
Surprisingly, no differences over time 
were found in FFMI (kg/m2) between the 
A/A and A/T genotype versus the T/T 
genotype.  
 
Leptin concentrations  
Figure 3 depicts the development of the 
leptin concentrations (ng/ml) of children 
with the A/A and A/T genotype versus the 
T/T genotype over time. Leptin 
concentrations were significantly higher at 
age 12 and 13y in children with the A/A 
and A/T genotype, when compared to 
children with the T/T genotype. A 
significant group x time effect was found 
in leptin concentration measurements 
(p<0.03, two-factor ANOVA repeated 
measures). A significant higher peak value 
was observed in children with the A/A and 
A/T genotype, when compared to children 
with the T/T genotype, as a stronger 
increase between 7 and 12y (5.7±8.3 vs. 
1.0±5.3 ng/ml, p<0.01) and a stronger 
decrease between 12 and 14y (-2.2±3.2 
vs. -1.2±5.3 ng/ml, p<0.10) was 
observed in children with the A/A and A/T 
genotype. 
 
Figure 3: Development of leptin concentrations (ng/ml) 
in children with the A/A and A/T genotype(n = 56) 
versus the T/T genotype (n = 45). Values are means.  
 
# P < 0.05 overall group x time interaction between A/A 
and A/T genotype vs. T/T genoype (2- factor ANOVA 
repeated measures) 
* P < 0.05 for differences in children with the A/A and 
A/T genotype vs. T/T genoype (2- factor ANOVA 
repeated measures) 
 
 
 
Activity scores 
Figure 4 depicts the development of the 
Baecke scores of children with the A/A 
and A/T genotype versus the T/T 
genotype over time. Baecke scores were 
significantly higher at age 13y in children 
with the T/T genotype, when compared to 
children with the A/A and A/T genotype. 
When adjusted for BMI, the association 
between FTO and Baecke scores 
remained. Over time Baecke scores in 
children with the T/T genotype were 
significantly higher, when compared to 
children with the A/A and A/T genotype 
(p<0.05). No alterations over time in 
Baecke scores were observed in both 
groups. 
 
Figure 4: Development of Baecke scores in children 
with the A/A and A/T genotype (n = 56) versus the T/T 
genotype (n = 45). Values are means.  
 
# P < 0.05 overall group x time interaction between A/A 
and A/T genotype vs. T/T genoype (2- factor ANOVA 
repeated measures) 
* P < 0.05 for differences in children with the A/A and 
A/T genotype vs. T/T genoype (2- factor ANOVA 
repeated measures) 
 
Table 3A depicts linear regression 
analyses with FTO allele genotypes 
(A=1/T=0) at a certain age as the 
dependent variable and BMI (kg/m2) at 
that age as the independent variable. The 
association between FTO allele genotype 
and BMI were not significant until age 12y 
and became weaker again from age 13y.  
Per year, multiple regression analyses 
were performed with BMI (kg/m2) as the 
dependent variable and leptin 
concentrations (ng/ml), Baecke scores, 
and FTO allele as the independent 
variables. Multiple regression analyses 
with BMI (kg/m2) at a certain age as the 
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dependent variable showed that only the 
leptin concentrations contributed 
significantly to the model at age 12y (R2 = 
0.45, p<0.01), at age 14y (R2 = 0.17, 
p<0.05), and at age 15y (R2 = 0.44, 
p<0.01). 
Only at age 13y a significant association 
was observed between all 3 independent 
variables, and therefore table 3B depicts 
the multiple regression analysis with BMI 
(kg/m2) at age 13y as the dependent 
variable and leptin concentrations 
(ng/ml), Baecke scores, and FTO allele 
genotypes at age 13y as the independent 
variables (R2 = 0.523, p<0.001).  
 
Table 3A: linear regression analysis with FTO allele 
genotypes (A=1/T=0) at a certain age as the dependent 
variable and BMI (kg/m2) at that age as the independent 
variable 
Age (year) Correlation coefficient (r) R2 P-value 
0 0.09 0.008 0.38 
1 0.10 0.01 0.34 
2 0.02 0.001 0.81 
3 0.10 0.01 0.37 
4 0.04 0.002 0.71 
7 0.08 0.007 0.42 
12 0.24 0.058 0.02 
13 0.28 0.078 0.001 
14 0.17 0.029 0.09 
15 0.17 0.030 0.09 
 
Table 3B: multiple regression with BMI (kg/m2) at age 
13y as the dependent variable and leptin concentrations 
(ng/ml), Baecke scores, and FTO allele genotypes at age 
13y as the independent variables 
 Partial β Std. Error P value 
Intercept 10.32 2.5 0.001 
Leptin concentrations  
(ng/ml) 
0.36 0.047 0.001 
Baecke scores 0.82 0.30 0.007 
FTO allele genotype  
(A=1/T=0) 
1.30 0.52 0.01 
R2 = 0.523, p < 0.001 
 
Discussion 
The objective of our study was to replicate 
earlier findings on the relationship 
between FTO and obesity related 
characteristics, as well as investigate the 
effect of FTO (rs9939609) on BMI, body 
composition, leptin concentrations, and 
physical activity longitudinally. We 
observed that children with the A/A and 
A/T genotype had a higher BMI at age 12 
to 15y, and a larger increase in BMI from 
age 7-15y, when compared to children 
with the T/T genotype. Children with the 
A/A and A/T genotype also had a higher 
FMI at age 12 and 13y, lower Baecke 
score at age 13y, higher leptin 
concentrations at age 12y, as well as a 
larger leptin peak at age 12y when 
compared to children with the T/T 
genotype. Additionally, the association 
between the FTO gene and BMI increased 
with age, and only at age 13y BMI was 
associated with leptin concentrations, 
Baecke scores and the FTO A allele.   
 
The strengths of our study is the fact that 
we have longitudinal data from a cohort of 
solely Caucasian children, thereby 
eliminating population stratification, as 
well as determination of body fat 
percentage using a high-quality method, 
such as the deuterium dilution technique 
[29]. Although the sample seems rather 
small, the genotype frequency distribution 
of our cohort was consistent with the 
frequency distributions in other Caucasian 
populations [7, 17], and because the 
minor allele frequency is over 30%, 
sufficient power will be present to study 
differences in physiological parameters. 
This reassured us that the use of the FTO 
genotype in this smaller cohort was a 
valid approach.  In concordance with 
previous studies [9, 10, 20, 21], we 
observed a significant association between 
FTO and BMI during childhood, and no 
association at birth. Furthermore, we 
observed a higher BMI from 7y onwards in 
subjects with the A/A and A/T genotype, 
which is supported by two other 
longitudinal studies [20, 21], but is in 
contrast to the longitudinal study by Jess 
et al. 2008 [9]. Differences may be 
explained by time of measurement, while 
we measured the children yearly, Jess et 
al. 2008 [9] only measured the children at 
birth, 7, 10, and 13y, thereby they 
possibly did not observe changes in BMI 
during puberty. We however observed 
that the association between the FTO 
gene and BMI increased with age, and 
became significant at age 12y, which has 
been reported by Haworth et al [20]. 
Overall, these results imply that the FTO A 
allele is associated with a higher BMI 
during early childhood, and that the 
association becomes stronger during 
puberty [20].   
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To determine if the FTO polymorphism 
was associated with differences in 
development of body composition and 
physical activity, we measured body 
composition and Baecke scores from age 
12 to 15y. Children with the A/A and A/T 
genotype had a significantly higher FMI at 
age 12 and 13y, as well as lower Baecke 
scores over time, when compared to 
children with the T/T genotype. These 
results confirm several cross-sectional 
studies on FTO and body composition [5, 
7, 8]. Previous studies observed 
inconsistent results on the relationship 
between FTO genotypes and physical 
activity; Andreasen et al [7] in 
concordance to our results observed an 
association, while others have observed 
no associations [21, 32]. Differences 
between the studies may be explained 
different study populations and different 
measurement techniques.  
Additionally, we measured leptin 
concentrations from age 7 to 15y and 
observed that children with the A/A and 
A/T genotype showed higher leptin 
concentrations at age 12y, which confirms 
several cross-sectional studies [12, 13]. 
Furthermore, we observed that children 
with the A/A and A/T genotype had a 
larger leptin peak at age 12y. The leptin 
peak has been observed to be the onset of 
sexual maturation [33, 34], and a larger 
leptin peak may result in increased 
gonadal hormones concentrations that in 
turn alter the relationship between leptin 
concentrations and body fat [35]. 
Together, these results suggest that the 
associations between the FTO A allele and 
decreased physical activity, increased FMI 
along with increased leptin concentrations 
are stable during puberty. 
 
Multiple linear regression analysis showed 
that at age 13y a larger BMI was 
associated to the FTO A allele, larger 
leptin concentrations, and decreased 
physical activity. These results implicate 
that at age 13y genetic, physiological and 
psychological factors are independent 
predictors for BMI. At age 12, 14, and 15y 
BMI was only associated to leptin 
concentrations, which implicates that 
during puberty BMI is only temporarily 
predicted by FTO. This has previously 
been suggested by Haworth et al. [20], 
which implicates that during puberty BMI 
is predominately predicted by 
physiological factors. The strong point of 
the present study is the fact that we found 
associations that change in strength over 
time, between FTO and a number of 
obesity related characteristics in this 
relatively small cohort. Our study can 
however not elucidate causality 
concerning the development of the obesity 
related characteristics. We conclude that 
the FTO A allele (rs9939609) is associated 
with higher BMI, FMI, leptin 
concentrations, and lower activity scores 
from childhood to puberty; these 
associations are independent and change 
in strength over time. 
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Abstract 
Background: the development of body weight is determined by different factors, namely 
genetic, behavioral, parental and physiological.  
Objective: to investigate whether genetic, behavioral, parental and physiological factors 
are involved and the extent of involvement in the development of body weight at age 12 
and 13y in a Dutch children cohort.  
Methods: In a Dutch cohort of 94 children at age 12 and 13y, we determined 
anthropometric measurements, body composition, leptin concentrations, TFEQ scores, 
physical activity, as well as 3 polymorphisms, and determined anthropometric 
measurements and TFEQ scores in the parents.   
Results: 11% of the children in the cohort were classified as overweight. The genotype 
frequency distributions of the PPARy2, BCLI and CNTF genes) at age 12 and 13y were not 
significantly different for the overweight children compared to the lean children. 
Overweight children showed higher dietary restraint and disinhibition scores. Overweight 
children’s parents had a higher BMI, dietary restraint and disinhibition scores, compared 
to lean children’s parents. A peak in leptin concentrations between 7 to 13y was shown at 
12y. In lean boys, the decrease in leptin concentrations between 12 and 13y was related 
to an increase in fat free mass. At the age of 12y predominantly the physiological factors 
were predictors for body weight, and at the age of 13y both the physiological and 
behavioral factors were predictors for body weight.  
Conclusion: we conclude from this longitudinal study, that leptin appeared to play an 
important role in the development of body weight during puberty, in addition to behavioral 
and parental factors. 
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Introduction 
The prevalence of childhood overweight is 
emerging as a major health problem [1] 
and is associated with several risk factors, 
such as the increased risk on overweight 
during adulthood [2, 3]. The development 
of body weight is determined by different 
factors, namely genetic, behavioral, 
parental and physiological factors [3-6].  
Several genetic factors have been linked 
to the development of body weight, three 
of them being the polymorphisms of the 
peroxisome proliferators-activated 
receptor (PPAR), the glucocorticoid 
receptor (GR) and the neurocytokine 
ciliary neurotrophic factor (CNTF). PPARy 
is a nuclear fatty acid receptor that is 
involved in adipocyte differentiation and 
represents a direct link between adiposity, 
food response and control of appetite in 
adults [7-9]. In children a link was found 
between the PPARy2 polymorphism 
Pro12Ala and obesity, as Cecil et al. found 
that the Proala12 mutation is related to 
deficiency in energy storage and 
utilization, leading to reduced growth 
[10]. The GR has an important role in the 
metabolism of adipose tissue and in the 
regulation of abdominal fat distribution. 
Mutations in the GR gene may result in 
perturbation of the glucocorticoid 
receptor, leading to diminished sensitivity 
to cortisol, which could lead to stress-
induced obesity. Adults with the GR 
polymorphism IVS2-BclI have been 
associated with increased BMI, waist-to-
hip circumference and leptin 
concentrations [11, 12]. In children the 
BclI polymorphism has been related to a 
larger increase in adiposity during puberty 
[13]. CNTF is a neurocytokine that works 
via the signaling pathway normally 
activated by leptin. The null mutation G > 
A leads to an inactive CNTF protein, 
resulting in diminished initiation of 
anorectic pathways, which leads to an 
increase in body mass. In adults with the 
G > A null mutation, a higher BMI and a 
smaller decrease in leptin concentrations 
during weight loss, have been found [8, 
14]. In children, no associations between 
the CNTF G > A null mutation and obesity 
have been found yet.  
 
Several behavioral factors such as eating 
behavior and physical activity have been 
related to the development of body 
weight. Eating behavior can be analyzed 
using the Three Factor Eating 
Questionnaire (TFEQ) and assesses 3 
factors involved in eating behavior: 
dietary restraint, disinhibition and feeling 
of hunger. Dietary restraint refers to 
conscious restriction of food intake to 
achieve or maintain a preferred 
bodyweight. Disinhibition reflects 
individual differences in the extent to 
which release from the cognitive 
suppression of eating occurs in response 
to the presence of palatable food or other 
disinhibiting stimuli, such as emotional 
distress [15, 16]. Before, we have shown 
that dietary restraint only occurred in the 
11-12 y old overweight children, thus it 
appeared to be an effect rather than a 
cause of overweight [6]. Additionally, 
physical activity can be analyzed using the 
BAECKE questionnaire, as several studies 
have shown that increased physical 
activity levels are protection against 
overweight development [17, 18]. 
 
Furthermore, several parental factors 
have been related to the development of 
body weight, like the fact that children 
with obese parents are more likely to 
become obese themselves [19]. It is likely 
that the family association is due to 
genetic factors and partly to shared 
lifestyles (i.e. diets and patterns of 
activity). Early experiences with food, 
feeding practices and family food choices 
affect children’s nutritional habits. 
Additionally, parents’ restrained eating 
behavior may affect children’s body-
weight development as dietary restraint of 
mothers, and their perception about their 
daughters’ risk of overweight, predicted 
maternal child feeding practices. This in 
turn predicted the daughters’ eating and 
relative weight [20].  
 
In addition several physiological, 
especially endocrine factors have been 
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related to the development of body 
weight. The start of puberty around the 
age is of 12y is a period of pronounced 
changes in the endocrine milieu. For the 
start of puberty, the achievement of a 
critical body weight or fat mass is thought 
to play a prominent role. In children and 
adults, leptin concentrations are directly 
related to the amount of adiposity, 
consequently the hormone leptin has been 
proposed as a physiological link between 
adiposity status and the start of sexual 
maturation [21, 22]. However, most 
studies investigating this physiological link 
were done in transversal cohorts, and not 
yet in a longitudinal cohort.  
 
Overall, the objective of our study was to 
investigate whether genetic, behavioral, 
parental and physiological factors are 
involved and the extent of involvement in 
the development of body weight at age 12 
and 13y in a Dutch children cohort. 
Therefore, we determined in a Dutch 
cohort of 94 children at age 12 and 13y 
anthropometric measurements, body 
composition, leptin concentrations, TFEQ 
scores, physical activity, as well as 3 
polymorphisms, and determined 
anthropometric measurements and TFEQ 
scores in the parents. We hypothesized 
that at the age of 12 and 13y body weight 
may be influenced by predominantly 
physiological factors, in addition to the 
genetic, behavioral, and parental factors 
that we previously described before in 
Vogels et al. 2006 [6]. 
 
Subjects and methods 
Subjects  
Subjects were recruited from a Dutch 
Caucasian cohort of children born between 
1990 and 1993 [6, 23]. As infants, these 
children and their mothers participated in 
i) a study of essential fatty acids during 
pregnancy and pregnancy outcome [23], 
and ii) a study, performed between 1997 
and 2000, about the long-term effects of 
fetal essential fatty acid availability [24]. 
Anthropometric data were available from 
these children and no interventions were 
provided. To evaluate the development of 
obesity and related parameters, follow-up 
studies were performed in 2004 and 2005 
with 94 children [6]. Each child and one of 
his or her parents gave written informed 
consent to participate in the study, which 
was approved by the CCMO (Central 
Committee Human Research) and by the 
MEC (Medical Ethical Committee) of the 
University Maastricht.  
 
Study design  
Children’s body weight (BW), height, body 
mass index (BMI), waist circumference, 
body composition, leptin concentrations, 
Three Factor Eating Questionnaire (TFEQ) 
scores and physical activity were 
determined in 2004 [6] and 2005, when 
the mean age was 12.4 and 13.4 years 
(range 11-15 years), respectively. 
Moreover, the polymorphisms of three 
relevant genes (PPARy2, BclI and CTNF) 
were determined [23, 24]. BW, height, 
BMI and TFEQ scores of both parents were 
determined in 2005. 
 
Measurements 
Anthropometry 
At the mean age of 12 and 13 year, the 
children’s BW was measured using a 
digital balance accurate to 0.1 kg (Sauter 
D7470, Ebingen, Germany) and height 
was measured using a wall-mounted 
stadiometer (Seca, model 220, Hamburg, 
Germany). Measurements were executed 
in underwear, after an overnight fast and 
after voiding the bladder. BMI was 
calculated by BW/height2 (kg/ m2) and 
BMI in childhood changes substantially 
with age. To define normal, overweight 
and obesity in children, we used the 
specific cut of points described by Cole et 
al. 2000 [2]. The waist circumference was 
measured at the site of the smallest 
circumference between the rib cage and 
the ileac crest, with the subjects in 
standing position. The pubertal stage 
(development of breast, genitalia, and 
pubic hair) was documented in all 
children, according to the classification by 
Tanner.  
 
Body composition 
Body composition was measured using the 
deuterium dilution technique (D2O). D2O 
dilution was used to measure total body 
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water (TBW). Subjects were asked to 
collect a urine sample in the evening just 
before drinking the deuterium-enriched 
water solution. After ingestion of this 
solution, no further consumption was 
allowed. Ten hours after drinking the 
water solution, another urine sample was 
collected. The dilution of the deuterium 
isotope is a measure of the TBW of the 
subject. Deuterium was measured in the 
urine samples with an isotope ratio mass 
spectrometer (VG-Isogas Aqua Sira, VG 
Isogas, Middlewich, Cheshire, England).  
TBW was obtained by dividing the 
measured deuterium dilution space by 
1.04. Fat free mass (FFM) was calculated 
by dividing TBW by the hydration factor 
0.73 [25-27].  Fat mass (FM) was 
determined as BW-FFM. 
 
Leptin 
Serum leptin concentrations were 
measured with a double-antibody, 
sandwich-type enzyme-linked 
immunosorbent assay that used a 
monoclonal antibody specific for human 
leptin. The lower limit of detection is 0.5 
μg/L and the upper limit is 50 μg/L. The 
intra- and inter assay CVs were 9% and 
12%, respectively. The leptin 
concentrations of normal-weight subjects 
range from 2 to 12 μg/L. Serum leptin 
concentrations were also measured at age 
7, 12 and 13y. 
 
Attitude towards eating 
Eating behavior was analyzed using a 
validated Dutch translation of the TFEQ 
[15], which was translated at some 
questions into an easier, understandable 
Dutch language for children. The TFEQ 
consists of 3 factors measuring a person’s 
attitude towards eating. Dietary restraint 
reflects the extent to which individuals 
attempt to cognitively control their food 
intake [15]. Inhibition of restraint reflects 
individual differences in the extent to 
which release from the cognitive 
suppression of eating occurs in response 
to the presence of palatable food or other 
disinhibiting stimuli, such as emotional 
distress [15]. The third factor refers to the 
subjective feeling of hunger [15].  
 
Physical activity 
Physical activity was estimated with the 
Baecke Questionnaire. This questionnaire 
consists of three components: work 
activity, sports activity and leisure activity 
[28] and has been validated using doubly 
labelled water [18, 29]. For the children 
the work index was replaced by a school 
index with exactly the same questions. 
 
Determination of the genotypes 
The genomic DNAs of the 94 subjects 
were isolated from peripheral blood 
leukocytes using a QIAamp kit (Qiagen, 
Hilden, Germany). Followed by genotyping 
of the PPARγ2, BCLI and CNTF 
polymorphisms, which has been 
previously described by Vogels 2006 et al 
[6].   
 
Parental characteristics 
Both the parents reported actual BW 
measured at home according to our 
standard instructions (as previously 
described). Height was copied from their 
passports, originally measured using a 
wall-mounted stadiometer. BMI was 
calculated by BW/height2 (kg/m2). In 
addition, attitude towards eating was 
measured with the TFEQ. 
 
Statistical analysis 
Student t-tests and ANOVA-tests (for the 
continuous variables), and chi-square 
tests (for the nominal variables) were 
executed to determine differences in 
single variables between groups (i.e. lean 
vs. overweight) and between 
polymorphisms. The ANOVA tests were 
followed by Scheffe’s test or a Fishers 
PLSD test. All tests were two-sided and 
differences were considered significant at 
P<0.05. Relationships between dependent 
and independent variables were tested 
using simple linear regression and 
multiple linear regression models. Values 
are expressed as mean ± standard 
deviation (s.d.).  
 
Results 
In our cohort 11% of the children were 
overweight, which was determined using 
two measures, BMI and body fat 
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percentage. BMI strongly related to body 
fat percentage (R2 = 0.60, p < 0.001), 
and also leptin concentrations were 
related to body fat percentage (R2 = 
0.825, p < 0.001), which has been shown 
previously [6, 30].  
The characteristics of the boys (n = 55) 
and girls (n = 39), divided by overweight 
status at age 12 and 13y are presented in 
table 1. At age 12 and 13y overweight 
boys and girls showed significantly higher 
BW, BMI, waist circumference, body fat 
percentage, fat mass and leptin levels 
when compared to lean children. At age 
12 and 13y no significant differences were 
shown in height. At age 12y no significant 
difference was shown in fat free mass, 
however, at age 13y overweight boys 
showed a significant higher fat free mass 
compared to lean girls.  
 
With respect to the genetic parameters 
i.e. analysis of the PPARy2, BclI and CNTF 
genotypes of the subjects, the overall 
genotype frequencies were in Hardy-
Weinberg equilibrium. The genotype 
frequency distributions of the PPARy2, 
BclI and CNTF genes (table 2) at age 12 
and 13y were not significantly different for 
the overweight children compared to the 
lean children.  
 
The behavioral characteristics (TFEQ and 
Baecke scores) of the boys and girls, 
divided by overweight status at age 12 
and 13y are presented in table 3. At age 
12y no differences were found in restraint 
score between the four groups, however, 
at age 13 lean boys showed significant 
lower restraint scores in comparison to 
other three groups. At age 12 and 13y the 
disinhibition scores were significantly 
higher in overweight boys compared to 
the other three groups. Overall, no 
differences between groups were found 
for feeling of hunger scores and Baecke 
scores. 
 
The characteristics of the parents of the 
lean and overweight children are 
presented in table 4. The fathers of 
overweight children have a higher BW, 
BMI and restraint score compared to the 
fathers of lean children. The mothers of 
the overweight children have a higher 
disinhibition score compared to the 
mothers of lean children.  
A simple linear regression was used to 
test the association between BMI and 
restraint or disinhibition scores of the 
children, fathers or mothers. A significant 
correlation was found between the 
restraint score and the BMI of the children 
(R2 = 0.131, p < 0.0001). Also, significant 
associations were found in the fathers and 
mothers between the disinhibition score 
and their BMI (R2 = 0.252, p < 0.001)( R2 
= 0.168, p < 0.001). No correlations were 
found between the TFEQ scores of the 
parents and the BMI of the children. 
 
Table 1: characteristics of the boys (n = 55) and girls (n = 39), divided by overweight status1 at age 12 and 13y  
12 year Total (n =94) Lean girls (n = 33)  Overweight girls (n = 6) Lean boys (n = 51) Overweight boys (n = 4) P-value2  
BW (kg) 3 48.4±10.3 47.3±8.2ab 61.4±11.2ac 46.6±10.1cd 60.7±6.4bd 0.01 
Height (cm) 159.2±10.2 158.7±9.7  160.7±10.3  159.2±10.6  161.6±12.5  0.94 
BMI (kg/m2) 3 18.9±2.6 18.6±1.8 a 23.7±2.7 a b 18.3±2.2 b 23.3±2.1 b 0.01 
Waist (cm) 66.4±6.2 64.4±5.1ab 73.5±5.0 ac 65.5±5.7cd 74.8±3.6bd 0.01 
Body fat (%) 19.6±7.6 21.7±5.2ab 29.7±6.1 ac 16.6±6.6cd 29.1±10.5bd 0.01 
  Fat mass (kg) 9.69±4.9 10.5±3.4ab 18.1±5.3ab 7.8±3.9a 17.4±5.8b 0.01 
  Fat free mass (kg) 38.4±7.7 37.4±6.3 43.1±8.1 38.5±8.0  43.3±9.4  0.26 
13 Year      0.26 
BW (kg) 3 53.1±10.6 50.9±8.3ab 66.1±9.8 ac 51.8±10cd 69.0±8.7 ab 0.01 
Height (cm) 164.9±10.1 163.1±8.6 163.7±8.4 165.8±10.9 168.9±14.4 0.54 
BMI (kg/m2) 3 19.5±2.9 19.0±1.9 a 26.2±2.8 a b 18.7±2.1 b 24.1±0.9 b 0.01 
Waist (cm) 68.0±6.2 65.6±5ab 76.2±5.8 ac 67.6±5.2cd 80.7±2.9bd 0.01 
Body fat (%) 19.8±7.5 21.8±4.4ab 31.3±6.9 ac 15.9±5.9cd 27.9±10bd  0.01 
  Fat mass (kg) 10.6±5.2 11.4±3.7ab 20.6±6.6 ac 8.3±3.5cd 18.6±5.3bd 0.01 
  Fat free mass (kg) 42.1±8.6 40±4.9 a 44.4±6.9 43.8±8.6 50.4±13.5 a   0.05 
1 Overweight as defined by age and sex specific cut off points described by Cole et al.  
2 Differences between lean vs. overweight boys and girls using ANOVA 
3 BW, body weight; BMI, body mass index 
a p < 0.05 (2-factor ANOVA with group x group interaction);  b p < 0.05 (2-factor ANOVA with group x group interaction) 
c p < 0.05 (2-factor ANOVA with group x group interaction); d p < 0.05 (2-factor ANOVA with group x group interaction) 
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Table 2: genotype frequency distributions of the PPARy2, GRL and CNTF genes in lean and overweight1 children at age 
12 and 13y 
12 and 13 year Total (n =92) Lean (n=84) Overweight (n=10) P-value2  
PPARy2 3 (PP/PA/AA) 75/24/1 % 77/22/1 % 60/40/0 % 0.43 
GRL 3 (CC/CG/GG) 49/36/15 % 47/37/16 % 10/30/60 % 0.74 
CNTF 3 (GG/GA/AA) 78/19/2 % 79/18/ 2% 70/30/0 % 0.96 
1 Overweight as defined by age and sex specific cut off points described by Cole et al.  
2 Differences between lean vs. overweight children using chi-square test  
3 PPARγ2, peroxisome proliferator-activated receptor γ2; GRL, glucocorticoid receptor; CNTF, ciliary neurotrophic factor 
 
Table 3: behavioral characteristics of the boys and girls, divided overweight status1 at age 12 and 13y 
12 year Total  
(n =94) 
Lean girls  
(n = 33) 
Overweight girls 
(n = 6) 
Lean boys  
(n = 51) 
Overweight boys  
(n=4)  
P-value2  
Factor 1 (TFEQ) 3 5.1±3.5 4.8±3.5 7.2±3.1 4.9±3.2 7.5±5.9 0.22 
Factor 2 (TFEQ) 3 2.7±1.3 2.6±1.4 a 3.3±1.5 2.6±1.1 b 4.3±0.9ab 0.04 
Factor 3 (TFEQ) 3 3.0±2.4 2.7±2.5  3.0±3.3 5.3±3.8 5.3±3.8  0.23 
Physical activity (Baecke) 8.2±1.0 8.3±0.8 7.6±1.1 8.3±0.9 8.2±2.2 0.38 
13 Year       
Factor 1 (TFEQ) 3 5.7±3.2 6.7±3.1 a 8.3±4.1b 4.7±2.6bcd 9.5±4.2c 0.01 
Factor 2 (TFEQ) 3 2.4±1.4 2.5±1.5 a 2.7±1.3 b 2.2±1.0 c 5.0±2.7abc 0.01 
Factor 3 (TFEQ) 3 3.1±2.3 2.8±2.1 2.5±0.8 3.5±2.2 4.5±5.8 0.35 
Physical activity (Baecke) 7.9±0.8 8.1±0.9 7.9±0.5 7.9±0.8 8.1±0.9 0.96 
1 Overweight as defined by age and sex specific cut off points described by Cole et al.  
2 Differences between lean vs. overweight children using ANOVA  
3 TFEQ, three-factor eating questionnaire; Factor 1, dietary restraint eating behavior; Factor 2, inhibition of restraint;  
Factor 3, general feelings of hunger 
a p < 0.05 (2-factor ANOVA with group x group interaction); b p < 0.05 (2-factor ANOVA with group x group interaction) 
c p < 0.05 (2-factor ANOVA with group x group interaction); d p < 0.05 (2-factor ANOVA with group x group interaction) 
 
Table 4: Parental characteristics of lean and overweight children 
 All children 
Father                  Mother 
Lean children 
Father                  Mother 
Overweight children 
Father                  Mother 
BW (kg) 2 84.9±15.8 69.3±13.8 83.7±13.5 69.2±14.2 94.5±27.71 69.9±10.7 
Height (cm) 179.9±6.8 166.9±5.9  180.0±6.9 166.9±5.9 179.9±6.3 167.3±5.9 
BMI (kg/m2) 2 26.1±4.4 24.4±3.9 25.7±3.6 24.4±4.0 29.1±8.31 25.0±3.7 
Factor 1 (TFEQ) 2 4.8±3.2 7.3±3.7  4.6±3.1 7.4±3.8 5.8±3.71 6.4±2.9 
Factor 2 (TFEQ) 2 2.7±1.5 3.4±2.2  2.8±1.6 3.4±2.1 2.3±0.8 3.5±2.81 
Factor 3 (TFEQ) 2 2.5±2.4 2.6±2.2 2.6±2.5 2.6±2.0 2.3±1.8 2.4±3.5 
1 Significant differences in characteristic between the father/mother of overweight children, compared to the 
father/mother of lean children (p < 0.05) 
2 BW, body weight; BMI, body mass index; TFEQ, three-factor eating questionnaire; Factor 1, dietary restraint eating 
behavior; Factor 2, inhibition of restraint; Factor 3, general feelings of hunger 
 
Table 5: Multiple linear regression analyses with body weight (kg) as the dependent variable at age 12 and 13y (n =94) 
12 year Partial β Std. Error P-value 
(Constant) 39.534 6.376 0.0001 
Leptin concentrations (μl/L) 0.450 0.170 0.0098 
Factor 1 child (TFEQ) 1 0.282 0.325 0.3883 
Factor 2 child (TFEQ) 1 1.142 0.800 0.1574 
BMI father (kg/m2) 1 -0.036 0.239 0.8790 
Factor 2 mother (TFEQ) 1 0.692 0.460 0.1363 
13 Year    
(Constant) 43.559 6.687 0.0001 
Leptin concentrations (μl/L) 0.514 0.226 0.0253 
Factor 1 child (TFEQ) 1 -0.132 0.381 0.7305 
Factor 2 child (TFEQ) 1 1.811 0.767 0.0206 
BMI father (kg/m2) 1 0.027 0.249 0.9147 
Factor 2 mother (TFEQ) 1 0.748 0.472 0.1165 
1 TFEQ, three-factor eating questionnaire; Factor 1, dietary restraint eating behavior; Factor 2, inhibition of restraint; 
BMI, body mass index. Model 12 year, R2 = 0.187; Model 13 year, R2 = 0.181 
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The mean leptin concentrations (μl/L) of 
the boys and girls, divided by overweight 
status at age 7, 12 and 13y are presented 
in figure 1.  
 
Figure 1: Mean of plasma leptin concentrations of the 
boys (n =55) and girls (n = 39), divided by overweight 
stage at age 7, 12 and13y.  
 
* overall group x group interaction at age 12, was 
significant (p<0.05) 
** overall group x group interaction at age 13, was 
significant (p<0.05) 
 
At age 7 no significant differences in leptin 
levels were shown between the four 
groups. At age 12 and 13y leptin levels 
were significantly different between all 
four groups (p < 0.001), except between 
the overweight boys and girls at age 13. 
The increase in leptin concentrations 
between 7 to 12y was significant in lean 
girls (4.3±3.9 μl/L), overweight girls 
(19.2± 8.6 μl/L), overweight boys (10.9± 
6.2 μl/L)(p < 0.001), except in the lean 
boys (0.5±6.4 μl/L). The decrease in 
leptin concentrations from 12 to 13y was 
significant in the lean boys (-2.1±3.3 
μl/L)(p <0.01), but not in lean girls (-
0.6±2.9 μl/L), overweight girls (-6.3±6.1 
μl/L) and overweight boys (-1.8±3.6 
μl/L). The differences between the 
increase from 7 to 12y and the decrease 
from 12 to 13y were significant (p < 0.01) 
in all four groups, suggesting a peak value 
of leptin at 12y in boys and girls.  
A simple linear regression was used to 
test the association between the leptin 
concentrations (μl/L) and fat mass (kg) at 
age 12 and 13y for lean overweight boys 
and girls. Leptin was associated to fat 
mass at age 12 and 13y in lean boys (R2 
= 0.36, p < 0.01 and R2 = 0.35, p < 
0.01) and in lean girls (R2 = 0.31, p < 
0.01 and R2 = 0.35, p < 0.01). No 
associations were found in overweight 
boys and girls. 
The multiple linear regression analyses at 
age 12 and 13y with body weight (kg) as 
the dependent variable and the 
behavioral, parental and physiological 
factors that were related to body weight 
(leptin concentrations, dietary restraint 
score of the child, disinhibition score of 
the child, BMI of the father and 
disinhibition score of the mother) as the 
independent variables are presented in 
table 5. From the model at age 12y, we 
concluded that the five variables together 
predicted 18,7% of the variance in body 
weight at age 12y, however only the 
leptin concentrations (p < 0.009) at age 
12y contributed significantly to the model. 
From the model at age 13y, we concluded 
that the five variables together predicted 
18,1% of the variance in body weight at 
age 13y, however only the leptin 
concentrations (p < 0.03) and 
disinhibition score (p < 0.02) at age 13y 
contributed significantly to the model. 
 
Discussion 
The objective of our study was to 
investigate whether genetic, behavioral, 
parental and physiological factors are 
involved and the extent of involvement in 
the development of body weight at age 12 
and 13y in a Dutch children cohort. We 
showed that in our cohort, 11% of the 
children were overweight. In 2006, the 
overall prevalence of childhood obesity in 
the Netherlands was 14.3%, which is the 
still the lowest in Europe. Like in adults 
[8], overweight in the children coincided 
with higher BW, waist circumference, 
BF%, fat mass and leptin levels.  
 
With respect to the genetic influences on 
the development of body weight, previous 
studies showed in adults an association 
between body weight and the genetic 
polymorphisms PPARγ2, BCLI and CNTF 
[7, 9, 10], however the genotype 
frequency distributions of the genes at 
age 12 and 13y were not significantly 
different for the overweight children 
compared to the lean children. Possible 
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reasons why we did not observe such 
associations could be the rather small 
sample size of the cohort, the small 
percentage of overweight in this cohort, or 
age-dependent expression of genotype.  
 
With respect to the behavioral factors 
involved in the development of body 
weight, previous studies showed that 
adults with high levels of both restraint 
and disinhibition are often overweight, 
since they are ‘unsuccessfully dietary 
restraint’, which beholds that their high 
restraint scores do not help them to 
control their weight [31]. In our cohort 
overweight boys and girls showed higher 
dietary restraint and disinhibition scores, 
which suggest they are also 
‘unsuccessfully dietary restraint’. 
Consequently, since overweight leads to 
dietary restraint, subsequent disinhibition 
of restraint leads to overeating, which 
leads to storing of excessive energy and 
thereby results in a vicious circle in which 
the children are caught that will lead to 
further increases in body weight. Lean 
girls showed an increase in dietary 
restraint scores between 12 and 13y, but 
since they have a normal weight, this 
might indicate that they are ‘successfully 
dietary restraint, which beholds that their 
high restraint scores help them to control 
their weight [6, 31]. No differences were 
found however, between lean and 
overweight boys and girls in physical 
activity measured by the Baecke 
questionnaire. We have shown previously 
in a study by Vogels 2007 et al. that this 
was caused by overestimation of activity 
by overweight children [18], when daily 
physical activity measured by tri-axial 
accelerometers was compared to 
estimation of physical activity measured 
by the Baecke questionnaire. 
 
With respect to the parental influences on 
the development of body weight, previous 
studies showed that children of 
overweight parents are more likely to be 
overweight themselves [6, 19]. In the 
current study the fathers of overweight 
children showed higher body weight, BMI 
and dietary restraint score; having an 
overweight and restraint father in the 
current cohort of children is therefore an 
important predictor for children to become 
overweight. In accordance to previous 
findings [6, 32] the mothers of overweight 
children showed a higher disinhibition 
score. The overall high restraint scores of 
the mothers and the association between 
the mother’s dietary restraint score and 
the BMI of the child may be a possible 
explanation for the fact that we found no 
association between BMI of the mother 
and the weight status of the child [6]. In 
general, one could state that the eating 
behavior of the parents may serve as a 
source of information for children what 
cues should trigger eating and how much 
to eat [32]. 
 
With respect to the physiological 
influences on the development of body 
weight, literature showed these are more 
pronounced during puberty. The hormone 
leptin is thought to be involved in the 
start of the changes in the endocrine 
milieu during puberty. Several transversal 
studies showed [22, 33-37] a rise in leptin 
levels progressively from 5 to 15y in girls, 
whereas in boys, levels increased between 
5 and 10y and declined thereafter. In the 
current longitudinal study we described 
the leptin levels at age 7, 12 and 13y, and 
showed an increase in leptin levels 
between 7 and 12y and a decrease, 
although only significant for the lean boys 
between 12 and 13y. Further analysis 
suggested a peak value of leptin at 12y in 
all children, which has been suggested to 
be a physiological trigger to the start of 
the increase in LH and FSH production; 
the first recognizable hormonal changes of 
puberty [38].  
 
In the current longitudinal study we also 
showed that the positive association 
between leptin concentrations and fat 
mass did not change in the lean boys 
between age 12 and 13y, but became 
stronger in the lean girls. No significant 
relationship between leptin concentrations 
and fat mass at age 12 and 13y was found 
in the overweight boys and girls, because 
the small percentage of overweight 
children in this cohort. Several 
explanations have been suggested for the 
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divergent correlations between leptin 
concentrations and fat mass in lean boys 
and girls during pubertal development. 
One explanation is the difference in body 
fat distribution, since in adipocytes taken 
from subcutaneous abdominal fat produce 
greater leptin concentrations compared to 
adipocytes taken from visceral fat. 
Therefore, increased serum concentrations 
of leptin in pubertal girls may be due to 
greater amounts of subcutaneous fat [39]. 
A second explanation is the rise in 
androgens levels in boys at the start of 
puberty. In vitro, when androgens are 
added to a culture medium of adipocytes, 
the leptin secretions are reduced by 62%, 
which suggests that in androgens 
suppresses leptin concentrations in boys 
during puberty [34]. A third explanation is 
that in boys the ratio of fat free mass/fat 
mass changes and becomes higher during 
puberty, when compared to girls [40], 
which is also shown in our cohort.  
 
With respect to the genetic, parental, 
behavioral and physiological factors only 
the last three factors seemed to have an 
effect on the development of body weight 
at age 12 and 13y. To determine whether 
these factors were predictors for body 
weight, we performed multiple linear 
regression analyses at age 12 and 13y 
with body weight as the dependent 
variable and the behavioral, parental and 
physiological factors that were related to 
body weight (leptin concentrations, 
dietary restraint score of the child, 
disinhibition score of the child, BMI of the 
father and disinhibition score of the 
mother) as the independent variables. 
From the model at age 12y, we concluded 
that only the leptin concentrations at age 
12y contributed significantly to the model 
and from the model at age 13y, that only 
the leptin concentrations and disinhibition 
scores of the child at age 13y contributed 
significantly to the model. These results 
imply that at the age of 12y 
predominantly the physiological factors 
were predictors for body weight, and at 
the age of 13y both the physiological and 
behavioral factors were predictors for 
body weight.  
 
The strengths of the present study is that 
we found associations between several 
factors and childhood overweight in this 
relativity small cohort and the accurate 
measurement method to determine body 
composition. We conclude from this 
longitudinal study, that leptin appeared to 
play an important role in the development 
of body weight during puberty, in addition 
to behavioral and parental factors. 
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Abstract 
Background: Short sleep duration is associated with obesity during childhood and 
adulthood. 
Objective: the objective of our study was to investigate the relationship between sleep 
duration and body mass index (BMI) from Tanner stage 1 to 5 in a Dutch children cohort. 
Design: we determined in 96 children, sleep duration, anthropometric measurements, 
body composition, physical activity (Baecke questionnaire), and leptin concentrations, 
from age 7 to 16y.  
Results: at Tanner stage 1, 2, 3, 4 and 5 sex differences were observed in height, body 
weight, waist circumference, fat mass per squared meter (FMI), and leptin concentrations 
per kg fat mass. From Tanner stage 1 to 5 an increase was observed in both boys and 
girls in height (0.25±0.15 and 0.25±0.15 m), body weight (24±12.5 and 26.4±12.5 kg), 
BMI (3.5±2.7 and 4.9±3.1 kg/m2), waist circumference (7.6±11.5 and 11.6±7.7 cm), as 
well as an increase over time in FMI (1.8±2.3 kg/m2) in girls. A decrease was observed in 
boys and girls in hours sleep per night (-1.2±0.4 and -1.4±0.5 h) and leptin 
concentrations per kg fat mass (-0.33±0.15 and -0.17±0.2 ng/ml/kg). Inverse 
relationships were observed between the change in BMI (kg/m2) and the change in hours 
of sleep per night (h) from Tanner stage 1 to 4 (r = 0.68, p<0.001), from Tanner stage 2 
to 5 (r = 0.35, p<0.05), and from Tanner stage 1 to 5 (r = 0.33, p<0.05).  
Conclusion: Development of BMI during puberty is inversely related to change in sleep 
duration. 
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Introduction 
The prevalence of childhood obesity is 
emerging as a major health problem (1). 
The increase in childhood obesity has 
developed over the same time period as 
the progressive decrease in self-reported 
sleep duration (2, 3). Several cross-
sectional studies reported on a negative 
relationship between sleep duration and 
body mass index (BMI) during childhood 
(4-9), while some even reported a 
curvilinear relationship between sleep 
duration and BMI (10, 11). Additionally, 
short sleep duration in children was linked 
to insulin resistance, a larger body fat 
percentage, a larger waist circumference, 
decreased physical activity and increased 
television watching (12-16).  
Sleep duration during childhood is 
however subjected to developmental 
changes, in particular during puberty 
when a significant decrease in sleep 
duration has been observed (17, 18). Until 
now only 4 studies have been described 
that study sleep duration and BMI 
development longitudinally (1, 19-21), 
which measured either only children from 
age 3 to 9y (1, 20, 21), or measured a 
group of 3 to 12 year old children twice 
with a 5-year interval not taking pubertal 
stage into account (19). Pubertal stage 
may however alter the relationship 
between sleep duration and BMI as well as 
other determinants of overweight in 
children, such as body composition, and 
waist circumference (22). This however 
has not been investigated until now.  
Consequently, the objective of our 
longitudinal study was to investigate the 
relationship between sleep duration and 
BMI from Tanner stage 1 to 5. 
Therefore, we determined in a Dutch 
cohort of 96 children, sleep duration, 
anthropometric measurements, body 
composition, Baecke questionnaire, and 
leptin concentrations, from age 7 to 16y.  
 
Subjects and methods 
Subjects  
Subjects were recruited from a Dutch 
Caucasian cohort of children born between 
1990 and 1993 (23, 24). As infants, these 
children and their mothers participated in 
i) a study of essential fatty acids during 
pregnancy and pregnancy outcome (23), 
and ii) a study, performed between 1997 
and 2000, about the long-term effects of 
fetal essential fatty acid availability (25). 
Anthropometric data were available from 
these children, no interventions were 
executed, and follow-up studies were 
performed with 96 children (24). 
Exclusion criteria for follow-up 
measurements were chronic illness and 
depression. Each child and their parents 
gave written informed consent to 
participate in the study, which was 
approved by the CCMO (Central 
Committee Human Research) and by the 
MEC (Medical Ethical Committee) of the 
Maastricht University.  
 
Study design  
Every year the follow-up measurements 
were performed in the months November 
and December to exclude seasonal 
effects. At 4 p.m. after a 3-hour fast 
children’s body weight (BW), height, body 
mass index (BMI), waist circumference, 
body composition (24, 26), leptin 
concentrations, physical activity, as well 
as sleep duration were determined at ages 
7 to 16y.  
 
Measurements 
Anthropometry 
The children’s BW was determined using a 
digital balance accurate to 0.1 kg (Sauter 
D7470, Ebingen, Germany) and height 
was determined using a wall-mounted 
stadiometer (Seca, model 220, Hamburg, 
Germany). Measurements were executed 
in underwear, after an overnight fast and 
after voiding the bladder. BMI was 
calculated by BW/height2 (kg/m2) and BMI 
in childhood changes substantially with 
age. To define normal, overweight and 
obesity in children, we used the specific 
cut off points described by Cole et al. 
2000 (27). The waist circumference was 
measured at the site of the smallest 
circumference between the rib cage and 
the ileac crest, with the subjects in 
standing position. The pubertal stage was 
documented in all children according to 
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the classification by Tanner (28). The 
Tanner stage is defined based on physical 
measurements of external primary and 
secondary sex characteristics, namely 
development of breast and pubic hair in 
girls or development of genitalia and pubic 
hair in boys (28). Boys with Tanner stage 
1 had LH and FSH levels of 1.7±1.4 and 
2.9±2.3 IU/l and boys with Tanner stage 
5 had LH and FSH levels of 5.7±2.8 and 
3.3±1.7 IU/l. Girls with Tanner stage 1 
had LH and FSH levels of 3.0±2.9 and 
3.8±2.1 IU/l and girls with Tanner stage 5 
had LH and FSH levels of 4.4±4.6 and 
5.0±4.4 IU/l. Tanner stage definition was 
thus supported by plasma LH and FSH 
measurements. Anthropometric 
measurements were determined at age 7, 
12, 13, 14, 15 and 16y. 
 
Body composition 
Body composition was measured using the 
deuterium dilution technique (D2O). D2O 
dilution was used to measure total body 
water (TBW). Subjects were asked to 
collect a urine sample in the evening just 
before drinking the deuterium-enriched 
water solution. After ingestion of this 
solution, no further consumption was 
allowed. In the morning the first urine 
sample was discarded, the whole second 
urine sample (about ten hours after 
drinking the water solution) was collected. 
The dilution of the deuterium isotope is a 
measure of the TBW of the subject. 
Deuterium was measured in the urine 
samples with an isotope ratio mass 
spectrometer (VG-Isogas Aqua Sira, VG 
Isogas, Middlewich, Cheshire, England).  
TBW was obtained by dividing the 
measured deuterium dilution space by 
1.04. Fat free mass (FFM) was calculated 
by dividing TBW by the hydration factor 
0.73 as defined by Fomon et al. 1982 
(29).  Fat mass (FM) was determined as 
BW-FFM. Fat mass index (FMI) was 
calculated by fat mass/height2 (kg/m2) 
and fat free mass index (FFMI) was 
calculated by fat free mass/height2 
(kg/m2) (30-32). Body composition was 
measured at age 12, 13, 14, 15 and 16y. 
 
Leptin 
Plasma leptin concentrations were 
measured with a double-antibody, 
sandwich-type enzyme-linked 
immunosorbent assay that used a 
monoclonal antibody specific for human 
leptin. The lower limit of detection is 0.5 
μg/L and the upper limit is 50 μg/L. The 
intra- and inter assay CVs were 9% and 
12%, respectively. The leptin 
concentrations of normal-weight subject’s 
range from 2 to 12 μg/L. Plasma leptin 
concentrations were measured at age 7, 
12, 13, 14, 15 and 16y. 
 
Physical activity  
Physical activity was measured with the 
Baecke questionnaire. Responses to 19 
questions were scored on a five-point 
scale and resulted in three scores: work 
activity score, sports activity score and 
leisure activity score, and has been 
validated using doubly labeled water (33). 
For the children, the work index was 
replaced by a school index with similar 
questions (e.g. ‘When I am at school, I 
walk: never/seldom/sometimes/often/all 
the time?’). The Baecke questionnaire for 
children was validated by Vogels et al. 
2007 (34). Physical activity was 
determined at age 12, 13, 14, 15 and 
16y. 
 
Sleep duration 
Sleep duration was measured using the 
question: ‘how many hours do you usually 
sleep per night?’ which would represent 
their habitual sleep duration (7, 9, 21, 
35). Sleep duration was determined at 
age 12, 13, 14, 15, and 15y. 
 
Statistical analysis 
Differences between boys and girls per 
Tanner stage were determined using 
unpaired t-tests. As hours of sleep per 
night were measured at age 12 to 16y, 
and not all children were at Tanner stage 
1 at age 12y or Tanner stage 5 at age 
16y, three groups appeared, namely from 
one with data from Tanner stage 1 to 4 
(17m/7f), one with data from Tanner 
stage 2 to 5 (23m/19f), and one with data 
from Tanner stage 1 to 5 (14m/18f). 
Relationships between the changes in BMI 
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and changes in sleep duration during the 
progressive Tanner stages were assessed 
using simple linear regression models. 
Relationships between the changes in BMI 
and changes in waist circumference and 
FMI during the progressive Tanner stages 
were assessed using simple linear 
regression models. Statistical analyses 
were performed with Statview SE 
GraphicsTM for Macintosh. All tests were 
two-sided and differences were considered 
significant at P<0.05. Values are 
expressed as mean ± standard deviation 
(s.d.).  
 
Results 
Data from 57 boys and 39 girls on height, 
body weight, BMI, waist circumference, 
fat mass per squared meter (FMI), leptin 
concentrations per kg fat mass, Baecke 
sport score, and hours sleep per night 
were collected from age 7 to 16y. The 
characteristics of the boys and girls from 
Tanner stage 1 to 5 are represented in 
table 1. At Tanner stage 1, 2, 3, 4 and 5 
sex differences were observed in height, 
body weight, waist circumference, fat 
mass per squared meter (FMI), and leptin 
concentrations per kg fat mass. No 
differences were found in BMI, Baecke 
sport score, and hours sleep per night 
between boys and girls. From Tanner 
stage 1 to 5 an increase was observed in 
both boys and girls in respectively height 
(0.25±0.15 and 0.25±0.15 m), body 
weight (24±12.5 and 26.4±12.5 kg), BMI 
(3.5±2.7 and 4.9±3.1 kg/m2), waist 
circumference (7.6±11.5 and 11.6±7.7 
cm), as well as an increase over time in 
FMI (1.8±2.3 kg/m2) in girls. A decrease 
was observed in boys and girls in hours 
sleep per night (-1.2±0.4 and -1.4±0.5 h) 
and leptin concentrations per kg fat mass 
(-0.33±0.15 and -0.17±0.2 ng/ml/kg). No 
alterations over time were observed in 
FMI and Baecke sport scores in boys, 
while in girls no alterations were observed 
in Baecke sport score. 
 
As hours of sleep per night were 
measured at age 12 to 16y, and not all 
children were at Tanner stage 1 at age 
12y or Tanner stage 5 at age 16y, three 
groups appeared, namely from one with 
data from Tanner stage 1 to 4 (17m/7f), 
one with data from Tanner stage 2 to 5 
(23m/19f), and one with data from 
Tanner stage 1 to 5 (14m/18f). In all 
three groups we tested whether changes 
in BMI over time were related to changes 
in hours of sleep per night over time. 
Inverse relationships were observed 
between the change in BMI (kg/m2) and 
the change in hours of sleep per night (h) 
from Tanner stage 1 to 4 (r = 0.68, 
p<0.001), from Tanner stage 2 to 5 (r = 
0.35, p<0.05), and from Tanner stage 1 
to 5 (r = 0.33, p<0.05).  
 
In all three groups positive relationships 
were found between the change in BMI 
over time and the change in waist 
circumference over time (r = 0.79, 
p<0.0001; r = 0.85, p<0.0001; r = 0.81, 
p<0.0001), and the change in FMI over 
time (r = 0.71, p<0.001; r = 0.62, 
p<0.001; r = 0.85, p<0.0001). 
 
Table 1: Characteristics of the boys and girls at Tanner stage 1 to 5 
 Tanner stage 1 Tanner stage 2 Tanner stage 3 Tanner stage 4 Tanner stage 5 
 Boys  Girls Boys  Girls Boys  Girls Boys  Girls Boys  Girls 
Number  57 39 53 40 52 40 51 41 35 36 
Height (m) 1.51±0.2 1.43±0.2# 1.66±0.1 1.61±0.1# 1.72±0.1 1.64±0.1# 1.74±0.1 1.67±0.1# 1.76±0.1 1.68±0.1# 
Body weight (kg) 42.9±13 37.2±14# 54.6±11 51.5±10# 60.7±9 55.6±10# 65.3±11 60.2±10# 66.9±12 63.6±11# 
BMI (kg/m2) 18.0±2.5 17.4±2.9 19.5±2.5 19.7±2.9 20.4±2.5 20.5±3.0 21.3±2.4 21.3±2.8 21.5±2.8 22.3±3.3 
Waist circumference 
(cm) 
66.7±17 60.6±7.5# 69.7±5.8 66.4±5.9# 71.7±5.5 68.1±6.5# 74.0±6.9 70.4±5.9# 74.3±6.1 72.2±7.8# 
Fat mass Index 
(kg/m2) 
3.3±1.9 4.7±1.8# 3.6±1.9 4.6±1.9# 3.2±1.6 5.2±2.1# 3.7±1.9 5.6±1.9# 3.7±1.6 6.5±2.8# 
Leptin/fat mass 
(ng/ml/kg) 
0.50±0.2 0.73±0.2# 0.51±0.4 0.73±0.3# 0.38±0.4 0.55±0.3# 0.26±0.3 0.39±0.2# 0.17±0.1 0.56±0.2# 
Baecke sport score 2.7±1.2 2.6±1.6 2.7±0.9 2.9±1.1 3.1±0.6 2.9±1.1 3.1±0.6 2.8±0.6 3.1±0.7 2.8±0.7 
Hours sleep per night 
(h) 
8.9±0.2 8.9±0.3 8.6±0.6 8.7±0.6 8.3±0.7 8.3±0.8 7.8±0.9 7.8±0.8 7.7±0.7 7.5±0.8 
#Differences between boys and girls per Tanner stage (unpaired t-test) (p<0.05) 
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Discussion 
The objective of our longitudinal study 
was to investigate the relationship 
between sleep duration and BMI from 
Tanner stage 1 to 5. We observed sex 
differences from Tanner stage 1 onwards 
in height, body weight, waist 
circumference, body composition, and 
leptin concentrations per kg fat mass. This 
was in concordance with previous 
literature on developmental changes in 
anthropometry and leptin concentrations 
normalized to fat mass during puberty 
(36, 37). 
 
In concordance with previous longitudinal 
studies on sleep duration (17-19), a 
significant decrease in sleep duration 
during puberty was observed in our 
cohort. Previous studies however have not 
corrected for pubertal stage, and we 
observed that the decrease in sleep 
duration is related to increasing Tanner 
stage. These results illustrate the 
importance for longitudinal and 
transversal studies on sleep duration to 
correct for pubertal stage and not for age.    
 
Previous longitudinal studies on sleep 
duration and BMI in children have 
observed a consistent negative linear 
association between baseline habitual 
sleep duration and later obesity (1, 19-
21). None of the longitudinal studies in 
children have however investigated 
whether changes in sleep duration are 
associated with changes in BMI. Our study 
is therefore the first to show that with 
progressive Tanner stages BMI increases 
and sleep duration decreases in an 
interrelated way. The increase in BMI from 
Tanner stage 1 to 5 is furthermore related 
to the increase in waist circumference and 
FMI, which suggest that the decrease in 
sleep duration leads to an increase in 
obesity related characteristics.  
 
From the observed correlations between 
development of BMI and changes in sleep 
duration cause and effect cannot be 
completely disentangled. Nevertheless, a 
larger increase in BMI following a larger 
reduction in sleep duration seems to be 
plausible based upon the longitudinal 
study from Snell et al. 2002 (19) that 
showed a relationship between sleep 
duration measured at the first time point 
and BMI measured after a 5-year interval, 
and not vice versa. On the other hand if 
sleep duration were to be reduced 
following an increase in BMI, a plausible 
theory would be sleep apnea. Sleep apnea 
however is only present in 1-3% of the 
children in a normal population and 
strongly related to obesity (38), and is 
therefore an unlikely explanation in our 
cohort as only 11% of the children were 
overweight and with no known cases of 
sleep apnea.   
We therefore suggest that based upon our 
data, that reduction of sleep duration may 
contribute to development of overweight 
during puberty. Taken together, we 
conclude that development of BMI during 
puberty is inversely related to change in 
sleep duration.  
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Abstract 
Objective: to investigate the relationship between leptin concentrations, gonadotropic 
hormone concentrations, and body composition during puberty in a Dutch children cohort. 
Design: In a cohort of 98 children, we determined anthropometric measurements, body 
composition, and concentrations of leptin, FSH, and LH.   
Results: sex differences were observed from Tanner stage 1 onwards in weight, body fat 
percentage, and leptin/fat mass ratio. In boys and girls the relationship between leptin 
concentrations and fat mass was weaker at Tanner stage 2 (R2=0.33 and R2=0.39, 
p<0.001), 3 (R2=0.27 and R2=0.36, p<0.002), and 4 (R2=0.21 and R2=0.28, p<0.03) 
than at Tanner stage 1 (R2=0.51 and R2=0.67, p<0.001) and 5 (R2=0.46 and R2=0.78, p< 
0.01). In girls, a peak in leptin concentrations  (8.5±6.0 ng/ml) preceded a peak in LH 
and FSH concentrations (15.1±3.5 and 5.0±4.5 IU/l). A lead/lag relationship was 
observed of leptin at Tanner stage 1 to LH and FSH at Tanner stage 2 (R2=0.12, p<0.05 
and R2=0.18, p<0.05). In boys, there was no peak in leptin, LH, and FSH and additionally, 
leptin at Tanner stage 3 was related FSH at Tanner stage 4 (R2=0.17, p<0.04). 
Conclusion: in boys and girls during puberty factors independent of fat mass become 
(transiently) more important in the regulation of plasma leptin concentrations. Moreover, 
in girls leptin is suggested to act as a permissive factor for the onset of puberty, while in 
boys leptin has a different timing and possibly different function.  
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Introduction 
The achievement of a critical body weight 
or fat mass is thought to play a prominent 
role in the start of sexual maturation [1, 
2], since underfeeding and malnutrition in 
humans, as seen in anorexia, is related to 
a delay in the onset puberty [1-3].  Leptin 
has been proposed as a physiological link 
between adiposity status and the start of 
sexual maturation [1-5]. Several cross-
sectional studies and three small 
longitudinal studies support this theory 
since they have found that leptin 
concentrations rose prepubertally, but 
then decreased at the initiation of 
puberty, as gonadal hormone 
concentrations began to increase [1, 4, 6-
11]. 
The proposed mechanism behind leptin as 
a trigger to puberty, beholds that leptin 
independently of fat mass acts on the 
hypothalamic luteinizing hormone-
releasing hormone (LHRH) pulse 
generator [12-14]. Consequently, LHRH 
stimulates the release of luteinizing 
hormone (LH) and follicle-stimulating 
hormone (FSH) from the pituitary, which 
in turn stimulate the gonads to release 
testosterone and estradiol [12-14]. 
Testosterone and estradiol inhibit the 
secretion of LHRH and respectively LH and 
FSH, which thereby form a negative 
feedback loop [13, 14]. Moreover, 
testosterone inhibits leptin secretion from 
the adipocytes, which forms a second 
negative feedback loop [14-16]. A positive 
feedback loop is formed by estradiol, 
which stimulates leptin secretion from the 
adipocytes [14, 16]. This proposed 
mechanism suggests that increased 
gonadotrophic and gonadal hormones 
concentrations may alter the relationship 
between leptin concentrations and body 
fat during puberty. 
Most studies, however, that investigated 
the role of leptin as a trigger to puberty, 
did not determine body composition [6], 
or were done in transversal cohorts [1, 6, 
8, 9] and relatively small longitudinal 
cohorts [4, 10, 11]. Consequently, 
previous studies have been unable to test 
the hypothesis that leptin and 
gonadotropic hormones are temporarily 
related during puberty, and whether 
consequently the relationship between 
leptin and body composition is temporarily 
altered. Therefore, the objective of our 
longitudinal study was to investigate the 
relationship between leptin 
concentrations, gonadotropic hormone 
concentrations, and body composition 
during puberty in a Dutch children cohort. 
Therefore, we determined in 98 children 
anthropometric measurements, body 
composition, and concentrations of leptin, 
FSH, LH, testosterone and estradiol.  
 
Subjects and methods 
Subjects  
Subjects were recruited from a Dutch 
Caucasian cohort of children born between 
1990 and 1993 [17, 18]. As infants, these 
children and their mothers participated in 
i) a study of essential fatty acids during 
pregnancy and pregnancy outcome [17], 
and ii) a study, performed between 1997 
and 2000, about the long-term effects of 
fetal essential fatty acid availability [19]. 
Anthropometric data were available from 
these children and no interventions were 
implemented. To evaluate the 
development of obesity and related 
parameters, follow-up studies were 
performed with 98 children, and the 
dropout rate was 0% [18]. Each child and 
one of his or her parents gave written 
informed consent to participate in the 
study, which was approved by the Central 
Committee Human Research and by the 
Medical Ethical Committee of the 
Maastricht University. 
 
Study design  
At 4 p.m. after a 3-hour fast children’s 
age, body weight (BW), height, body 
mass index (BMI), body composition [7, 
18], leptin concentrations, follicle-
stimulating hormone (FSH) 
concentrations, luteinizing hormone (LH) 
concentrations, testosterone 
concentrations and estradiol 
concentrations were determined. 
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Measurements 
Anthropometry 
The children’s BW was determined using a 
digital balance accurate to 0.1 kg (Sauter 
D7470, Ebingen, Germany) and height 
was determined using a wall-mounted 
stadiometer (Seca, model 220, Hamburg, 
Germany). Measurements were executed 
in underwear and after voiding the 
bladder. BMI in childhood changes 
substantially with age and was calculated 
by BW/height2 (kg/m2). Therefore to 
define normal, overweight and obesity in 
children, we used the specific cut off 
points described by Cole et al. 2000 [20]. 
For example, at age 12y a BMI of 21.22 
and 21.68 kg/m2 in boys and girls is 
defined as overweight, and a BMI of 26.02 
and 26.67 kg/m2 as obese. The pubertal 
stage was documented in all children 
according to the classification by Tanner 
[21]. The Tanner stage is defined based 
on physical measurements of external 
primary and secondary sex 
characteristics, namely development of 
breast and pubic hair in girls or 
development of genitalia and pubic hair in 
boys [21]. At age 15y, boys in Tanner 
stage 3 had testosterone levels of 8.3 ± 
5.1 ng/l and boys with Tanner stage 5 had 
testosterone levels of 16.5 ± 5.4 ng/l. At 
age 15, girls in Tanner stage 3 had 
estradiol levels of 14.8 ± 15.8 ng/l and 
girls with Tanner stage 5 had estradiol 
levels of 32.7 ± 32.4 ng/l. Tanner stage 
definition was thus supported by plasma 
testosterone and estradiol measurements 
(ng/l) at age 15. Anthropometric 
measurements were determined at ages 
7, 12, 13, 14 and 15y. 
 
Body composition 
Body composition was measured using the 
deuterium dilution technique (D2O). D2O 
dilution was used to measure total body 
water (TBW). Subjects were asked to 
collect a urine sample in the evening just 
before drinking the deuterium-enriched 
water solution. After ingestion of this 
solution, no further consumption was 
allowed. Ten hours after drinking the 
water solution, another urine sample was 
collected. The dilution of the deuterium 
isotope is a measure of the TBW of the 
subject. Deuterium was measured in the 
urine samples with an isotope ratio mass 
spectrometer (VG-Isogas Aqua Sira, VG 
Isogas, Middlewich, Cheshire, England).  
TBW was obtained by dividing the 
measured deuterium dilution space by 
1.04. Fat free mass (FFM) was calculated 
by dividing TBW by the hydration factor 
0.73 [22-24].  Fat mass (FM) was 
determined as BW-FFM. Body composition 
was measured at ages 12,13,14 and 15y. 
 
Leptin 
At 4 p.m. after a 3-hour fast blood was 
drawn for determination of leptin 
concentrations. Plasma leptin 
concentrations were measured with a 
double-antibody, sandwich-type enzyme-
linked immunosorbent assay that used a 
monoclonal antibody specific for human 
leptin. The lower limit of detection is 0.5 
μg/L and the upper limit is 50 μg/L. The 
intra- and inter assay CVs were 9% and 
12%, respectively. The leptin 
concentrations of normal-weight subjects’ 
range from 2 to 12 μg/L. Plasma leptin 
concentrations (ng/ml) were measured at 
ages 7, 12, 13, 14 and 15y. 
 
Follicle-stimulating hormone (FSH) 
At 4 p.m. after a 3-hour fast blood was 
drawn for determination of FSH 
concentrations. Plasma FSH 
concentrations were measured with a 
double-antibody, sandwich-type enzyme-
linked immunosorbent assay that used a 
monoclonal antibody specific for human 
FSH. The lower limit of detection is 0.100 
IU /L and the upper limit is 200.0 IU/L. 
The intra- and inter assay CVs were 1.8% 
and 5.1%, respectively. The FSH 
concentrations range from 1.5 to 12.4 IU 
/L in boys and from 1.7 to 21.5 IU /L in 
girls. Plasma FSH concentrations (IU /L) 
were measured at ages 12, 13, 14 and 
15y. 
 
Luteinizing hormone (LH) 
At 4 p.m. after a 3-hour fast blood was 
drawn for determination of LH 
concentrations. Plasma LH concentrations 
were measured with a double-antibody, 
sandwich-type enzyme-linked 
immunosorbent assay that used a 
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monoclonal antibody specific for human 
LH. The lower limit of detection is 0.100 
IU /L and the upper limit is 200 IU /L. The 
intra- and inter assay CVs were 0.8% and 
2.0%, respectively. The LH concentrations 
range from 1.7 to 8.6 IU /L in boys and 
from 1.0 to 95.6 IU /L in girls. Plasma LH 
concentrations (IU /L) were measured at 
ages 12, 13, 14 and 15y. 
 
Statistical analysis 
Differences between two groups were 
determined using unpaired t-tests. 
Differences over time and between 
conditions were determined using two-
factor ANOVA with repeated measures. 
Relationships between dependent and 
independent variables were determined 
using simple linear regression models. To 
investigate a time-dependent relationship 
in the sequence of the hormonal changes 
during puberty, we used the lead/lag 
technique, which correlates hormones 
secreted in one stage, with those secreted 
in the next stage [11].  All tests were two-
sided and differences were considered 
significant at P<0.05. Values are 
expressed as mean ± standard deviation 
(s.d.).  
 
Results 
At Tanner stage 1 we collected data from 
95 (57 m/38f) children, at Tanner stage 2 
from 95 children (54 m/41f), at Tanner 
stage 3 from 95 children (55 m/40f), at 
Tanner stage 4 from 63 children 
(35m/28f), as well as from 33 children 
(14m/19f) at Tanner stage 5.  11% of the 
children were classified as overweight 
using specific cut off points described by 
Cole et al. 2000 [20]. In our cohort 
annual height velocity in boys and girls 
was 5.7 ± 1.3 and 5.7 ± 1.2 cm/y at 
Tanner stage 1; 6.5 ± 1.8 and 5.7 ± 1.2 
cm/y at Tanner stage 2; 6.9 ± 2.6 and 
5.7 ± 2.4 cm/y at Tanner stage 3; 6.1 ± 
3.0 and 3.1 ± 2.3 cm/y at Tanner stage 
4; and 3.7 ± 3.1 and 1.5 ± 1.4 cm/y 
Tanner stage 5. Figure 1 shows sex 
differences  (boys vs. girls) in weight at 
Tanner stage 1, 3, 4, and 5 (43.1 ± 12.5 
vs. 36.9 ± 14.2 kg, p< 0.02; 61.5 ± 10.5 
vs. 56.2 ± 9.7 kg, p< 0.01; 66.1 ± 9.5 
vs. 59.9 ± 9.7 kg, p< 0.01; 68.5 ± 9.2 
vs. 60.7 ± 8.8 kg, p< 0.02). Differences 
were absent at Tanner stage 2, caused by 
a larger increase in weight in girls when 
compared to boys between Tanner stage 1 
to 2 (15.6 ± 12.4 vs. 12.4 ± 10.4 kg, p< 
0.18), and a significant larger increase in 
weight in boys when compared to girls 
between Tanner stage 2 to 3 (6.6 ± 3.2 
vs. 3.9 ± 2.2 kg, p< 0.001). Additionally, 
sex differences in body fat percentage 
were shown at all Tanner stages (16.9 ± 
7.2 vs. 23.8 ± 8.1%, p< 0.05; 18.1 ± 7.9 
vs. 22.9 ± 5.9%, p< 0.002; 16.6 ± 6.7 
vs. 24.9 ± 6.3%, p< 0.001; 17.1 ± 6.9 
vs. 25.9 ± 5.7%, p< 0.001; 16.7 ± 5.9 
vs. 27.9 ± 6.3%, p< 0.001). Because of 
sex differences, the results on body 
composition, leptin concentrations, and 
gonadotropic hormone concentrations 
were analyzed separately for boys and 
girls.  
 
Figure 1: Mean of weight (kg) and body fat percentage 
(%) in the boys (n = 57) and girls (n = 41) as a 
function of Tanner stage. 
 
* p < 0.05 for differences between boys and girls 
(ANOVA repeated measures) 
 
Figure 2a shows the mean of plasma 
leptin concentrations (ng/ml), LH 
concentrations (IU/l) and FSH 
concentrations (IU/l) in the boys (n = 57) 
as a function of Tanner stage. In lean and 
overweight boys no differences were 
found in the leptin and gonadotropic 
hormone patterns. The leptin 
concentrations increased from Tanner 
stage 1 to 2 (3.9 ± 2.3 to 4.9 ± 5.1 
ng/ml, p < 0.5), and decreased 
significantly from Tanner stage 2 to 5 (4.9 
± 5.1 to. 2.1 ± 1.9 ng/ml, p < 0.01). FSH 
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concentrations increased from Tanner 
stage 1 to 4 (2.9 ± 2.3 to 3.6 ± 1.9 IU/l, 
p< 0.09), and LH concentrations 
significantly increased from Tanner stage 
1 to 5 (1.8 ± 1.4 to 5.7 ± 2.8 IU/l, p < 
0.01). 
 
Figure 2a: Mean of plasma leptin concentrations 
(ng/ml), LH concentrations (IU/l), and FSH 
concentrations (IU/l) in the boys (n = 57) as a function 
of Tanner stage.  
 
* p < 0.05 for differences in time in the leptin and LH 
concentrations (ANOVA repeated measures) 
 
Figure 2b: Mean of plasma leptin concentrations 
(ng/ml), LH concentrations (IU/l), and FSH 
concentrations (IU/l) in the girls (n = 41) as a function 
of Tanner stage.  
 
* p < 0.05 for differences in time in the leptin and LH 
concentrations (ANOVA repeated measures) 
 
Figure 2b shows the mean of plasma 
leptin concentrations (ng/ml), LH 
concentrations (IU/l) and FSH 
concentrations (IU/l) in girls (n = 41) as a 
function of Tanner stage. In lean and 
overweight girls no differences were found 
in the leptin and gonadotropic hormone 
patterns. The leptin concentrations 
increased significantly from Tanner stage 
1 to 2 (6.2 ± 4.9 to 8.5 ± 6.0 ng/ml, p < 
0.02), decreased significantly from Tanner 
stage 2 to 4 (8.5 ± 6.0 to 6.2 ± 3.3 
ng/ml, p < 0.04), and significantly 
increased again from Tanner stage 4 to 5 
(6.2 ± 3.3 vs. 10.4 ± 6.6 ng/ml p < 
0.01). The peak in leptin concentrations 
was followed by an increase LH and FSH 
concentrations from Tanner stage 2 to 3 
(3.4 ± 2.3 to 5.1 ± 3.5 IU/l, p < 0.05 and 
5.1 ± 3.5 to 3.9 ± 4.3 IU/l, p < 0.14), 
and a decrease in LH and FSH 
concentrations from Tanner stage 3 to 4 
(4.4 ± 5.0 to 5.0 ± 4.5 IU/l, p < 0.24 and 
5.0 ± 4.5 to 3.8 ± 2.1 IU/l, p < 0.33). 
 
Figure 3 shows the mean leptin 
concentrations per kilogram of fat mass 
(FM) of the boys and girls as a function of 
Tanner stage. Sex differences in leptin/fat 
mass ratio were observed at Tanner stage 
1, 2, 3, 4, and 5 (0.49 ± 0.2 vs. 0.70 ± 
0.2 ng/ml/kg, p< 0.009; 0.51 ± 0.4 vs. 
0.73 ± 0.3 ng/ml/kg, p< 0.005; 0.38 ± 
0.4 vs. 0.55 ± 0.3 ng/ml/kg, p< 0.04; 
0.26 ± 0.3 vs. 0.39 ± 0.2 ng/ml/kg, p< 
0.04; 0.17 ± 0.1 vs. 0.56 ± 0.2 ng/ml/kg, 
p< 0.001). 
 
Figure 3: Mean leptin concentrations (ng/ml) per 
kilogram of fat mass (FM) of the boys and girls as a 
function of Tanner stage.  
 
* p < 0.05 for differences between boys and girls 
(ANOVA repeated measures) 
 
Table 1 shows regression analyses 
between plasma leptin concentrations 
(ng/ml) as the dependent variable and fat 
mass (kg) as the independent variable in 
boys (n = 57) and girls (n = 41) at 
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Tanner stage 1-5. In both boys and girls a 
positive relationship was observed 
between leptin concentrations and fat 
mass from Tanner stage 1 onwards. In the 
girls only at Tanner stage 2, 3, and 4 a 
smaller proportion of the variance in the 
leptin concentrations was accounted for by 
using fat mass as the independent 
variable.  
 
Table 1: Regression between plasma leptin 
concentrations (ng/ml) as the dependent variable and 
fat mass (kg) as the independent variable in boys (n = 
57) and girls (n = 41) at Tanner stage 1-5. 
Boys   
Tanner stage R2 P value 
1 0.51 0.001 
2 0.33 0.001 
3 0.27 0.001 
4 0.21 0.01 
5 0.46 0.01 
Girls   
Tanner stage R2 P value 
1 0.67 0.001 
2 0.39 0.001 
3 0.36 0.002 
4 0.28 0.03 
5 0.78 0.001 
 
To test whether leptin can be considered 
as the ‘lead’ hormone in relation to LH, 
and FSH or vice versa, in boys and girls 
leptin concentrations in a certain Tanner 
stage were paired with the other 
hormones in the following Tanner stage 
and vice versa, which results in 32 sets of 
paired data per child.  In boys at Tanner 
stage 1 LH and FSH concentrations were 
related to Tanner stage 2 leptin 
concentrations (R2 = 0.16, p < 0.02 and 
R2 = 0.13, p < 0.03), in turn Tanner stage 
3 leptin concentrations were related to 
Tanner stage 4 FSH concentrations (R2 = 
0.17, p < 0.04).  
In girls at Tanner stage 1 leptin 
concentrations were related to Tanner 
stage 2 LH and FSH concentrations (R2 = 
0.12, p < 0.05 and R2 = 0.18, p < 0.05). 
 
Discussion 
The objective of our longitudinal study 
was to investigate the relationship 
between leptin concentrations, 
gonadotropic hormone concentrations, 
and body composition during puberty in a 
Dutch children cohort. We observed sex 
differences from Tanner stage 1 onwards 
in weight, body composition, and leptin 
concentrations per kg fat mass. This was 
in concordance with previous literature on 
developmental changes in anthropometry 
and leptin concentrations normalized to 
fat mass during puberty [8, 25].  
 
Sex differences were also observed in the 
development of leptin, LH, and FSH 
concentrations over time. In girls a peak 
in leptin concentrations was observed at 
Tanner stage 2, followed by a peak in LH 
and FSH concentrations at Tanner stage 3, 
thereby confirming results from previous 
cross-sectional and small longitudinal 
studies [1, 4, 6-11]. In boys no peak in 
leptin was observed at Tanner stage 2, as 
leptin decreased from Tanner stage 2 
onwards and LH and FSH concentrations 
increased from Tanner stage 1 to 4, 
thereby confirming results from previous 
small longitudinal studies [4, 26]. 
Transversal studies, however, did show a 
leptin peak in boys during puberty [1, 6], 
which may be explained by 
methodological differences as well as 
presentation of the data by age group 
instead of by pubertal stage.  
 
The observations of our longitudinal study 
shed more light on the temporal 
alterations in the relationship between 
leptin and body composition [8]. Both in 
boys and girls, the leptin/fat mass ratio 
decreased from Tanner stage 2 onwards. 
In boys, this decrease continued 
throughout puberty, while in girls this 
ratio increased again at Tanner stage 5, 
which confirms results by Horlick et al [8]. 
These results imply that during puberty 
factors independent of fat mass become 
(transiently) more important in the 
regulation of plasma leptin concentrations.  
 
To investigate a time-dependent 
relationship in the sequence of the 
hormonal changes during puberty, we 
used the lead/lag technique, which 
correlates hormones secreted in one 
stage, with those secreted in the next 
stage [11]. In girls we observed that 
prepubertal leptin concentrations (Tanner 
stage 1), when acting as a lead, related to 
early pubertal LH and FSH concentrations 
(Tanner stage 2), as observed in both 
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boys and girls by Masqood et al [11]. 
These results imply a temporal 
relationship between leptin and 
gonadotropic hormones during early 
puberty.  
In boys, opposing results were found: 
prepubertal LH and FSH concentrations 
(Tanner stage 1) were related to early 
pubertal leptin concentrations (Tanner 
stage 2), as observed in boys and girls by 
Masqood et al [11]. They however 
observed prepubertal leptin 
concentrations to be related to early 
pubertal gonadotropic hormones and vice 
versa in both boys and girls [11], while 
we observed the first relationship in girls 
and the second one in boys. The 
discrepancy between the two studies is 
presumably caused by the difference in 
study population, because we analyzed 
boys and girls separately, each group 
consisting of about 40 children, and 
Masqood et al. [11] analyzed only 13 boys 
and 7 girls, 20 children together as one 
group, thereby being unable to separate 
the two different relationships. It should 
be noted that in both studies LH and FSH 
concentrations were determined in 
morning urine or plasma samples. Both 
methods do not provide information on 
the night-day rhythm and on pulsatile 
secretory patterns, typical for the 
gonadotropic hormones [27]. Moreover, 
we observed in boys a lead/lag 
relationship of leptin concentrations 
Tanner stage 3 and FSH concentrations at 
Tanner stage 4.  Our results show that 
during puberty the relationship between 
leptin and gonadotropic hormones is sex 
specific, since during puberty in boys 
leptin seems to have a different function 
and different timing.  Still, previous 
studies have shown that leptin is essential 
in reproductive functioning in both boys 
and girls, as male and female sterile 
ob/ob mice that became fertile again by 
leptin treatment [28]. The observations 
from our and other studies show that in a 
deficiency in leptin and fat mass as seen 
in anorexia nervosa or hyperleptinemia as 
seen in morbid obesity, will disturb the 
role of leptin during puberty, and thereby 
the start and progression of puberty [3].  
 
Thus, we observed in our longitudinal 
cohort that during puberty the leptin/fat 
mass ratio decreased from Tanner stage 2 
onwards. In girls, a peak in plasma leptin 
concentrations precedes a peak in LH and 
FSH concentrations, which supports a 
permissive role for leptin in the onset of 
puberty in girls. In girls, temporal 
relationships were observed between 
leptin and gonadotropic hormones during 
early puberty.  In boys, however there 
were no peaks in leptin, LH, and FSH, and 
leptin was only related to LH and FSH 
during late puberty. We therefore 
conclude that in boys and girls during 
puberty factors independent of fat mass 
become (transiently) more important in 
the regulation of plasma leptin 
concentrations. Moreover, in girls leptin is 
suggested to act as a permissive factor for 
the onset of puberty, while in boys leptin 
has a different timing and possibly 
different function.  
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Abstract  
Human (visceral) obesity is associated with alterations hypothalamus-pituitary-adrenal 
(HPA) axis functioning. It is however not completely clear whether the HPA axis is causally 
or co-incidentally related to (visceral) obesity. This review summarizes supporting data of 
an involvement of the HPA axis in the development of (visceral) obesity. First, several 
DNA polymorphisms related to HPA axis functioning are correlated to the development of 
obesity. Second, chronic elevation of circulatory glucocorticoid concentrations, as in 
Cushing’s disease, results in increased abdominal adiposity. Third, (visceral) obesity is 
associated with a diminished capacity of cortisol to suppress its own secretion. HPA axis 
functioning might affect energy balance through affecting energy intake. Both CRH and 
cortisol influence physiological, central mechanisms involved in the regulation of food 
intake. Still, general activation of the HPA axis has shown to have inconsistent effects on 
food intake in humans. This inconsistency may partially be explained by gender 
differences, individual differences in the functioning of the HPA axis, as well as differences 
in attitude towards eating. In particular, women with high scores on dietary restraint are 
prone to stress-induced hyperphagia. Dietary restraint scores, in turn, are positively 
correlated to basal and dexamethasone-suppressed cortisol levels, indicating a complex 
dual relationship between stress, HPA axis functioning, attitude towards eating and the 
risk for stress-induced hyperphagia. In the Western society, with chronically high ambient 
levels of stress and the availability of high caloric foods, this relationship may imply a risk 
for the development of (visceral) obesity and the metabolic syndrome. 
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Introduction 
Evidence suggests that the HPA axis is 
involved in the pathogenesis of human 
obesity, in particular characterized by 
visceral fat distribution. The HPA axis 
functioning plays an important role in the 
regulation of energy balance and body 
weight; it is, however, not completely 
clear whether the HPA axis is causally or 
co-incidentally related to the development 
of (visceral) obesity. 
The hypothalamus-pituitary-adrenal (HPA) 
axis is a neuro-endocrine system involved 
in the stress-response, by regulating the 
secretion of cortisol [1]. The cascade of 
the HPA axis beholds that first the 
hypothalamus produces and releases 
corticotropin-releasing hormone (CRH), 
which subsequently stimulates the 
synthesis and release of 
adrenocortiocotropin (ATCH) from the 
anterior pituitary. ACTH is produced from 
a larger precursor namely the 
proopiomelanocortin (POMC) protein, and 
stimulates the synthesis and release of 
cortisol by the adrenal cortex. In the 
circulation, cortisol is bound to 
corticosteroid-binding globulin (CBG) with 
high affinity, facilitating transport of 
cortisol in blood, followed by conversion of 
cortisol at the peripheral level by 11b-
hydroxysteroid dehydrogenase (11b-HSD) 
1 and 11b-HSD 11. The 11b-HSD 1 
enzyme, converts cortisone into the active 
form, and 11b-HSD 11 inactivates cortisol 
by conversion into cortisone. Cortisol 
exerts his actions through binding to and 
activation of two types of intracellular 
receptors, the glucocorticoid receptor (GR) 
and mineralocorticoid receptor (MR). The 
GR initiates or represses gene 
transcription, and induces negative 
feedback of the HPA axis through GR on 
the hypothalamus and pituitary level. The 
MR regulates basal activity of the HPA 
axis. Physiological cortisol levels follow a 
circadian rhythm; an early morning peak 
after awakening, a rapid decrease over 
the next few hours, and then a more 
gradual decline over the course of the 
day, to very low levels by bedtime [2].  
Addison’s disease and Cushing’s syndrome 
represent two extremes of plasma 
cortisolism in human pathology. Addison’s 
disease shows hypocortisolism, which 
causes symptoms such as fatigue, muscle 
weakness, changes in mood, and weight 
loss [3]. Also hypocortisolism caused by 
adrenalectomy will induce body weight 
loss in humans [4]. In animals, 
adrenalectomy will even prevent genetic 
as well as diet-induced form of obesity 
[5]. Cushing’s syndrome is characterized 
by hypercortisolism, which causes 
symptoms such as hypertension, insulin 
resistance, hyperglycemia and rapid 
weight gain, particularly of the trunk and 
face with sparing of the limbs [6]. In the 
adipose tissue the glucocorticoids promote 
differentiation of pre-adipocytes into 
mature adipocytes and increase 
lipoprotein lipase activity, thus promoting 
adipose tissue increase and weight gain 
[7]. The clinical observations in Addison’s 
disease and Cushing’s syndrome clearly 
demonstrate a role for the HPA axis in the 
regulation of energy balance [8]. 
The pathology of visceral obesity shows a 
marked resemblance with Cushing’s 
syndrome, including a central fat 
distribution of excess body-fat mass, 
elevated blood pressure, insulin 
resistance, and dyslipidemia. This form of 
obesity is associated with 
hypercortisolism, which becomes more 
pronounced when the HPA axis is 
stimulated (physiological or psychological) 
[9-11] and is associated with a diminished 
capacity of a low-dose (0.5 mg) 
dexamethasone (a GR agonist) to 
suppress plasma cortisol concentrations 
[12]. The latter finding suggest that the 
negative feedback loop, with cortisol 
activity on GR in both the hypothalamus 
and pituitary to inhibit HPA axis activity, is 
impaired in visceral obese subjects. This 
might explain (partially) the HPA 
hyperactivity and hypercortisolism of 
visceral obesity. In contrast, obese with a 
more peripheral body fat distribution do 
not show health risk markers, 
hypercortisolism, and diminished feedback 
capacity.  
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This review summarizes supporting data 
of an involvement of HPA axis 
hyperactivity in the development of 
(visceral) obesity. We start by describing 
physiological consequences of 
polymorphisms related to HPA axis 
functioning and the development of 
obesity. This will be followed by 
description of pathways through which the 
HPA axis might affect energy balance, and 
ultimately body weight, which will lead to 
a proposal of a model on the relationship 
between alterations in HPA axis 
functioning and (visceral) obesity.  
 
Physiological consequences of 
polymorphisms related to HPA 
axis functioning 
Visceral obesity shows considerable 
heritability, which results from 
contributions from many genes, so it is 
plausible that genetic variation in the 
cascade of the HPA axis may be involved 
in visceral obesity development [13]. 
Several polymorphisms in the cascade of 
the HPA axis have been described in the 
literature, which cause differences in HPA 
functioning and/or are involved in obesity 
development. In table 1 the 
polymorphisms, the functional variation in 
HPA axis functioning caused by the 
mutations, and the possible association to 
obesity have been described.  
Regarding the initial step of the HPA axis 
cascade, a variant in the 5’-flaking region 
of the corticotropin-releasing hormone 
(CRH) gene (T255G) the of (CRH) has 
been found. This polymorphism has been 
associated with increased cortisol levels 
during physiological stress and total 
diurnal cortisol secretion, when combined 
with a variant in the gene of the GR. Still, 
no association between the T255G 
mutation and obesity has been shown yet 
[14]. 
With respect to functional variations of the 
POMC gene related to ACTH production, a 
rare mutation in exon 2 (C3804A) of the 
POMC gene, that causes ACTH 
insufficiency, has been associated with 
early-onset obesity [15].  
Several polymorphisms have been 
described that can be linked to 
glucocorticoid action and may be related 
to specific aspects of obesity. Thus, a 
(GTTT)n repeat in intron 1 of the 
corticosteroid-binding globulin (CBG) has 
been associated with increased 
proliferation/differentiation of pre-
adipocytes, higher salivary cortisol after 
dexamethasone suppression test, higher 
waist-to-hip ratio and a higher risk on 
obesity development [16, 17].  
At the level of cortisol conversion, the 
ns4436A polymorphism of the 11b-
hydroxysteroid dehydrogenase (11b-HSD) 
1 gene has been associated with increased 
waist-to-hip ratio in women and pediatric 
obesity. No functional variation in HPA 
axis functioning caused by the ns4436A 
polymorphism has been described yet 
[18]. Additionally, a polymorphism at the 
(CA)n repeat in the first intron of the 11b-
HSD 11 gene has been associated with 
increased activity of the 11b-HSD 11 
enzyme in vitro, which was observed in 
the subcutaneous adipose tissue of obese 
men. This results in higher local cortisol 
levels in adipose tissue and an increase in 
the ratio of urinary free cortisol/urinary 
free cortisone [19].  
At the level of cortisol binding by the 
glucocorticoid receptor (GR) and 
mineralocorticoid receptor (MR) several 
polymorphisms have been described [20]. 
Three of the most prominent 
polymorphisms in the GR gene are the 
N363S, ER22/23EK and BclI 
polymorphisms, which all have been 
associated to obesity. The N363S 
polymorphism has been associated with 
increased glucocorticoid sensitivity, 
increased BMI, increased waist-hip ratio, 
and increased cholesterol levels [21, 22]. 
Secondly, the ER22/23EK polymorphism, 
which has been associated with decreased 
glucocorticoid sensitivity, decreased 
cholesterol levels, decreased insulin 
levels, and increased fat free mass [23]. 
Thirdly, the BclI polymorphism which has 
been associated with increased 
glucocorticoid sensitivity, increased insulin 
levels, increased blood pressure, 
increased abdominal visceral fat, and 
increased cholesterol levels [14, 24-26]. 
The most common described 
polymorphism in the MR gene is the 
Thesis_Rutters_v10.pdf   62 2-7-2009   14:50:39
 63 
Table 1: Description of polymorphisms in the cascade of the HPA axis  
Gene Name Obesity Functional genetic variant 
Corticotropin-releasing hormone (CRH) T255G No increase cortisol levels  
Proopiomelanocortin (POMC) Exon 3 (AAC)(AGC)2(GGC) No  No influence 
Proopiomelanocortin (POMC) C3804A yes ACTH insufficiency 
Corticosteroid binding globulin (CBG) Intron 1 (GTTT)n repeat yes Decrease feedback functioning 
11b-HSD 1 ns4436A yes No influence 
11b-HSD 11 Intron 1 (CA)n repeat yes increase local cortisol levels 
Glucocorticoid receptor (GR) N363S yes Increase cortisol sensitivity 
Glucocorticoid receptor (GR) ER22/23EK yes Decrease cortisol sensitivity 
Glucocorticoid receptor (GR) BclI yes increase cortisol sensitivity 
Mineralocorticoid receptor (MR) M180V no increase cortisol secretion 
 
 
MR180V polymorphism, which has been 
shown to enhance responses in cortisol 
secretion to a psychological stressor. In 
vitro studies showed a mild loss of 
function of the MR180V polymorphism, 
when cortisol was used as a ligand [27]. 
No associations have been found between 
the MR180V allele and the prevalence of 
obesity. 
One can conclude that genetic variation in 
the cascade of the HPA axis does not only 
influence HPA axis functioning, but is also 
frequently related to differences in body 
composition and metabolic parameters. 
These findings stress that the HPA axis 
plays an essential role in the regulation of 
body weight, body composition and 
energy balance. The next paragraphs will 
extend on the physiological role of the 
HPA axis in the regulation of energy 
balance. 
 
HPA axis functioning and energy 
balance 
In the literature several possible 
mechanisms have been described through 
which the HPA axis might affect energy 
balance, which is composed of energy 
intake and energy expenditure. Obesity 
results from a chronic deregulation of 
energy balance, with energy intake 
exceeding energy expenditure, which 
leads to the storage of the excessive 
energy as fat. 
 
HPA axis functioning and energy 
intake 
The literature consists of ample human 
data on the effects of stress on food 
intake [28]; however, these data are 
difficult to interpret with respect to the 
role of the HPA axis for various reasons. 
First of all, a wide variation in the type of 
stressor is used, resulting in different 
outcomes. Thus, stress in the workplace 
has been associated with higher energy 
intake [29, 30] while examination stress 
and surgical stress have produced mixed 
results [31, 32]. Secondly, there is a large 
inter-individual variance in HPA axis 
responses, i.e., plasma ACTH and cortisol 
production, to stress [8, 33]. A few 
studies on the effects of stress on food 
intake included measurements of plasma 
cortisol levels [34, 35]. Both studies 
showed a higher increase in stress-
induced food intake in women who 
showed high cortisol responses to the 
stressor, suggesting a relationship 
between cortisol responses and food 
intake. 
Most of the data directly indicating a 
crucial role of the HPA axis in the 
regulation of food intake are derived from 
animal studies, showing that the anorectic 
effects of adrenalectomy can be reversed 
by glucocorticoid (corticosterone) 
replacement [36, 37]. Human studies on 
the effects of glucocorticoids on food 
intake are limited, but generally support 
the findings in laboratory animals of an 
orexigenic effect of glucocorticoids [7, 
33]. The stimulation of food intake by 
glucocorticoids seems to be macronutrient 
specific: when rats had a free choice for 
different chow compositions, 
corticosterone withdrawal 
(adrenalectomy) and subsequent 
replacement principally affected 
carbohydrate intake [38, 39]. In another 
paradigm, where adrenalectomized rats 
were offered a choice between chow and 
lard, corticosterone replacement dose-
dependently increased intake of the more 
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palatable lard, but only in the presence of 
insulin [37]. These actions of 
glucocorticoids may underlie the 
preference for certain macronutrients and 
kinds of foods in humans after stress, in 
particular high saturated fat and sweet 
food items [30, 34, 40, 41]. Additionally, 
studies have shown that snack 
consumption may be more susceptible to 
stress-induced eating than meals [42]. 
Such foods may be preferred during 
stressful conditions, through learning that 
small energy-dense snacks are more 
easily ingested and digested when gut 
activity is suppressed by sympathetic 
arousal [43]. Several homeostatic and 
non-homeostatic mechanisms have been 
proposed through which HPA axis 
functioning may regulate food intake, and 
they will be discussed below. 
 
HPA axis functioning and homeostatic 
regulation of food intake 
The HPA axis seems to have many cross-
links with the neuro-endocrine pathways 
that control the homeostatic regulation of 
food intake [44]. First of all, the CRH 
containing neurons, which comprise the 
initial component of the HPA axis, are 
located in the paraventricular nucleus 
(PVN) of the hypothalamus, which is also 
considered to be a major centre in the 
control of feeding behavior [45]. Central 
(intraventricular) administration of CRH 
inhibits feeding in rats [45, 46], and CRH 
is suggested to be an important 
intermediate in the anorectic effects of 
leptin [46-48] The hypophagic effect of 
central CRH may (in part) result from 
inhibitory control of the orexigenic neural 
pathways involving neuropeptide Y (NPY), 
as paraventricular administration of the 
CRH-antagonist, alpha-helical CRF9-41, 
potentiated NPY-induced food intake [49]. 
CRH may be involved in the pathogenesis 
of obesity, at least in specific animal 
models: in the obese fa/fa zucker rat a 
reduced level of CRH mRNA expression 
has been found [50]. Whether CRH is also 
involved in the pathogenesis of human 
obesity is unknown, but when 
subcutaneous fat cells from humans were 
incubated in vitro with CRH, it decreased 
11b-HSD 11 enzyme activity, thereby 
reducing local cortisol production and 
reducing adiposity [48]. 
Thus, CRH exerts an opposite effect on 
appetite when compared to 
glucocorticoids. Physiologically, the (later) 
orexigenic effect of glucocorticoids, 
following the anorectic effect of CRH at 
the beginning of the stress response, may 
play a role in the recovery stage for the 
replacement of the replenishment of 
energy required during the ‘fight of flight 
response’. The inhibitory effects of 
glucocorticoids on hypothalamic CRH 
release [46] may be involved in the 
stimulatory effect of glucocorticoids on 
food intake. 
The opposite effects of CRH and 
glucocorticoids on food intake also emerge 
at a mechanistic level: where CRH exerts 
inhibitory control on NPY-induced food 
intake [49], (central) glucocorticoids 
potentiate the orexigenic actions of NPY. 
Additionally, dexamethasone stimulated 
NPY release in the mediobasal 
hypothalamus of female rats, and NPY 
production of cultured hypothalamic 
neurons [47]. In addition, recent research 
shows that cortisol up regulates the NPY 
Y2 receptor in the abdominal fat. Release 
of NPY and activation of the NPY Y2 
receptor stimulates fat angiogenesis, 
proliferation and differentiation of new 
adipocytes, thereby linking HPA axis 
activation, NPY and increased abdominal 
fat storage [51]. 
 
The HPA axis interferes with leptin 
release, in that glucocorticoids stimulate 
secretion of leptin by (rat) adipocytes 
[52]. This stimulatory effect of cortisol on 
leptin secretion has also been shown in 
vivo [53, 54]. On the other hand, 
glucocorticoids may reduce the efficacy of 
leptin to suppress food intake, hence, 
induce leptin resistance. In rats, 
adrenalectomy has shown to increase the 
anorectic potency of leptin, while this 
effect was reversed by glucocorticoid 
replacement [55]. Leptin exerts its 
anorectic actions in part through 
activation of the central melanocortin 
system [56]. Similar to the results on 
leptin, the anorectic response to the 
melanocortin agonist, melanotan II, in 
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rats is enhanced by adrenalectomy, which 
can be reversed by glucocorticoid 
replacement [39]. These data suggest 
that glucocorticoids potentially decrease 
leptin sensitivity, partially through 
inducing insensitivity to central 
melanocortins. Induction of leptin 
resistance may also explain why 
glucocorticoid administration in humans 
results in elevated leptin concentrations 
on the one hand, and an increased food 
intake on the other [7]. Indeed, HPA axis 
hyperactivity, and a subsequent elevation 
of glucocorticoid concentrations, has been 
hypothesized to be involved in the leptin 
resistance of human obesity [57, 58]. 
 
Glucocorticoids also interact with the 
action and secretion of insulin, another 
endocrine adiposity signal. In vitro, 
glucocorticoids interfere with insulin-
induced glucose uptake and metabolism in 
both cultured myocytes and adipocytes 
[59-62]. In vivo, dexamethasone 
administration to humans decreases whole 
body insulin sensitivity [63, 64]. This is 
associated with a compensatory increase 
in plasma insulin concentrations [65]. 
Since intraventricular administration of 
insulin has shown to suppress food intake 
[66], one might speculate that insulin (or 
insulin resistance) is involved in the 
effects of glucocorticoids on energy 
intake. Still, studies in glucocorticoid-
treated adrenalectomized, streptozotocin-
diabetic rats showed that total energy 
intake was not affected by insulin 
supplementation [36, 37], although 
insulin did dose-dependently increase the 
relative contribution of palatable high-fat 
food to total energy consumption [37]. 
Thus, insulin is likely to be involved in the 
effects of glucocorticoids on feeding 
behavior through modulation of food 
choice, rather than energy intake. 
Furthermore, through its anabolic actions 
on adipocytes, the hyperinsulinaemia 
caused by glucocorticoids may facilitate 
fat deposition. Remarkably, 
dexamethasone and insulin synergistically 
stimulate lipoprotein lipase activity in 
human adipose tissues, thereby 
facilitating free fatty acid uptake and 
lipogenesis [67]. 
HPA axis functioning and non-
homeostatic regulation of food intake 
In addition to the hypothalamic 
homeostatic pathways involved in food 
intake regulation, cortico-limbic brain 
areas are important structures for 
determining non-homeostatic regulation of 
food intake. These brain areas are 
involved in processes such as cognition, 
reward, memory and cognition, which are 
able to overrule the above-mentioned 
homeostatic regulatory mechanisms [44]. 
 
To a certain extent, humans show 
tendencies to cognitively moderate their 
food intake, a phenomenon that has been 
called “dietary restraint”. Under some 
conditions, however, some subjects loose 
their cognitive control of caloric intake, 
which is called “disinhibition”. The level of 
dietary restraint and disinhibition can be 
assessed by using specific questionnaires, 
such as the Three Factor Eating 
Questionnaire (TFEQ) [68]. We previously 
showed [Rutters, submitted] that the level 
of dietary restraint was positively 
correlated to 5-hour plasma cortisol 
patterns, and negatively correlated to the 
ability of the GR-agonist, dexamethasone, 
to suppress cortisol release under a 
strenuous exercise protocol. Accordingly, 
three studies reported that salivary 
cortisol at one time point (time point not 
specified) and 24-hour cortisol excretion 
were significantly higher in restrained 
women compared to unrestrained women 
[69-71]. Notably, some other studies did 
not find this relationship [72-74], possibly 
because cortisol concentrations where 
only measured at one time point or during 
the night.  
One can speculate about the causality of 
this relationship. Although it cannot be 
excluded that high ambient cortisol levels 
increase cognitive awareness of caloric 
intake, the opposite (i.e., high level of 
dietary stress causes HPA axis activity) 
seems a somewhat more tempting 
hypothesis. Dietary restraint is positively 
correlated with body fat percentage [73, 
75, 76], and the load of continuously 
restrained eating behavior is reportedly 
perceived as stressful  [77]. Still, dietary 
restraint may be a risk factor for stress-
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induced hyperphagia, as studies showed 
that restrained eaters experiencing 
psychological stress increased their food 
intake, while unrestrained eaters 
decreased food intake [30, 78-80]. Also, 
women with high disinhibition scores 
showed an increase in food intake 
following psychological stress [81, 82]. 
 
In the concept of non-homeostatic 
regulation of food intake, as lined out by 
Berthoud [44], food reward plays an 
important role. Like addictive drugs, 
palatable foods may act as a reinforcer, 
thereby influencing their own intake. 
Berridge and Robinson defined two 
distinct psychological processes 
determining the reinforcing value: “liking” 
and “wanting” [83]. These processes are 
regulated by different neural networks 
and mediated by different 
neurotransmitters [84]. 
In the process of “liking”, mu-opioid 
systems in the nucleus accumbens seem 
to play an important role [85, 86]. Thus, 
local administration of the opioid agonist, 
morphine, or the mu-opioid agonist, (d-
Ala(2), N-Me-Phe(4), Glycinol(5))-
enkephalin (DAMGO), into the nucleus 
accumbens of rats increased food intake 
[85, 87]. In humans, the opioid 
antagonist, naltrexone, results in a 
reduction of both the intake and the 
reported pleasantness of food [88-90]. 
The expression of the mu-opioid receptor, 
and, hence, opioid sensitivity, is 
modulated by glucocorticoids: its 
expression is diminished in CRH-deficient 
mice and increased by corticosterone 
administration [91]. Indeed, activation of 
the endogenous opioid system has been 
suggested to be involved in stress-induced 
eating [92].  
The endogenous opioid system may exert 
its effects in interaction with the 
endocannabinoid system, which has also 
been shown to be involved in the 
regulation of feeding behavior [93] and 
reward [94]. Endocannabinoid receptors 
of the CB1 type are abundantly expressed 
in the nucleus accumbens [95], and 
combined administration of the opioid 
antagonist, naloxone, and the CB1 
receptor antagonist SR141716 decrease 
food intake in rats in a synergistic fashion 
[96]. Direct evidence for a role of 
endocannabinoids in the orexigenic effects 
of glucocorticoids is lacking at present, 
but it is noteworthy that the 
endocannabinoid antagonist, AM281, 
antagonizes the effects of corticosterone 
on neuronal activity and on sexual 
behavior in amphibians [97].  
With respect to the “wanting” or 
motivational aspect of reward, it is 
thought that dopamineric neurons, 
originating the ventral tegmental area 
(VTA) of the mid brain, and projecting to 
forebrain areas such as the orbitofrontal 
cortex and the nucleus accumbens or 
ventral striatum play a crucial role [83]. 
In rats, peripheral administration of 
corticosterone increases dopamine outflow 
in the nucleus accumbens [98]. Hence, 
both in rats [99] and in humans [100] 
glucocorticoids are suggested to 
contribute to the stress-induced increase 
of dopamine release in this brain area. 
The relationship between (striatal) 
dopamine and food intake seems, 
however, rather complex. Dopamine acts 
through several dopamine receptors (D1-
D5), which seem to mediate distinct 
effects on food intake and food 
preference: selective D1 receptor 
activation resulted in increased caloric 
intake and preference for highly palatable 
foods, whereas combined D2/D3 
activation showed an opposite effect 
[101]. Human studies showed that a 
single bolus administration the dopamine 
transporter protein (DAT)-inhibitor, 
methylphenidate, results in a reduction of 
food intake, suggesting that high synaptic 
dopamine levels reduce the reinforcing 
value of food [102]. In contrast to acute 
effects, chronic elevation of synaptic 
dopamine may result in an increased 
wanting for rewarding foods, as indicated 
by the increased efforts and motivation of 
DAT-knockdown mice to obtain a sweet 
reward [103]. Possibly, shifts in the 
sensitivity and/or distribution of the 
different dopamine receptors may underlie 
this apparent discrepancy. In this case, it 
is noteworthy that obese subjects exhibit 
lower striatal D2 receptor availability 
[104], hence, it cannot be excluded that 
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in obesity the orexigenic effect of D1 
activation may become considerably more 
predominant in the effects of dopamine on 
food intake. Whether this mechanism is 
also involved in the effects of 
glucocorticoids or stress on food intake in 
obesity, however, needs to be established. 
It should be noted, however, that above 
homeostatic and non-homeostatic 
pathways regulating feeding behavior are 
not 2 completely separate neural systems: 
significant interaction at different levels 
exists. In this respect, the adipocyte-
derived hormone, leptin, has gained a 
particular interest. Leptin receptors have 
been found in the VTA, leptin has been 
shown to reduce firing rate of VTA 
dopaminergic neurons in brain slices, and 
direct administration of leptin into the VTA 
of rats decreased food intake [105]. 
Notably, a decreased performance in 
behavioral paradigms that assess the 
rewarding properties of food has also been 
observed when leptin was administered 
intracerebroventricular [106] and even 
intrahypothalamic [107]. Thus, leptin may 
reduce food intake by lowering the 
rewarding value of food. It is tempting to 
speculate that the leptin resistance 
following glucocorticoid suppletion [55] is 
also represented by a diminished influence 
of leptin on the neuronal pathways 
involved in food reward [43, 56].  
In conclusion we described several 
mechanisms such as hormonal pathways, 
food reward and dietary restraint, through 
which HPA axis functioning influences 
energy intake, but also energy 
expenditure is influenced. 
 
HPA axis functioning and energy 
expenditure 
With respect to the effect of HPA axis 
functioning on energy expenditure, the 
literature is not as extensive as on the 
effect on energy intake. Like with the 
regulation of food intake, CRH and cortisol 
may exert distinct effects on energy 
expenditure. CRH infusion in humans 
resulted in a 14% increase in resting 
energy expenditure [108]. CRH may act 
through activation of the central 
sympathetic system, both in the 
hypothalamus as well as in the locus 
ceruleus of the brain stem [1]. However, 
as the increase in energy expenditure 
following CRH infusion was not associated 
with increases in plasma catecholamines, 
other mechanisms may also be involved. 
 
With respect to the effects of 
glucocorticoids on energy expenditure, the 
literature shows a dichotomous response. 
When hydrocortisone was infused for 60 
h, it led to an increase in resting energy 
expenditure [109]. Also, when 
hydrocortisone was infused for 16h at two 
different concentrations, it lead to an 
increase in resting energy expenditure of 
9-15% [110]. On the contrary, two other 
studies showed that infusion of 
glucocorticoids for 168 h did not alter 
energy expenditure [111]. In addition, 
chronic dexamethasone treatment in 
infants did not affect energy expenditure 
[112]. Also, no difference in resting 
energy expenditure (corrected for the 
amount of lean body mass) was found 
between normal and patients with 
Cushing’s syndrome [113, 114]. It may be 
hypothesized that glucocorticoids exert 
dual effects on energy expenditure, and 
that the stimulatory actions of 
glucocorticoids on energy expenditure 
[109, 110] are overruled by other, 
inhibitory actions during prolonged or 
chronic exposure [115]. 
 
Several mechanisms may underlie the 
inhibition of energy expenditure by 
glucocorticoids. Firstly, suppression of 
CRH release by glucocorticoids as part of 
the negative feedback regulation of HPA 
axis functioning [1]. Secondly, it has been 
shown that chronic increased levels of 
cortisol in Cushing’s disease leads to 
inhibition and promotes breakdown of 
muscle, resulting in muscle wastage. 
Since the amount of muscle mass is 
positively correlated to (resting) energy 
expenditure, chronic hypercortisolism, as 
in patients with Cushing’s disease, may 
ultimately result in lower energy 
expenditure [61]. Thirdly, glucocorticoids 
have shown to affect the hypothalamus-
pituitary-thyroid axis. Glucocorticoids 
inhibit the production of thyrotropin-
releasing hormone as well as thyroid-
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stimulating hormone, and the conversion 
of thyroxine (T4) to triiodothyronine (T3), 
ultimately resulting in decreased plasma 
T3 levels [1, 116], which may 
subsequently result in a reduced basal 
metabolic rate [115]. 
In summary we described that 
glucocorticoids exert dual effects on 
energy expenditure, and that the 
stimulatory actions of glucocorticoids on 
energy expenditure are overruled by 
other, inhibitory actions during prolonged 
or chronic exposure. 
 
Summary and conclusions 
The hypothalamus-pituitary-adrenal axis 
affects energy balance on different levels, 
at different ways, and with different 
underlying mechanisms. All in all, 
prolonged exposure to elevated 
glucocorticoid levels may result in a 
positive energy balance, by increasing 
energy intake, without affecting resting 
energy expenditure. The stimulatory 
effects of glucocorticoids on energy intake 
may involve both homeostatic and non-
homeostatic pathways involved in the 
regulation of eating behavior. The 
homeostatic pathways may include a 
suppression of CRH release, induction of 
leptin resistance and the stimulation of 
NPY release. Non-homeostatic pathways 
may include the individuals’ attitude 
towards eating, as well as neural systems 
involved in both the “wanting” 
(dopaminergic) and “liking” (opioidergic) 
aspects of food reward. The latter systems 
may, just such as insulin [37], also be 
involved in a shift in food choice towards 
high energetic sweet and high fat foods. 
The effects of glucocorticoids on energy 
expenditure may depend on the duration 
of exposure, with mechanisms such as a 
decrease in CRH release, increased loss of 
lean body mass and decreased circulating 
T3 levels ultimately counteracting an 
initial stimulation of resting metabolic 
rate. 
 
The resulting positive energy balance is 
likely to result in increased lipogenesis 
and fat storage, under influence of 
glucocorticoids and elevated 
concentrations of insulin. In addition, 
glucocorticoids may even increase 
adipogenesis due to an up-regulation of 
the NPY Y2 receptor in abdominal adipose 
tissue [51]. Notably, visceral adipocytes 
have a fourfold higher number of 
glucorticoid receptors than adipocytes in 
other fat depots [8]. Accordingly, the 
stimulatory effects of dexamethasone on 
lipoprotein lipase activity were more 
pronounced in visceral adipocytes than in 
subcutaneous adipocytes [67]. Thus, the 
increased fat storage due to prolonged 
hypercortisolism may show some site-
specificity, with a preference for the 
visceral regions. 
 
The increased adiposity may lead to an 
increase in weight dissatisfaction [75], 
which will lead to dieting in an attempt 
achievement and maintenance of desired 
body weight. Dieting is done through 
cognitively controlling eating behavior 
and, hence, is accompanied with an 
increase in dietary restraint [117]. 
However, dietary restraint can act as a 
chronic physiological stressor, and like all 
other chronic stress will lead to alterations 
in HPA axis functioning. We found that the 
level of dietary restraint was positively 
correlated to 5-hour plasma cortisol 
patterns, and negatively correlated to the 
ability of the GR-agonist, dexamethasone, 
to suppress cortisol release under a 
strenuous exercise protocol [Rutters, in 
press]. 
 
Therefore, we propose that chronic 
hyperactivity of the HPA axis initiates a 
vicious circle (figure 1), which puts 
chronic stress as a major risk factor for 
excessive weight gain and (visceral) 
obesity. Whether this mechanism is the 
primary cause for the obese state in the 
visceral obese remains to be elucidated, 
but it should be noted that HPA axis 
hyperactivity is typical in visceral obese 
subjects [9-11] and that HPA axis 
functioning in obese women was not 
significantly affected by weight loss [118]. 
Therefore, the HPA axis may therefore be 
an important causal factor in to the 
obesity epidemics of the Western society, 
where high levels of ambient stress and 
availability of high fat, sweet foods are 
abundantly present. 
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Figure 1: a model for the possible relationship between HPA axis functioning, eating behavior, energy 
balance, and body composition (solid lines represent stimulation and dashed lines represent inhibition).  
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Abstract 
Objective: to investigate, in men and women, the relationship between the BclI 
genotypes and circulating cortisol concentrations, HPA axis feedback sensitivity, as well as 
HPA axis feedback sensitivity under stress.  
Methods: we assessed in 77 men and 89 women, aged between 18 to 55 y and BMI 
between 19.8 and 41.2 kg/m2, HPA axis functioning through measuring 5-hour cortisol 
exposure as well as cortisol feedback sensitivity under stress through a standardized high 
intensity test with 4 mg dexamethasone.  
Results: the BclI genotype frequency distribution (CC/CG/GG) was 41/42/17 in men and 
45/42/13 in women. The G/G BclI genotype had higher cortisol concentrations after 
dexamethasone exposure when compared to the C/C genotype in men (42.2±8.7 vs. 
27.3±2.2 nmol/L, p<0.05), and to the C/G genotypes in women (70.5±14.6 vs 47.1 ± 9.1 
nmol/L, p<0.05). Only in women, the G/G BclI genotype had a higher area under the 
curve (AUC) of the cortisol concentrations over a 5-hour time period when compared to 
the C/G genotype (178458 ± 85818 vs. 135063.7 ± 65511 nmol/L.min, p < 0.05). 
Additionally, women with the G/G BclI genotype had a higher AUC of the cortisol 
concentrations over a 70 minutes time period after a high intensity test with 
dexamethasone suppression when compared to the C/G and C/C genotypes 
(3788.7±2248 vs. 3323.2±1716 and 5392.9±3545 nmol/L.min, p < 0.05).  
Conclusion: the BclI genotype is sex specifically associated with increased cortisol 
exposure as well as decreased cortisol feedback sensitivity under stress. 
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Introduction 
The hypothalamus/pituitary/adrenal (HPA) 
axis is a neuro-endocrine system involved 
in the stress-response and homeostasis, 
by regulating the secretion of cortisol [1]. 
Cortisol affects several systems, such as 
the cardiovascular system, the immune 
system, metabolism, cell growth, 
behavior, and the HPA axis itself through 
negative feedback [2]. Literature has 
shown large intra-individual and inter-
individual variation in HPA axis 
functioning, such as the efficacy of cortisol 
to suppress its own secretion (negative 
feedback). This results in considerable 
variation in circulation cortisol 
concentrations [3].  The variation has 
been related to several polymorphisms of 
the glucocorticoid receptor gene, such as 
N363S [4], the ER22/23EK [5], Tth111I 
[6], and BclI polymorphisms [3]. The 
latter polymorphism, BclI (rs41423247), 
has been related to insulin resistance in 
obese women [7], increased BMI, waist-
hip ratio, leptin levels [6, 8-10], as well as 
better weight loss during a very low 
calorie diet [11, 12]. Additionally, in men, 
the BclI G/G genotype has been 
associated with increased salivary 
concentrations of cortisol [6], increased 
levels of salivary cortisol after a 
standardized lunch [6], increased levels of 
cortisol after a 0.5 mg dexamethasone 
suppression test [6], as well as a 
diminished cortisol response to 
psychosocial stress [2]. In women, 
however the BclI G/G genotype has been 
associated with an increased cortisol 
response to psychosocial stress [13], 
which suggests possible sex specific 
associations between the BclI genotypes 
and HPA axis functioning. Besides the 
study from Kumsta et al. 2007 [13], no 
previous studies have examined the 
possible sex specific associations, since 
other studies only included males [2, 6]. 
Furthermore, HPA axis functioning was 
studied via basal cortisol levels, a 
dexamethasone suppression test, or 
subjection to a psychosocial test, never 
via a combination of physical stress and 
dexamethasone suppression, which 
indicates sensitivity of the HPA axis to 
negative feedback under stress [14]. 
Consequently, the objective of our study 
was to investigate, in men and women, 
the relationship between the BclI 
genotypes and circulating cortisol 
concentrations, HPA axis feedback 
sensitivity, as well as HPA axis feedback 
sensitivity under stress. 
 
Materials and methods 
Protocol 
The Medical Ethical Committee of the 
University of Maastricht approved of the 
study, and written consent was obtained 
from all participants. Healthy, medication-
free, non-smoking men (n = 80) and 
women (n = 90) aged between 18 to 55 y 
and BMI between 19.8 and 41.2 kg/m2 
were recruited to complete all phases of 
the study. A medical history was obtained 
from each participant before entry into the 
study and exclusion criteria were 
menopause, chronic illness, depression, 
and a history of eating disorders or 
current dieting. From 170 participants 
recruited, 77 men and 89 women 
completed the study, 4 participants 
dropped out before the actual start of the 
study. 
From each participant we obtained: 5-
hour cortisol exposure, a progressive 
maximal cycling test to volitional 
exhaustion and a high intensity test under 
4 mg dexamethasone, anthropometry, 
and BclI genotypes.   
 
Measurements 
5-hour cortisol exposure 
At 8 a.m. after an overnight fast an 
intravenous catheter for blood sampling 
was inserted into the forearm vein. Direct 
after insertion of the catheter the first 
blood sample (9 ml) was drawn (0 
minutes), and after 15 minutes the 
participants received their breakfast (20 
% of the participants’ daily energy 
requirement). At 45, 90 and 210 minutes 
the second, third and fourth blood 
samples were drawn. At 225 minutes the 
participants received their lunch (30 % of 
the participants’ daily energy 
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requirement) and at 255 and 300 minutes 
the fifth and sixth blood samples were 
drawn. During the test participants were 
able to drink water ad libitum. Breakfast 
and lunch consisted of typical Dutch 
products namely brown bread (1.0 MJ per 
100 g; en% C/P/F: 74/15/11) with young 
cheese (1.6 MJ per 100 g; en% C/P/F: 
0/26/74) as well as ab libitum tea or 
water consumption. The daily energy 
requirements were calculated by 
multiplying the basal metabolic rate (BMR) 
by an activity index of 1.75. The BMR 
(MJ/day) was calculated according to the 
equations of Harris-Benedict [15]. 
Participants remained seated during 
sampling, and daytime naps were not 
allowed. The participants’ 5-hour cortisol 
exposure was measured by calculating the 
area under the curve (AUC) (0-300 
minutes). 
 
Progressive maximal cycling test to 
volitional exhaustion 
The 5-hour cortisol exposure 
measurement and the progressive 
maximal cycling test (VO2max) were 
separated by at least one day. Each 
participant underwent a progressive 
maximal cycling test to volitional 
exhaustion for quantification of VO2max 
[16]. Participants cycled on an 
electromagnetically braked bicycle 
ergometer (Lode, Groningen, The 
Netherlands) at 80 rpm, at a workload of 
75 W for women and 100 W for men [16]. 
After 5 minutes, the workload was 
increased every 2.5 minutes with 50 W, 
until participants were no longer able to 
maintain a pedaling frequency above 80 
rpm. Open-circuit spirometry was 
performed with an Oxycon (Mijnhardt 
Jaeger, Mannheim, Germany), and oxygen 
consumption (VO2) and carbon dioxide 
production (CO2) were measured in the 
breath-by-breath mode and averaged 
over 15 seconds [16]. Heart rate was 
monitored continuously throughout all 
exercise protocols (Polar s610). 
Verification that each participant actually 
achieved VO2max consisted of meeting 
the following criteria: 1) achieving 
predicted maximal heart rate and 2) a 
respiratory exchange ratio of 1.10 or more 
[16]. The results of the progressive 
maximal cycling test were used to 
measure the resistance to elicit an 
exercise intensity of 90 % of each 
participants maximal workload (Wmax, V) 
for the high intensity test under 4 mg 
dexamethasone. 
 
High intensity test under 4 mg 
dexamethasone 
The progressive maximal cycling test and 
high intensity test under 4 mg 
dexamethasone [14] were separated by at 
least one week. Each participant received 
4 mg dexamethasone 8 hours before the 
high intensity test. Each participant 
participated in the treatment, and no 
adverse reactions were reported. 
Participants abstained from alcohol 
consumption and strenuous exercise 15 h 
before testing. At 8 a.m. after an 
overnight fast, an intravenous catheter for 
blood sampling was inserted into the 
forearm vein and the first blood sample 
was drawn for a baseline measurement (0 
minutes). After 5 minutes the participants 
received their breakfast (20 % of the 
participants’ daily energy requirement). At 
15 minutes the second blood sample was 
taken and the high intensity test was 
started. At 30 minutes the high intensity 
test ended and the third blood sample was 
taken. At 40, 50, 60 and 70 minutes, the 
fourth, fifth, sixth and seventh blood 
samples were taken [14].  
The high intensity test consisted of 15 
minutes of cycling. The initial 5 minutes 
served as a warming-up, during which 
each participant cycled at a workload of 
40 % of his/her Wmax (V), at 80 rpm. 
After the warming-up, the workload was 
increased with 50 % of his/her Wmax (V) 
for 30 sec at 80 rpm, followed by a 
decrease of the workload with 50 % of 
his/her Wmax (V) for 30 sec at 80 rpm. 
The increase and decrease of workload 
were repeated 10 times. After the third 
blood sample was drawn a 5 minutes 
cooling-down was performed at 30 % of 
his/her Wmax (V) at 60 rpm [14].  
 
Blood samples 
Blood samples were collected and mixed 
in serum tubes (BD Vacutainer, 9.5 ml). 
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Serum was obtained by centrifugation 
(4°C, 3000 rpm, 10 minutes), frozen in 
liquid nitrogen and stored at -80°C until 
analysis of cortisol concentrations. 
Serum cortisol concentrations were 
measured using RIA (Buhlmann 
Laboratories) and detection limits for 
cortisol concentrations were 2.9 ng/ml. 
Intra-assay coefficient variation for 
cortisol concentrations was less than 6 % 
for all samples. 
 
Anthropometry  
Measurements were carried out in the 
morning after voiding the bladder and 
before breakfast. Body weight and height 
were measured to the nearest 0.01 kg 
and 0.1 cm respectively. BMI (kg/m2) was 
calculated as body weight divided by 
height (m) squared. 
 
Determination of BclI genotypes 
The genomic DNAs of 166 participants 
were isolated from peripheral blood 
leukocytes using a QIAamp kit (QIAgen, 
Germany). A 87 bp fragment of the GRL 
gene was generated from genomic DNA 
by PCR using forward primer 5’-
GCTCACAGGGTTCTTGCCATA-3’ and 
reverse primer 5’-
TTGCACCATGTTGACACCAAT-3’, which 
includes a C/G polymorphism in intron 2, 
646 nucleotides downstream from exon 2 
[11]. The PCR products were digested 
with BclI at 50°C for 60 minutes, 
electrophoresed on a 3% agarose gel and 
stained with ethidium bromide. The 
expected products after digestion with 
BclI are 87 bp for G/G homozygotes, 47 
and 40 bp for C/C homozygotes, and 87, 
47, and 40 bp for G/C heterozygotes. 
 
Statistical analysis 
Student t-test and ANOVA (for continuous 
variables) were executed to determine 
differences in single variables between 
groups. Hardy-Weinberg equilibrium for 
BclI was calculated using the chi-square 
test. The BclI polymorphism was in Hardy-
Weinberg equilibrium. The differences 
over time and between conditions were 
determined using three-factor ANOVA with 
repeated measures. All statistical tests 
were two-tailed, differences were 
considered significant at p < 0.05 and 
values are expressed as mean ± standard 
deviation.  
 
Results 
Table 1 shows the characteristics of the 
male (n = 77) and female (n = 89) 
participants. No significant differences 
were shown in age, BMI, and BclI 
genotype frequency distribution between 
men and women. Men showed a higher 
body weight, height, and maximal 
workload during the progressive maximal 
cycling test when compared to women. 
Women showed a higher area under the 
curve (AUC) of the cortisol concentrations 
over a 5-hour time period, as well as a 
higher AUC of the cortisol concentrations 
over a 70 minutes time period after a high 
intensity test with dexamethasone 
suppression. Therefore, the results of men 
and women were analyzed separately.  
 
Table 1. Characteristics of the male (n = 77) and 
female (n = 89) participants 
 Male (n = 77) Female (n = 89) P value1 
Age (year) 29 ± 10 26.9 ± 9 0.16 
Body weight (kg) 81.4 ± 13 70.1 ± 12.4 0.001 
Height (cm) 181.6 ± 6.8 169.3 ± 6.6 0.001 
BMI (kg/m2) 24.4 ± 23.6 24.4 ± 4.1 0.99 
Maximal workload (V) 299.2 ± 58 208.9 ± 43 0.001 
AUC2 of 5-hour  
cortisol exposure  
(nmol/L.min) 
9.8 (105) ± 2.9 14.9 (105) ± 7.3 0.001 
AUC2 cortisol after  
high intensity test 
(nmol/L.min) 
2556 ± 1970 4217 ± 4445 0.004 
BclI genotype  
frequency distribution 
(CC/CG/GG) (%) 
41/42/17 45/42/13 0.80 
1 Differences between men vs. women (t-test for 
continuous variables or Chi-square test for nominal 
variables) 
2AUC, area under curve 
 
Figure 1A shows the changes in cortisol 
concentrations (nmol/L.min) over a 5-
hour time period in men. No differences in 
cortisol concentrations were observed 
between the three BclI genotypes. Over 
time there was a significant decrease of 
cortisol concentrations in all men, 
however, over time no differences were 
seen between the three BclI genotypes.  
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Figure 1A. Changes in cortisol concentrations (nmol/l) 
over a 5-hour time period in men with the BclI G/G (n = 
13), CC (n = 32) or C/G (n = 33) genotype. Values are 
means with standard errors.  
 
 
Figure 1B. Changes in cortisol concentrations (nmol/l) 
over a 5-hour time period in women with the BclI G/G (n 
= 12), CC (n = 39) or C/G (n = 38) genotype. Values 
are means with standard errors.  
 
* P < 0.05 for differences between women with the BclI 
G/G and the C/G genotype (ANOVA) 
 
Figure 1B shows the changes in cortisol 
concentrations (nmol/L.min) over a 5-
hour time period in the women. The 
cortisol concentrations were significantly 
higher at 210, 255, and 300 minutes in 
women with the G/G genotype when 
compared to the C/G genotype. Over time 
there was a significant decrease of cortisol 
concentrations in all women, however, 
over time no differences were seen 
between the three BclI genotypes. The 
area under the curve (AUC) of the cortisol 
concentrations over a 5-hour time period 
was significantly higher in women with the 
G/G genotype when compared to women 
with the C/G genotype (178458 ± 85818 
vs. 135063.7 ± 65511 nmol/L.min, p < 
0.05).  
Figure 2A shows the changes in cortisol 
concentrations (nmol/L.min) over time 
after a high intensity test with 
dexamethasone suppression in men. After 
dexamethasone exposure (t=0), the 
cortisol concentrations were significantly 
higher in men with the G/G genotype 
when compared to men with the C/C 
genotype (42.2±8.7 vs. 27.3±2.2 nmol/L, 
p<0.05). After the high intensity test in 
combination with dexamethasone 
suppression, the cortisol concentrations 
were significantly higher at 15, 30, 40, 
50, and 60 minutes in men with the G/G 
genotype when compared to men with the 
C/C genotype. Over time as well as 
between the three genotypes no 
differences were observed in the men.  
 
Figure 2A: Cortisol concentrations (nmol/l) over time 
after a high intensity test with dexamethasone 
suppression in men with the BclI G/G (n = 13), CC (n = 
32) or C/G (n = 33) genotype. Values are means with 
standard errors. 
 
a P < 0.05 for differences between men with the BclI 
G/G and the C/C genotype (ANOVA) 
 
Figure 2B shows the changes in cortisol 
concentrations (nmol/L.min) over time 
after a high intensity test with 
dexamethasone suppression in women. 
After dexamethasone exposure (t=0), the 
cortisol concentrations were significantly 
higher in women with the G/G genotype 
when compared to women with the C/G 
genotype (70.5±14.6 vs. 47.1 ± 9.1 
nmol/L, p<0.05). After the high intensity 
test in combination with dexamethasone 
suppression, the cortisol concentrations 
were significantly higher at all time points 
in women with the G/G genotype when 
compared to women with the C/G and C/C 
genotype. From 0 to 40 minutes a 
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significant increase in cortisol was seen in 
women with the G/G genotype, while this 
was absent in women with the C/G and 
C/C genotypes (13.1 ± 15.1 vs. 8.5 ± 38 
and 3.1 ± 9.4 nmol/L, p < 0.05). 
Additionally, from 40 to 70 minutes a 
significant decrease in cortisol was seen in 
women with the G/G genotype, while an 
increase in cortisol was seen in women 
with the C/G and C/C genotype (-8.2 ± 
21.6 vs. 0.6 ± 12.6 and 2.2 ± 9.8 nmol/L, 
p < 0.01).   
 
Figure 2B: Cortisol concentrations (nmol/l) over time 
after a high intensity test with dexamethasone 
suppression in  women with the BclI G/G (n = 12), CC 
(n = 39) or C/G (n = 38) genotype. Values are means 
with standard errors. 
 
* P < 0.05 for differences between women with the BclI 
G/G and the C/G as well as C/C genotype (ANOVA) 
$ P < 0.05 for differences between men with the BclI 
G/G and the C/C genotype (ANOVA) 
# P < 0.05 overall group x time interaction  
 
The AUC of the cortisol concentrations 
corrected for baseline, over a 70 minutes 
time period after a high intensity test with 
dexamethasone suppression was 
significantly higher in women with the G/G 
genotype when compared to women with 
the C/G genotype (460 ± 408 vs. 38.3 ± 
666 nmol/L.min, p < 0.03).  
 
Discussion 
The objective of our study was to 
investigate, in men and women, the 
relationship between the BclI genotypes 
and circulating cortisol concentrations, 
HPA axis feedback sensitivity, as well as 
HPA axis feedback sensitivity under 
stress. In both men and women the G/G 
BclI genotype was associated with 
increased cortisol concentrations after a 
dexamethasone exposure test. Only in 
women the G/G BclI genotype was 
associated with increased cortisol 
concentrations over a 5-hour time period, 
and increases in cortisol concentrations 
after a high intensity test with 
dexamethasone suppression. 
 
With these results, our study adds to the 
growing literature on the relationship 
between the BclI genotypes and HPA axis 
functioning, and this study is the first to 
analyze the effect of the BclI genotypes 
on HPA axis feedback sensitivity under 
stress, as well as sex specific associations. 
In our study, we measured cortisol 
concentrations (nmol/L.min) over a 5-
hour time period to determine cortisol 
exposure under resting conditions. We 
showed that women with the G/G BclI 
genotype had significant higher cortisol 
concentrations just before and after lunch, 
in addition to a higher AUC of the cortisol 
concentrations over a 5-hour time period 
when compared to the C/G genotype. This 
suggests that women with the G/G BclI 
genotype have increased daily cortisol 
exposure.  
 
Additionally, we measured feedback 
sensitivity through a dexamethasone 
exposure test [17], which determines the 
amount of cortisol that escapes from 
dexamethasone suppression (a type II 
glucocorticoid receptor agonist) [6]. When 
cortisol feedback is strong low amounts of 
cortisol will be present, and when high 
amounts of cortisol escape, cortisol 
feedback is decreased [17]. We showed 
that both in men and women the G/G BclI 
genotype was associated with higher 
cortisol concentrations after a 
dexamethasone exposure test, when 
compared to other genotypes. The results 
in men are in accordance with literature 
[6], and together these results imply that 
men and women with the G/G BclI 
genotype have decreased sensitivity to 
negative feedback of the HPA axis. 
 
Furthermore, to assess HPA axis feedback 
sensitivity under stress, we measured 
cortisol concentrations (nmol/L.min) 
corrected for baseline, over a 70 minutes 
time period after a high intensity test in 
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combination with dexamethasone 
suppression [14]. The high intensity 
exercise promotes the escape of cortisol 
from dexamethasone suppression, which 
indicates cortisol feedback sensitivity 
under stress [14]. We showed that after 
the high intensity test with 
dexamethasone suppression women with 
G/G BclI genotype had higher amounts of 
cortisol that escaped, as well as higher 
AUC of the cortisol concentrations, when 
compared to women with the C/G 
genotype. These results imply that women 
with the G/G BclI genotype have 
decreased sensitivity of the HPA axis to 
negative feedback under stress. 
 
Besides our study and the study from 
Kumsta et al. 2007 [13], no previous 
studies examined possible sex specific 
associations between BclI polymorphisms 
and HPA axis functioning, since other 
studies only included males [2, 6]. 
Kumstra et al. 2007 [13] have shown a 
sex specific association between BclI and 
HPA axis responses to psychosocial stress; 
together with the present study, these 
results point towards sex by genotype 
interactions, which suggests that the 
same genetic variant of the GR gene can 
have differential, or perhaps even 
opposite effects on HPA axis functioning 
depending on sex. The BclI polymorphism 
of the glucocorticoid receptor is thought to 
impact the efficacy of cortisol signaling 
and thereby influences the downstream 
biology of peripheral and central cortisol 
responsive systems [6]. The BclI 
polymorphism might therefore be one of 
the factors that underlie individual 
susceptibility to stress related disorders, 
such as depression and the metabolic 
syndrome [18].  From our study we 
conclude that the BclI genotype is sex 
specifically associated with increased 
cortisol exposure as well as decreased 
cortisol feedback sensitivity under stress. 
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Abstract 
Objective: to relate HPA axis functioning and HPA feedback functioning to body fat 
distribution in normal weight to obese subjects. 
Patients: 91 men and 103 women (age 18-45y, BMI 19-35 kg/m2, waist-to-hip ratio 
(WHR) 0.6-1.1)  
Measurements: we assessed anthropometry, body composition through 
hydrodensitometry and deuterium dilution method, cortisol variability through measuring 
5-hour cortisol concentrations, HPA axis feedback functioning through a dexamethasone 
suppression test, and HPA axis functioning under in a challenged condition through a 
standardized high intensity test under 4 mg dexamethasone. 
Results: in men an inverse relationship was observed between 5h cortisol exposure 
(nmol/ml) and fat mass index (FMI) (kg/m2) (r=0.55, p<0.001). In women inverse 
relationships were observed between 5h cortisol exposure (nmol/ml) and WHR (r=0.49, 
p<0.001), maximal workload (r=0.32, p<0.001) as well as oral contraceptive use 
(r=0.38, p<0.001). Similarly, in men an inverse relationship was observed between 
negative feedback expressed as baseline cortisol concentrations minus post 
dexamethasone cortisol concentrations (nmol/ml) and FMI (r=0.53, p<0.001). In women 
an inverse relationship was observed between negative feedback expressed as baseline 
cortisol concentrations minus post dexamethasone cortisol concentrations (nmol/ml) and 
WHR (r=0.43, p<0.001), maximal workload (r=0.30, p<0.001) as well as oral 
contraceptive use (r=0.43, p<0.001) in women. Moreover, an inverse relationship was 
observed between HPA axis functioning in a challenged condition expressed as percentage 
increase of cortisol concentrations after standardized high intensity test under 4 mg 
dexamethasone (%) and waist (r=0.21, p<0.10) in men and WHR (r=0.21, p<0.05) in 
women. In male subjects, strong positive relationships were observed between FMI and 
waist circumference (r = 0.85, p<0.001), as well as waist-to-hip ratio (r = 0.70, 
p<0.001).  
Conclusion: disturbance of HPA axis functioning under basal and challenged conditions is 
related to visceral fat accumulation. 
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Introduction 
The hypothalamus-pituitary-adrenal (HPA) 
axis is a neuro-endocrine system that 
plays an important role in the regulation 
of the stress-response [1]. The HPA axis is 
suggested to be involved in the 
pathogenesis of human obesity, in 
particular characterized by visceral fat 
distribution (visceral obesity). Support for 
the involvement of the HPA axis in the 
regulation of body weight and body fat 
distribution is found in two extremes of 
plasma cortisol levels in humans; 
Addison’s disease (hypocortisolism) that is 
related to weight loss, and Cushing’s 
syndrome (hypercortisolism) that is 
related to rapid weight gain, particularly 
of the trunk and face with sparing of the 
limbs [2].  
Additional support is found in obese 
subjects with visceral fat accumulation 
that show decreased salivary and serum 
cortisol levels [3-8], increased urinary 
secretion of cortisol [6, 9], decreased 
cortisol exposure [3, 4, 10-12], and 
enhanced awakening cortisol response 
[13]. In both lean and obese subjects 
visceral fat distribution has been 
associated with increased cortisol 
secretion after physical and psychological 
stressors [3-6, 9, 14]. These conflicting 
findings, such as decreased exposure and 
increased secretion after stressors, 
suggest a reset of the HPA axis toward 
chronic hyper-activation [15].  
The ability of cortisol to suppress its own 
secretion through activation of 
hypothalamic and pituitary glucocorticoid 
receptors (negative feedback) is an 
important part of adequate HPA axis 
functioning. Studies on the relationship 
between negative feedback and body fat 
distribution have however yielded 
inconclusive results.  Some studies found 
an increased capacity of dexamethasone 
(a glucocorticoid receptor agonist) to 
suppress plasma cortisol concentrations 
[4, 16], some studies found no differences 
in the capacity of dexamethasone to 
suppress plasma cortisol concentrations 
[3, 5, 6, 10] and some even a decreased 
capacity [17, 18]. This inconclusiveness 
possibly results from differences in 
techniques to test HPA feedback 
functioning.  
Ten years ago, Petrides et al. (1997) [19] 
developed a more elaborate technique to 
test HPA axis functioning, using a physical 
challenge to promote escape of cortisol 
from dexamethasone suppression. Using 
this technique they observed even in a 
relative homogenous population of young 
men a large inter-individual variance in 
HPA functioning [19]. It remains unknown 
whether inter-individual variation in HPA 
axis functioning can be related to fat 
distribution in a normal-weight to obese 
population, and whether HPA axis 
functioning tested under 4 mg 
dexamethasone in combination with a 
physical stressor is related to fat 
distribution. Therefore, the objective of 
our study was to relate HPA axis 
functioning and HPA feedback functioning 
to body fat distribution in normal weight 
to obese subjects.  
 
Subjects and methods 
Subjects and protocol 
The study was approved by the Medical 
Ethical Committee of Maastricht 
University, and a written consent was 
obtained from all subjects. Healthy, 
medication-free, non-smoking men (n = 
91) and women (n = 105) aged between 
18 to 45 y and with a BMI between 19 and 
35 kg/m2 were recruited to complete all 
phases of this study. From 196 subjects 
recruited, 91 men and 103 women 
completed the study, 2 subjects dropped 
out before the actual start of the study. A 
medical history was obtained from each 
subject before entry into the study 
containing questions on illness, medicine 
use, smoking habits, daily coffee intake, 
weekly alcohol intake and food allergies. 
Exclusion criteria for our study were: 
smoking, excessive alcohol consumption, 
chronic illness, depression, and a history 
of eating disorders or current dieting. The 
women were examined regardless of the 
phase of the menstrual cycle. From each 
subject we obtained:  
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anthropometry as well as body 
composition,5-hour cortisol exposure 
measurement, a progressive maximal 
cycling test to volitional exhaustion and a 
high intensity test under 4 mg 
dexamethasone. 
 
Measurements 
Anthropometry and body composition  
Measurements were carried out in the 
morning after voiding the bladder and 
before breakfast. Body weight (Sauter 
D7470, Ebingen, Germany) and height 
(Seca, model 220, Hamburg, Germany) 
were measured to the nearest 0.01 kg 
and 0.1 cm respectively. BMI (kg/m2) was 
calculated as body weight (kg) divided by 
height (m) squared. The waist 
circumference was measured to the 
nearest 0.1 cm at the site of the smallest 
circumference between the rib cage and 
the ileac crest, whereas the hip 
circumference was measured to the 
nearest 0.1 cm at the level of maximum 
extension of the buttocks. The waist-to-
hip ratio (WHR) was calculated 
accordingly. Both measurements were 
done with the subjects in standing 
position. Additionally, both waist 
circumference and the WHR were used to 
define different patterns of body fat 
distribution. Waist circumference and 
waist-to-hip measurements were used as 
surrogates for body fat distribution 
measurements, as anthropometric 
measurements have been shown to 
predict total and abdominal fat content 
[20-22]. 
Body density was determined by 
hydrodensitometry with simultaneous 
measurements of residual lung volume 
with the helium dilution technique. Total 
body water (TBW) was determined with 
the deuterium dilution method following 
the Maastricht protocol [23]. Body 
composition was calculated from body 
density and TBW using the three-
compartment model of Siri. Fat free mass 
(FFM) was calculated by dividing TBW by 
the hydration factor 0.73.  Fat mass (FM) 
was determined as BW-FFM. Fat mass 
index (FMI) was calculated by fat 
mass/height2 (kg/m2) and fat free mass 
index (FFMI) was calculated by fat free 
mass/height2 (kg/m2). 
 
5-hour cortisol exposure measurement 
At 8 a.m. after an overnight fast an 
intravenous catheter for blood sampling 
was inserted into the forearm vein. Direct 
after insertion of the catheter the first 
blood sample (9 ml) was drawn (0 
minutes), and after 15 minutes the 
subjects received their breakfast (20 % of 
the subjects’ daily energy requirement). 
The daily energy requirements were 
calculated by multiplying the basal 
metabolic rate (BMR) by an activity index 
of 1.75. The BMR (MJ/day) was calculated 
according to the equations of Harris-
Benedict [24]. At 45, 90 and 210 minutes 
the second, third and fourth blood 
samples were drawn. At 225 minutes the 
subjects received their lunch (30 % of the 
subjects’ daily energy requirement) and at 
255 and 300 minutes the fifth and sixth 
blood samples were drawn. During the 
test subjects were able to drink water ad 
libitum. The participants’ 5-hour cortisol 
exposure was measured by calculating the 
area under the curve (AUC) (0-300 
minutes). 
 
Progressive maximal cycling test to 
volitional exhaustion 
Each subject underwent a progressive 
maximal cycling test to volitional 
exhaustion for quantification of maximal 
workload (Wmax) [25]. Subjects cycled 
on an electromagnetically braked bicycle 
ergometer (Lode, Groningen, The 
Netherlands) at 80 rpm, at a workload of 
75 W for women and 100 W for men. 
After 5 minutes, the workload was 
increased every 2.5 minutes with 50 W, 
until subjects were no longer able to 
maintain a pedaling frequency above 80 
rpm. Heart rate was monitored 
continuously throughout all exercise 
protocols (Polar s610). Verification that 
each subject actually achieved Wmax 
consisted of meeting the criteria of 
achieving predicted maximal heart rate. 
The results of the progressive maximal 
cycling test were used to measure the 
resistance to elicit an exercise intensity of 
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90 % of each Wmax (V) for the high 
intensity test under 4 mg dexamethasone.  
 
High intensity test under 4 mg 
dexamethasone 
The maximal cycling test and high 
intensity test under 4 mg dexamethasone 
[19] were separated by at least one week. 
Each subject received 4 mg 
dexamethasone 8 hours before the high 
intensity test. Each subject participated in 
the treatment, and no adverse reactions 
were reported. Subjects abstained from 
alcohol consumption and strenuous 
exercise 15 h before testing. At 8 a.m. 
after an overnight fast, an intravenous 
catheter for blood sampling was inserted 
into the forearm vein and the first blood 
sample was drawn for a baseline 
measurement (0 minutes), and after 5 
minutes the subjects received their 
breakfast (20 % of the subjects’ daily 
energy requirement). At 15 minutes the 
second blood sample was taken and the 
high intensity test was started. At 30 
minutes the high intensity test ended and 
the third blood sample was taken. At 40, 
50, 60 and 70 minutes, the fourth, fifth, 
sixth and seventh blood samples were 
taken.  
The high intensity test consisted of 15 
minutes of cycling. The initial 5 minutes 
served as a warming-up, during which 
each subject cycled at a workload of 40 % 
of his/her Wmax (V), at 80 rpm. After the 
warming-up, the workload was increased 
with 50 % of his/her Wmax (V) for 30 sec 
at 80 rpm, followed by a decrease of the 
workload with 50 % for 30 sec at 80 rpm. 
The increase and decrease of workload 
was repeated 10 times. After the third 
blood sample was drawn a 5 minutes 
cooling-down was performed at 30 % of 
Wmax (V) at 60 rpm.  
Subjects’ negative feedback functioning 
(nmol/ml) was calculated as the cortisol 
concentrations of the baseline sample of 
the cortisol exposure measurement (0 
min) minus the cortisol concentrations of 
the baseline sample after dexamethasone 
ingestion (0 min). When low amounts of 
cortisol were present after 
dexamethasone suppression, cortisol 
feedback was strong and when high 
amounts of cortisol were present, cortisol 
feedback was decreased. 
Subjects’ HPA axis functioning in a 
challenged condition under 4 mg 
dexamethasone (%) was calculated as the 
difference between the highest cortisol 
concentrations after the high intensity test 
(30 or 40 minutes) and the cortisol 
concentration of the baseline sample after 
dexamethasone ingestion (0 min), 
subsequently divided by the cortisol 
concentrations of the baseline sample 
after dexamethasone ingestion (0 min). 
When low amounts of cortisol escaped 
during the high intensity test, cortisol 
feedback was strong and/or cortisol 
production was low, when high amounts 
of cortisol escaped, cortisol feedback was 
decreased and/or cortisol production was 
high [19].  
 
Blood samples 
Serum cortisol concentrations were 
measured using RIA (Buhlmann 
Laboratories) with a intra-assay coefficient 
variation of < 6%.  
 
Statistical analysis 
Differences between two groups were 
determined using t-tests. Relationships 
between dependent and independent 
variables were determined using simple 
linear and multiple regression models. All 
statistical tests were two-tailed, 
differences were considered significant at 
p < 0.05 and values are expressed as 
mean ± standard deviation.  
 
Results 
Table 1 shows the characteristics of the 
male (n = 91) and female (n = 103) 
subjects. No significant differences were 
observed in age, BMI and hip 
circumference. The men showed 
significantly larger height, weight, waist 
circumference, waist-to-hip ratio (WHR) 
and maximal workload when compared to 
the women. The women showed 
significantly larger body fat percentage, 
and fat mass index when compared to the 
men. FMI (kg/m2) was used to define 
body composition, and waist 
circumference (cm) as well as WHR was  
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Table 1: Characteristics of the male (n = 91) and female subjects (n = 103) 
 Men   Women  P value1 
Age (year) 28.1 ± 8.9 27.1 ± 8.6 0.84 
Height (cm) 181.4 ± 6.9  169.0 ± 6.4  0.01 
Body weight (kg) 82.4 ± 11.9 72.3 ± 12.5  0.01 
Body mass index (kg/m2)  25.1 ± 3.6 25.3 ± 4.1  0.68 
Body fat percentage (%) 20.3 ± 9.6 32.0 ± 8.9 0.01 
Fat Mass Index (FMI) (kg/m2) 5.4 ± 3.2 8.5 ± 3.5 0.01 
Waist circumference (cm) 88.1 ± 10.1 79.9 ± 10.3 0.01 
Hip circumference (cm) 103.4 ± 6.6 105.3 ± 9.5  0.14 
Waist hip ratio 0.85 ± 0.07 0.75 ± 0.06 0.01 
Maximal workload (Wmax) (V) 292.8 ± 56 204.5 ± 47 0.01 
5-hour cortisol exposure (nmol/L.min) 0.9 (105) ± 0.2 1.3 (105) ± 0.7 0.01 
Baseline cortisol minus post dexamethasone 
cortisol concentrations (nmol/ml) 
432.3 ± 103.9 624.7 ± 279.6 0.05 
Percentage increase of cortisol concentrations 
after standardized high intensity test under 
4mg dexamethasone (%) 
17.7 ± 12.6 20.8 ± 19.9 0.05 
Values are means ± sd.  
1 Differences between men vs. women (t-test) 
 
used to define different patterns of body 
fat distribution. Additionally, the women 
showed significantly higher 5-hour cortisol 
exposure (nmol/L.min), baseline cortisol 
minus post dexamethasone cortisol 
concentrations (nmol/ml), and percentage 
increase of cortisol concentrations after 
standardized high intensity test under 4 
mg dexamethasone (%) when compared 
to the men. Because of differences in HPA 
axis functioning the results for male and 
female subjects were analyzed separately. 
Subsequently, to study the relationship 
between HPA axis functioning and body 
fat distribution, the three parameters of 
HPA axis functioning were related to FMI, 
waist circumference, waist-to-hip ratio 
and possible confounders which have been 
related previously to HPA axis functioning, 
such as maximal workload, oral 
contraceptive intake and daily coffee 
intake.  
 
Subjects’ 5-hour cortisol exposure 
(nmol/L.min) 
In male subjects, inverse relationships 
were observed between 5h cortisol 
exposure and BMI (r = 0.43, p<0.001), 
FMI (r = 0.55, p<0.001), waist 
circumference (r = 0.23, p<0.001) and 
waist-to-hip ratio (r = 0.27, p<0.02). 
Multiple regression analysis with 5h 
cortisol exposure as the dependent 
variable showed that only FMI significantly 
contributed to the explained variance. 
 
In female subjects, inverse relationships 
were observed between 5h cortisol 
exposure and BMI (r = 0.39, p<0.001), 
FMI (r = 0.38, p<0.001), waist 
circumference (r = 0.47, p<0.001), and 
waist-to-hip ratio (r = 0.49, p<0.001). 
Positive relationships were observed 
between 5h cortisol exposure and 
maximal workload (r = 0.32, p<0.001) 
and oral contraceptive use (r = 0.39, 
p<0.001). Multiple regression analysis 
with 5h cortisol exposure as the 
dependent variable showed that only 
waist-to-hip ratio, maximal workload and 
oral contraceptive use significantly 
contributed to the explained variance (r = 
0.60, p<0.001). 
 
Subjects’ negative feedback functioning 
(nmol/ml) 
In male subjects, inverse relationships 
were observed between baseline cortisol 
minus post dexamethasone cortisol 
concentrations and BMI (r = 0.43, 
p<0.001), FMI (r = 0.53, p<0.001) 
(figure 1a), waist circumference  
(r = 0.48, p<0.001) and waist-to-hip ratio 
(r = 0.36, p<0.002). Multiple regression 
analysis with baseline cortisol minus post 
dexamethasone cortisol concentrations as 
the dependent variable showed that only 
FMI significantly contributed to the 
explained variance.  
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Figure 1a: relationship between baseline cortisol minus 
post dexamethasone cortisol concentrations (nmol/ml) 
and fat mass index (FMI) (kg/m2) (r = 0.43, p<0.001) 
in male subjects (n = 91) 
 
 
In female subjects, inverse relationships 
were observed between baseline cortisol 
minus post dexamethasone cortisol 
concentrations and BMI (r = 0.34, 
p<0.001), FMI (r = 0.32, p<0.001), waist 
circumference (r = 0.41, p<0.001), and 
waist-to-hip ratio (r = 0.43, 
p<0.001)(figure 1b). Positive 
relationships were observed between 
baseline cortisol minus post 
dexamethasone cortisol concentrations 
and maximum workload (r = 0.30, 
p<0.001) and oral contraceptive use (r = 
0.43, p<0.001).  
 
Figure 1b: relationship between baseline cortisol minus 
post dexamethasone cortisol concentrations (nmol/ml) 
and waist-to-hip ratio (r = 0.43, p<0.001) in female 
subjects (n = 103) 
 
 
Multiple regression analysis with baseline 
cortisol minus post dexamethasone 
cortisol concentrations as the dependent 
variable showed that only waist-to-hip 
ratio, maximum workload and oral 
contraceptive use significantly contributed 
to the explained variance (r = 0.59, 
p<0.001).  
 
Subjects’ HPA axis functioning in a 
challenged condition under 4 mg 
dexamethasone (%) 
In male subjects, an inverse relationship 
was observed between percentage 
increase of cortisol concentrations after 
standardized high intensity test under 4 
mg dexamethasone and waist 
circumference (r = 0.21, p<0.10). 
In female subjects, inverse relationships 
were observed between percentage 
increase of cortisol concentrations after 
standardized high intensity test under 4 
mg dexamethasone and BMI (r = 0.19, 
p<0.05), waist circumference (r = 0.23, 
p<0.04), and waist-to-hip ratio (r = 0.21, 
p<0.05). Multiple regression analysis with 
percentage increase of cortisol 
concentrations after standardized high 
intensity test under 4 mg dexamethasone 
as the dependent variable showed that 
only waist-to-hip ratio significantly 
contributed to the explained variance.  
 
In both male and female subjects, a 
positive relationship was observed 
between 5-hour cortisol exposure 
(nmol/ml) and baseline cortisol minus 
post dexamethasone cortisol 
concentrations (nmol/ml) (r = 0.68, 
p<0.001 and r = 0.86, p<0.001). 
 
In male subjects, strong positive 
relationships were observed between FMI 
and waist circumference (r = 0.85, 
p<0.001), as well as waist-to-hip ratio (r 
= 0.70, p<0.001). 
 
Discussion 
The objective of our study was to relate 
HPA axis functioning and HPA feedback 
functioning to body fat distribution in 
normal weight to obese subjects. We 
therefore tested the relationship between 
several parameters of HPA axis 
functioning, body composition and body 
fat distribution measured as waist 
circumference and waist-to-hip ratio. 
Waist circumference and waist-to-hip 
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measurements were used as surrogates 
for body fat distribution measurements, as 
anthropometric measurements have been 
shown to predict total and abdominal fat 
content[20-22].  
 
Firstly, we investigated the relationships 
between cortisol exposure measured over 
5 hours, body composition and body fat 
distribution. In accordance to the 
literature [3, 4, 10-12] we observed that 
cortisol exposure was related to a higher 
FMI in men and a higher waist-to-hip ratio 
in women. This sex difference is likely to 
be caused by the fact that men tend to 
progressively increase visceral fat depots 
with increasing adiposity, while women 
tend to develop different types of body fat 
distribution (visceral or peripheral) [26], 
which is supported by the strong 
relationship between FMI and waist 
circumference as well as waist-to-hip ratio 
in men in our study. This suggests that in 
both men and women low cortisol 
exposure is related to visceral fat 
distribution. Low cortisol exposure is a 
sign of a decreased HPA axis activity, 
which is for instance also observed in 
subjects with chronic stress and 
depression [4, 27]. As expected and in 
concordance with previous studies we 
observed that in the women HPA axis 
functioning was related to oral 
contraceptive use [28, 29], but also to 
baseline exercise levels. These 
relationships were however independent 
of the relationship between HPA axis 
functioning and visceral fat disposition. A 
limitation of the present study is that the 
women were examined regardless of the 
phase of their menstrual cycle, as 
previous studies have shown differences 
in basal cortisol concentrations between 
the luteal and follicular phase, which is 
about 3% [28].  The women being in 
different phases of the menstrual cycle 
can thus not explain the differences in 
basal cortisol concentrations between 
women with a high or low waist-to-hip 
ratio. However, for future studies 
information on the menstrual cycle should 
be taken into account. 
 
Secondly, we investigated the 
relationships between HPA axis feedback 
functioning, body composition and body 
fat distribution, measured through a 4 mg 
dexamethasone suppression test. In 
accordance to part of the literature [17, 
18] we observed that reduced negative 
feedback of the HPA axis in a non-
challenged condition (i.e. high amounts of 
cortisol present after dexamethasone 
suppression) was related to a higher FMI 
in men and a higher waist-to-hip ratio in 
women. Other studies however have 
shown an inverse [4, 16], no relationship 
[3, 5, 6, 10] or sex specific associations 
[16]; this inconclusiveness may result 
from different dosages of dexamethasone, 
as they used smaller dosages of 
dexamethasone (0.05 to 0.25 mg). Low 
dosages of dexamethasone may not be 
potent enough to detect possible 
differences in HPA axis feedback 
functioning, as Ljung et al 1996 [17] 
observe no differences in inhibition when 
using low dosages (0.05 and 0.125 mg) 
but did observe differences when using a 
higher dosage (0.5 mg). We therefore 
suggest that a protocol that includes the 
range of dexamethasone dosage of 0.5 to 
4 mg is necessary to detect subtle 
differences in HPA axis feedback 
functioning. The relationship between 5-h 
cortisol exposure and the suppression of 
non-challenged cortisol levels by 
dexamethasone that was observed in both 
men and women, strongly suggest that a 
diminished negative HPA axis feedback is 
one of the mechanisms that is responsible 
for the relatively low 5-h cortisol exposure 
in visceral obesity.  
 
Thirdly, we investigated the relationship 
between HPA axis functioning in a 
challenged condition under 4 mg 
dexamethasone, body composition and 
body fat distribution, measured through a 
high intensity test under 4 mg 
dexamethasone [19]. In accordance to 
previous studies that only measured lean 
subjects [19, 30] a significant sex 
difference was observed in HPA axis 
functioning in a challenged condition 
under 4 mg dexamethasone. Moreover, 
we observed differences in HPA axis 
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functioning i.e. relatively lower cortisol 
levels after a challenged condition under 
dexamethasone that related to a higher 
waist circumference in men and a higher 
waist-to-hip ratio in women. This is in 
contrast with the non-challenged condition 
under dexamethasone, where relatively 
higher cortisol levels after dexamethasone 
suppression were related to a higher fat 
mass index in men and a higher waist-to-
hip ratio in women. Several mechanisms 
are hypothesized that could underlie the 
discrepancy between the challenged and 
the non-challenged condition. Since 
dexamethasone is unable to cross the 
blood-rain barrier [31], cortisol levels 
after dexamethasone suppression reflect 
negative feedback functioning only at the 
level of the pituitary. Therefore, it cannot 
be excluded that the negative feedback 
mechanisms at the level of the pituitary 
and the hypothalamus are distinctly 
influenced by visceral obesity, and that 
visceral obesity is associated with an 
increased negative feedback at the level 
of the hypothalamus, which in the current 
study became predominant in the 
exercise-challenged condition. 
Alternatively, it can be hypothesized that 
the decreased negative feedback signaling 
in visceral obesity, as shown in our non-
challenged condition and confirmed by 
others [17, 18], is associated with a 
decreased responsiveness of the HPA axis 
to (physical) stress. Under normal, 
dexamethasone-free conditions, where 
differences in feedback sensitivity may 
play a role, the increased cortisol 
response to stress [3-6, 9, 14] could then 
be attributed to the decreased efficacy of 
cortisol to suppress its own secretion.  
 
Taken together all our observations 
pointed into the same direction, as we 
observed that in lean to overweight 
subjects, low cortisol exposure, enhanced 
negative feedback, and altered HPA axis 
functioning in a challenged condition 
under 4 mg dexamethasone is related to 
waist circumference in men and to waist-
to-hip ratio in women. Our results are 
thus consistent with previous work that 
suggests a deregulation of the HPA axis in 
humans with relative more visceral fat. It 
is however still not clear whether the HPA 
axis is causally or co-incidentally related 
to (visceral) obesity, which only can be 
determined using a longitudinal study. 
From our results, we conclude that 
disturbance of HPA axis functioning under 
basal and challenged conditions is related 
to visceral fat accumulation. 
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Abstract 
Background: obesity results from chronic deregulation of energy balance, which may in 
part be caused by stress.  
Objective: to investigate the effect of acute and psychological stress on food intake, 
using the eating in the absence of hunger paradigm, in normal- and overweight men and 
women ,while taking dietary restraint and disinhibition into account. In 129 subjects (BMI 
= 24.5±3.4 kg/m2 and age = 27.6±8.8y), scores were determined on the Three Factor 
Eating Questionnaire (dietary restraint = 7.2±4.4; disinhibition = 4.5±2.6; feeling of 
hunger = 3.9±2.6) and State-Trait Anxiety Inventory (trait score = 31.7±24.2). In a 
randomized crossover design, the ‘eating in absence of hunger’ protocol was measured as 
a function of acute stress versus a control task and of state anxiety scores. 
Results: energy intake from sweet foods (708.1 vs. 599.4 kJ, p<0.03) and total energy 
intake (965.2 vs. 793.8 kJ, p<0.01) were significantly higher in the stress compared to 
the control condition. Differences in energy intake between the stress and control 
condition were a function of increase in state anxiety scores during the stress task (R2 = 
0.05, p<0.01). This positive relationship was stronger in subjects with high disinhibition 
scores (R2 = 0.12, p<0.05). Differences in state anxiety scores were a function of trait 
anxiety scores (R2 = 0.07, p<0.05).  
Conclusion: acute psychological stress is associated with eating in the absence of 
hunger, especially in vulnerable individuals characterized by disinhibited eating behavior 
and sensitivity to chronic stress. 
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Introduction 
The prevalence of overweight and obesity 
has increased worldwide to epidemic 
proportions [1]. Obesity results from a 
chronic deregulation of energy balance, 
with energy intake exceeding energy 
expenditure, leading to the storage of the 
excessive energy as fat [2]. This chronic 
deregulation of energy balance may be 
caused, in part, by stress, since in 
Western society high levels of ambient 
stress are abundantly present [3].  
Several human studies in laboratory 
settings indicate that, in adults, acute 
stress may influence energy intake [3-7]. 
Acute stress alters food preference, eating 
frequency, and amount of energy intake 
[3, 5]. During stress, food preference is 
altered towards intake of sweet foods and 
foods with saturated fats, next to an 
increase in the intake frequency and 
amount of food intake [4, 6, 7]. However, 
not all studies that investigated the 
relationship between energy intake and 
stress have yielded conclusive results [8, 
9]. Stress may also result in a decrease in 
energy intake [8, 9]. These individual 
differences in response to stress may 
relate to eating behavior characteristics 
[4-7], as are determined using the Three 
Factor Eating Questionnaire (TFEQ). The 
TFEQ assesses three factors involved in 
eating behavior: dietary restraint; 
disinhibition; and hunger [10]. An 
increase in energy intake during stress 
has been found in individuals with high 
scores on dietary restraint and/or 
disinhibition [4-7].  
A possible technique to study the effect of 
stress on food intake is the ‘Eating in the 
absence of hunger’ paradigm [11]. Eating 
in the absence of hunger is the behavioral 
phenotype in which individuals eat when 
exposed to large portions of palatable 
foods in the absence of hunger. The 
paradigm has primarily been used in 
children [11] and was thought to 
resemble disinhibited eating patterns 
observed in adults [11]. Therefore, the 
objective of our study was to investigate 
the effect of acute psychological stress on 
food intake, using the eating in the 
absence of hunger paradigm, in normal- 
and overweight men and women, while 
taking dietary restraint and disinhibition 
into account.  
 
Subjects and methods 
Subjects  
The study was approved by the Medical 
Ethical Committee of Maastricht 
University, and informed, written consent 
was obtained from all subjects. Healthy, 
medication-free, non-smoking men (n = 
65) and women (n = 65), 18 to 45 y and 
with a BMI of 20 to 35 kg/m2 were 
recruited to complete all phases of this 
study. A medical history was obtained 
from each subject before entry into the 
study, and exclusion criteria were chronic 
illness, depression, and a history of eating 
disorders or current dieting. From 130 
subjects recruited, 65 men and 64 women 
completed the study, and 1 subject 
dropped out before the actual start of the 
study. Subjects were not told the real 
purpose of the study but instead were 
given a cover story on the effect of 
activity on leptin concentrations. 
 
Experimental design 
The study was performed in a within-
subjects, randomized, crossover design. 
Each subject reported to the laboratory on 
3 occasions for: 1) measurement of 
anthropometry and subject 
characterization; 2) measurement of 
‘eating in absence of hunger’ protocol in 
combination with a stress task; and 3) 
measurement of ‘eating in absence of 
hunger’ protocol in combination with a 
control task.  
The anthropometry measurements 
consisted of body weight, height, waist 
and hip circumference determination. 
Subjects also completed the State-Trait 
Anxiety Inventory (STAI trait) and the 
Three Factor Eating Questionnaire (TFEQ), 
which assesses restraint, disinhibition, and 
feeling of hunger. 
‘Eating in absence of hunger’ was 
measured as a function of acute stress 
versus control. Analog scales (VAS) that 
measure hunger and satiety were used to 
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determine if subjects ate beyond fullness. 
A mental arithmetic task with sums that 
subjects could (control task) or could not 
solve (stress task) was used as a stress 
manipulation. To investigate whether the 
stress condition inflicted psychological or 
physiological changes, we used the profile 
of mood states (POMS) and state-anxiety 
(STAI state) questionnaires, as well as 
heart rate and blood pressure 
measurements. Before the eating in 
absence of hunger measurements, 
subjects were made familiar with the VAS, 
POMS, and STAI state questionnaires and 
were trained to complete them 
routinously, in order not to disturb the 
actual activity they were involved in 
during the measurements.   
 
Measurements 
Anthropometry  
Measurements were obtained in the 
morning after voiding the bladder and 
before breakfast. Body weight (Sauter 
D7470, Ebingen, Germany) and height 
(Seca, model 220, Hamburg, Germany) 
were measured to the nearest 0.01 kg 
and 0.1 cm, respectively. BMI (kg/m2) 
was calculated as body weight (kg) 
divided by height (m) squared. The waist 
circumference was measured to the 
nearest 0.1 cm at the site of the smallest 
circumference between the rib cage and 
the iliac crest, whereas the hip 
circumference was measured to the 
nearest 0.1 cm at the level of maximum 
extension of the buttocks. The waist and 
hip circumference measurements were 
obtained with subjects in the standing 
position [12]. 
 
Eating behavior 
Eating behavior was analyzed using a 
validated Dutch translation of the TFEQ 
[10, 13]. The TFEQ measures three 
components of eating behavior. Dietary 
restraint reflects the extent to which 
individuals attempt to cognitively control 
their food intake. Disinhibition of restraint 
reflects loss over control over eating in 
response to the presence of palatable food 
or other disinhibiting stimuli, such as 
emotional distress. The third factor 
measures the subjective feeling of hunger. 
Based upon the median for the TFEQ 
scores in the South of the Netherlands, 
subjects were characterized as 
unrestrained when dietary restraint scores 
were < 9, and as restrained when scores 
were ≥ 9. Subjects were characterized as 
having low disinhibition when disinhibition 
scores were  < 5, and as having high 
disinhibition when scores were ≥ 5 [13]. 
 
Visual Analog Scales (VAS) 
Aspects of appetite were assessed using 
100 mm visual analog scales (VAS) with 
questions about feelings of hunger, 
satiety, thirst, and desire to eat. Opposing 
extremes of each feeling were described 
at either end of the 100-mm horizontal 
line, and subjects marked the line to 
indicate how they felt at that moment 
[14]. Completion of the VAS questionnaire 
took our experienced subjects about 0.5 
minute. During the ‘eating in absence of 
hunger’ protocol, appetite profiles were 
assessed three times: before lunch, 5 
minutes after lunch, and 30 minutes after 
the stress or control task.  
 
Profile of Mood States (POMS) 
Aspects of mood were assessed using the 
Dutch translation of the Profile of Mood 
States (POMS) [15]. This questionnaire 
contains 70 adjectives that are rated on a 
five-point scale, anchored by “much like 
this” to “much unlike this” and is divided 
into five subscales (depression, tension, 
confusion, fatigue and anger), each 
scoring a maximum of 35 points. An 
increase in POMS scores is associated with 
a worsening in mood, except in the case 
of “vigor” [15]. Completion of the POMS 
questionnaire took our experienced 
subjects only 3 minutes. During the 
‘eating in absence of hunger’ protocol, 
mood profiles were assessed five times: 5 
minutes after lunch, and at 0, 10, 20 and 
30 minutes after the stress or control 
task. 
   
State-Trait Anxiety Inventory (STAI) 
Anxiety was assessed using the Dutch 
translation of the State-Trait Anxiety 
Inventory (STAI) [16]. This questionnaire 
consists of two subscales: the trait scale 
(anxiety-trait) and the state scale 
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(anxiety-state). The trait scale refers to 
individual differences in the likelihood that 
a person would experience state anxiety 
in a stressful situation, and thereby refers 
to chronic feelings of anxiety. The state 
scale refers to the transitory emotional 
response involving unpleasant feelings of 
tension and apprehensive thoughts. Both 
scales are composed of 20 questions rated 
on a four-point scale, ranging from  “much 
like this,” to “much unlike this” and 
require that subjects describe how they 
feel generally, on the anxiety-trait scale, 
and how they feel at a specific moment, 
on the anxiety-state scale [16]. Each 
subscale of the questionnaire can score a 
maximum of 80 points and an increase in 
STAI trait or state scores is associated 
with an increase in anxiety. Completion of 
the STAI state questionnaire took our 
experienced subjects only 2 minutes. At 
the start of the experiment subjects filled 
in the trait scale and during the ‘eating in 
absence of hunger’ protocol, state anxiety 
was assessed five times: 5 minutes after 
lunch, and at 0, 10, 20 and 30 minutes 
after the stress or control task. 
 
Stress/control task 
During the ‘eating in the absence of 
hunger’ protocol subjects received a 
mental arithmetic task with sums that 
they could or could not solve  (control 
versus stress task). Subjects were told to 
solve the sums within the time limits 
specified by the assignment. The control 
and stress tasks were presented in 
random order to the subjects. The 
arithmetic task was a modified and 
improved version of the computer 
program previously described and 
validated by Peters et al. 1998 [17]. 
 
‘Eating in the absence of hunger’ protocol 
The ‘eating in the absence of hunger’ 
protocol consisted of consumption of a 
standard lunch, followed by completion of 
a stress or control task, and was 
concluded with half an hour in which 
subjects had free-access to snacks. The 
‘eating in the absence of hunger’ protocol 
was started by completing a VAS, and 
followed by a standard lunch to minimize 
the influence of hunger on the subjects’ 
snack intake. The lunch contained 30% of 
the subjects’ daily energy requirement 
and consisted of typical Dutch lunch 
products, namely brown bread (1.0 MJ per 
100 g; en% C/P/F: 74/15/11) with young 
cheese (1.6 MJ per 100 g; en% C/P/F: 
0/26/74), as well as ab libitum tea or 
water consumption. The daily energy 
requirements were calculated by 
multiplying the basal metabolic rate (BMR) 
by an activity index of 1.75. The BMR 
(MJ/day) was calculated according to the 
equations of Harris-Benedict [18]. 
Subjects were given 15 minutes to 
consume the lunch and were instructed to 
eat until they were satiated. Immediately 
after lunch, subjects completed POMS and 
state anxiety questionnaires and 
completed a stress or control task. After 
completing VAS, POMS and state anxiety 
questionnaires, which took about 5 
minutes, subjects were retained in the 
research room for half an hour in which 
they were allowed to relax and read 
magazines. During this half hour the 
subjects were presented a tray with 
containers holding generous pre-weighed 
portions of sweet snack foods, including 
100 g chocolate (2.2 MJ per 100 g) and 
200 g fruit-chew candy (1.5 MJ per 100 
g), as well as salty snack foods that 
included 100 g potato chips (2.4 MJ per 
100 g), 50 g pretzels (2.1 MJ per 100 g), 
and 200 g nuts (2.7 MJ per 100 g). The 
subjects were instructed to eat as much 
as they wished of any of the foods. Every 
10 minutes during the half hour, subjects 
completed POMS and state anxiety 
questionnaires. At the end of the half hour 
the subjects completed VAS, POMS and 
state questionnaires one more time. After 
the subjects left, each of the containers 
holding the snack foods were weighed to 
determine food choice and the amount 
eaten. Before and after completing the 
stress or control tasks, heart rate (bpm), 
and systolic and diastolic blood pressure 
(mmHg) were measured using an 
automated device (WelclAllyn OSZ 5 easy, 
Spreidel and Keller GmBH and Co, KG, 
Jungingen, Germany). 
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Statistical analysis 
Differences between men and women, as 
well as treatments (control and stress), 
were determined using unpaired t-tests. 
Differences over time and between 
treatments (control and stress) were 
determined using two-factor ANOVA with 
repeated measures. To analyze whether 
the amount of stress experienced during 
the stress task predicted the difference in 
energy intake between the stress and 
control condition, a simple linear 
regression model was used, depicting the 
differences in energy intake between the 
stress and control condition (∆ energy 
intake) as the dependent variable and the 
differences in state anxiety scores 
immediately after compared to before the 
stress task (∆ state anxiety scores) as the 
independent variable. The relation 
between dependent (∆ state anxiety 
scores) and independent (trait anxiety 
scores) variable was determined using a 
linear regression model. 
All statistical tests were two-sided. 
Differences were considered significant at 
p < 0.05, and values were expressed as 
mean ± standard deviation.  
 
Results 
Subject characteristics 
The characteristics of the subjects are 
summarized in table 1. Participants were 
18 to 48 years old, and their BMI ranged 
from 19.8 to 34.8 kg/m2. Men had a 
predictably higher height, body weight, 
and waist circumference than women. 
Women had higher dietary restraint, 
disinhibition, and feeling of hunger scores 
than men. The age, BMI, hip 
circumference and trait anxiety scores did 
not differ between the sexes. We did not 
analyze the results of men and women 
separately, because no significant 
differences were found between men and 
women in VAS, POMS, and state anxiety 
scores, or in energy intake during the 
eating in absence of hunger protocol (data 
not shown).  
 
 
 
 
Table 1: Characteristics of subjects (n = 129) 
 Men  
(n = 65) 
Women  
(n = 64)  
P value1 
Age (year) 28.1 ± 8.9 27.1 ± 8.6 0.84 
Height (cm) 181.2 ± 7.5  168.7 ± 6.2  0.01 
Body weight (kg) 79.8 ± 10.2 69.9 ± 10.4  0.01 
Body mass index (kg/m2)  24.4 ± 3.3  24.6 ± 3.6  0.74 
Waist circumference (cm) 85.7 ± 9.5 78.8 ± 7.9 0.01 
Hip circumference (cm) 102.2 ± 6.2 104.7 ± 8.5  0.12 
Trait anxiety score  31.6 ± 6.7 31.9 ± 6.7 0.77 
Dietary restraint score 5.8 ± 3.9 8.8 ± 4.4  0.01 
Disinhibition score 3.4 ± 1.7   5.6 ± 2.8  0.01 
Feeling of hunger score 3.5 ± 2.5    4.4 ± 2.6  0.03 
Values are means ± sd.  
1 Differences between men vs. women (t-test) 
 
State anxiety scores 
The changes in state anxiety scores over 
time in the stress and control condition 
are depicted in figure 1. The state 
anxiety scores were significantly higher in 
the stress condition compared to the 
control condition, immediately (31.3 ± 8.8 
vs. 27.9 ± 6.4, p <0.001) and 10 minutes 
(28.4 ± 7.7 vs. 27.3 ± 6.9, p < 0.05) 
after receiving the stress or control task 
(figure 1). After receiving the stress task, 
state anxiety scores increased 
significantly, while in the control condition 
no significant changes were observed (4.2 
± 5.7 vs. -0.8 ± 0.3, p < 0.001) (figure 
1). 
 
Figure 1: Changes in state anxiety scores (means) over 
time in the stress and control condition in all subjects (n 
= 129)  
 
* p < 0.05 for differences in time in the stress compared 
to the control condition (ANOVA repeated measures) 
 
POMS scores 
The POMS scores were significantly higher 
in the stress condition compared to the 
control condition, namely immediately 
after receiving the stress task in four out 
of five POMS categories, which are 
depression (15.7 ± 4.1 vs. 14.2 ± 3.5, p 
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< 0.05), tension (14.7 ± 5.1 vs. 12.7 ± 
3.7, p < 0.05), confusion (15.9 ± 4.3 vs. 
14.7 ± 3.1, p < 0.05) and anger (14.6 ± 
4.8 vs. 12.6 ± 3.3, p < 0.05). After 
receiving the stress task POMS scores 
increased significantly, while in the control 
condition no significant alterations were 
shown in the categories depression (0.5 ± 
3.2 vs. -1.0 ± 2.5, p < 0.05), tension (1.8 
± 3.9 vs. -0.7 ± 2.5, p < 0.05), confusion 
(0.9 ± 3.2 vs. -0.7 ± 2.4, p < 0.05) and 
anger (1.7 ± 3.9 vs. -0.4 ± 1.8, p < 
0.05).  
Heart rate and blood pressure 
measurements, immediately before and 
directly after completion of the arithmetic 
task, showed no changes over time. 
Additionally, no changes were seen 
between the stress and control condition 
in heart rate (70.3 ± 13 vs. 72.3 ± 12.3 
bpm, p < 0.86) and systolic (123.7 ± 14.1 
vs. 125.7 ± 12.9 mmHg, p < 0.45) and 
diastolic (73.5 ± 10.2 vs. 72.3 ± 12.3 
mmHg, p < 0.89) blood pressure.  
 
VAS hunger and satiety scores 
During the lunch the average energy 
intake for men was 4.0 ± 0.5 MJ and for 
women 3.5 ± 0.4 MJ. The changes in 
satiety and hunger scores over time in the 
stress and control condition are depicted 
in figure 2. No significant differences in 
satiety scores were seen between the 
stress and control condition before lunch 
(32.5 ± 21.1 vs. 27.6 ± 15.8), directly 
after lunch (65.6 ± 17.7 vs. 65.9 ± 18.3) 
and after the eating in absence of hunger 
protocol (70.7 ± 16.9 vs. 69.1 ± 18.5). 
No significant differences in hunger scores 
were seen between the stress and control 
conditions before lunch (54.2 ± 22.9 vs. 
58.5 ± 19.8), directly after lunch (18.6 ± 
13.9 vs. 17.5 ± 13.8) and after the eating 
in absence of hunger protocol (13.5 ± 
19.5 vs. 15.8 ± 13.7). A significant 
increase in satiety scores and a significant 
decrease in hunger scores were seen over 
time in both conditions.  
 
 
 
 
 
 
Figure 2: Changes in satiety and hunger scores 
(means) over time in the stress and control condition in 
all subjects (n = 129) 
 
* p < 0.05 for differences in time in both the stress and 
control condition (ANOVA repeated measures) 
 
Differences in energy intake in 
stress/control condition 
The differences in energy intake (kJ) 
during stress and control condition are 
depicted in figure 3. Significant 
differences were found between the stress 
and control conditions in energy intake 
from sweet snack foods (708.1 ± 798.8 
vs. 599.4 ± 734.4 kJ, p < 0.03) and total 
energy intake (965.2 ± 970.6 vs. 793.8 ± 
912.5 kJ, p < 0.01).  
 
Figure 3: Differences in means (± sd) of energy intake 
of snack foods (kJ) during stress and control condition in 
all subjects (n = 129) 
 
* P < 0.05 for stress versus control condition, t-test 
 
Figure 4 depicts the differences in energy 
intake of snack foods between the stress 
and control conditions (∆ energy intake) 
as a function of the differences in STAI 
state scores between immediately after 
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compared to before the stress task (∆ 
state anxiety scores). A positive 
relationship was shown between ∆ energy 
intake (kJ) and ∆ state anxiety scores (R2 
= 0.05, p < 0.01). Apart from that, no 
relationship between ∆ energy intake (kJ) 
and trait anxiety scores was present.  
 
Figure 4: differences in energy intake of snack foods 
(kJ) between the stress and control condition (∆ energy 
intake) as a function of the differences in state anxiety 
scores between immediately after compared to before 
the stress task (∆ state anxiety scores) in all subjects (n 
= 129)  
 
R2 = 0.05, p < 0.01 
 
Differences in energy intake in 
stress/control conditions combined with 
eating behavior 
First, linear regression analyses with ∆ 
energy intake (kJ) as the dependent 
variable and ∆ state anxiety scores as the 
independent variable were performed for 
subjects with low dietary restraint scores 
(R2 = 0.05, ns) and high dietary restraint 
scores (R2 = 0.01, ns). 
Second, a multiple linear regression 
analysis was performed with ∆ energy 
intake (kJ) as the dependent variable and 
∆ state anxiety scores, disinhibition scores 
and interaction between the ∆ state 
anxiety scores and the disinhibition 
scores, as the three independent 
variables. A significant interaction 
between ∆ state anxiety scores and 
disinhibition scores was found, indicating 
that the explained variance of ∆ of energy 
intake by ∆ state anxiety scores was 
different in subjects, namely with low or 
high disinhibition scores. Therefore, 
figure 5 depicts the ∆ energy intake (kJ) 
as a function of ∆ state anxiety scores 
plotted for two groups of subjects namely 
those with a low disinhibition score (R2 = 
0.02, p = 0.23) and a high disinhibition 
score (R2 = 0.12, p < 0.05).  
 
Figure 5: differences in energy intake (kJ) between the 
stress and control condition (∆ energy intake) as a 
function of the differences in state anxiety scores 
between immediately after compared to before the 
stress task (∆ state anxiety scores), plotted for a low 
disinhibition scores group (in black, R2 = 0.02, p = 0.23) 
and a high disinhibition scores group (in grey, R2 = 
0.12, p < 0.05), in all subjects (n = 129) 
 
 
Linear regression model with ∆ state 
anxiety scores 
A linear regression model showed a 
positive relationship between the ∆ state 
anxiety scores as the dependent variable 
and the trait anxiety scores as the 
independent variable (R2 = 0.07, p < 
0.01). 
 
Discussion 
The objective of our study was to 
investigate the effect of acute 
psychological stress on food intake, using 
the eating in the absence of hunger 
paradigm, in normal- and overweight men 
and women, taking dietary restraint and 
disinhibition into account. Acute 
psychological stress, indicated as an 
increase in state anxiety and POMS 
scores, was related to an increase in 
energy intake in the absence of hunger in 
adults. Moreover, subject specific features 
including higher trait anxiety scores, were 
related to a larger increase in state 
anxiety scores during the stress condition. 
 
With these results, our study adds to the 
growing literature on the effect of stress 
on energy intake. To investigate whether 
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the stress condition induced stress, we 
measured anxiety (STAI questionnaire) 
[16] mood profiles (POMS questionnaire) 
[15] over time and heart rate and blood 
pressure. We showed an increase in 
anxiety and a deterioration of mood 
during the stress condition, which 
confirms previous findings [19, 20] and 
thereby confirms stress induction. The 
changes in anxiety and mood after 
receiving the stress task compared to the 
control were observed immediately and 
after 10 minutes, which indicates acute 
psychological stress induction that has 
been shown in previous studies using this 
particular stress task [17]. Completion of 
the various questionnaires could be 
considered a potential stressor. 
Nevertheless, the number of 
questionnaires was identical in both 
conditions, and the control condition 
showed a decrease in state anxiety and 
POMS scores, indicating no stressful 
experience.  
 
However, contrary to previous studies 
[17, 21], no differences were found in 
heart rate and blood pressure over time 
and between the stress and control 
condition. A possible explanation may be 
the frequency of the measurements; we 
measured at two time points (before and 
after stress/control task), thereby possibly 
running the risk of missing some changes 
in heart rate and blood pressure. For 
future experiments we recommend to 
focus on heart rate variability [22]. 
 
To determine whether subjects were 
eating beyond fullness, satiety and hunger 
scores (VAS questionnaire) were 
measured over time, and in both 
conditions (stress and control) an increase 
in satiety scores and a decrease in hunger 
scores over time were shown.  These 
satiety and hunger scores indicate a state 
of satiety after the consumption of the 
lunch, as confirmed by previous research 
on ab libitum food intake [23], and 
suggested that possible snack intake was 
not hunger based. No differences in 
satiety and hunger scores were seen 
between the stress and control conditions, 
suggesting that acute psychological stress 
did not affect appetite, which is contrary 
to other studies that did show a decrease 
in hunger ratings after stress [5]. The 
contradiction may be due to the fact that 
in our experiment, the subjects were fed 
before the exposure to stress, while in the 
other studies subjects were hungry during 
stress exposure. The observed food 
intake, ingested in the absence of hunger 
after stress exposure, hardly led to further 
decreases in hunger, underscoring that 
this may not be a homeostatic 
mechanism, yet rather a non-homeostatic 
regulatory mechanisms involved in 
feeding behavior, such as reward [9, 24]. 
 
In accordance with the literature [4-7], 
we found that (acute psychological) stress 
altered food preference and amount of 
energy intake; namely, it increased intake 
of sweet foods and increased total amount 
of energy intake. Our study is the first to 
show that, in adults, eating beyond 
fullness (‘eating in absence of hunger’) is 
affected by acute stress. Before, the 
paradigm of eating in the absence of 
hunger only has been used in children 
[11]. Here it appears to be a sensitive 
paradigm in adults as well. Since there is 
no literature on the validity of the 
paradigm in adults, the paradigm should 
be used in different studies in order to 
show reproducibility and sensitivity. A 
linear regression showed that differences 
in energy intake between the stress and 
control conditions was a function of the 
differences in state anxiety scores 
between immediately after compared to 
before the stress task. These results imply 
that subjects who experienced a greater 
amount of acute stress had the largest 
increase in energy intake. Here trait 
anxiety scores did not play a role, since 
these did not contribute to the explanation 
of ∆ energy intake. 
 
Taking subject characteristics into 
account, it has been suggested that 
dietary restraint may account for the 
differences in reaction to stress with 
respect to energy intake. In contrast to 
other studies [5, 6], our study did not 
show a relationship between energy 
intake, stress and dietary restraint. 
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Instead, an effect of disinhibition was 
shown. The relationship between 
differences in energy intake between the 
stress and control conditions and 
differences in state anxiety scores 
between immediately after compared to 
before the stress task, was only significant 
in subjects with a high disinhibition 
scores, when compared to the subjects 
with a low disinhibition scores. Thus, 
disinhibition scores appeared to be a 
subject specific feature that contributed to 
increased energy intake during acute 
stress.  
 
In addition, a linear regression analysis 
showed that subjects who experienced 
acute stress had higher trait anxiety 
scores. These results implicate that a 
higher likelihood to experience state 
anxiety in a stressful situation [16], 
contributes to a higher sensitivity to acute 
stress from the stress task. Therefore, we 
conclude that acute psychological stress is 
associated to eating in absence of hunger, 
especially in vulnerable individuals 
characterized by disinhibited eating 
behavior and sensitivity to chronic stress. 
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Abstract 
Objective: to investigate the relationship between hypothalamus/pituitary/adrenal (HPA) 
axis functioning and dietary restraint in normal weight (BMI between 20 and 25 kg/m2) 
men and women.  
Methods: we assessed in 38 men and 38 women HPA axis functioning, through 
measuring 5-hour cortisol exposure and cortisol feedback functioning through a 
dexamethasone (4 mg) suppression test. Eating behavior was assessed through the Three 
Factor Eating Questionnaire and body composition through hydro densitometry and 
deuterium dilution method.   
Results: no relationship between HPA axis functioning and dietary restraint was found in 
men. Normal weight women with a restraint score ≥ 9 showed increased cortisol 
concentrations over a 5-hour time period, increased cortisol concentrations after a 
dexamethasone (4 mg) suppression test, higher BMI, and higher body fat percentage, 
when compared to women with a restraint score < 9. Moreover, a positive relationship 
was found between cortisol concentrations over a 5-hour time period and dietary restraint 
in combination with the disinhibition score (R2=0.23, p<0.001).  
Conclusion: in normal weight women hyperactivity of the HPA-axis is related to dietary 
restraint especially in combination with disinhibition. 
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Introduction 
In order to either prevent weight gain or 
induce weight loss, people attempt to 
restrict food intake through controlled 
eating behavior [1]. Eating behavior 
characteristics can be determined using 
the Three Factor Eating Questionnaire 
(TFEQ) [2]. The TFEQ assesses 3 factors 
involved in eating behavior: dietary 
restraint, disinhibition and feeling of 
hunger. Dietary restraint reflects the 
extent to which individuals attempt to 
cognitively control their food intake. 
Disinhibition or inhibition of restraint 
reflects individual differences in the extent 
to which release from the cognitive 
suppression of eating occurs in response 
to the presence of palatable food or other 
disinhibiting stimuli, such as emotional 
distress. The third factor refers to the 
general feeling of hunger [2].  
Studies have shown behavioral, metabolic 
and endocrinological differences between 
normal weight women with a low score 
and a high score on dietary restraint. 
Normal weight dietary restrained women 
showed behavioral and metabolic 
differences such as lower self-reported 
energy consumption, lower energy 
expenditure, higher body mass index 
(BMI) and higher body fat percentage 
when compared to the dietary 
unrestrained women [3, 4]. Furthermore, 
a number of studies showed that normal 
weight dietary restrained women showed 
endocrinological differences such as lower 
post-meal insulin levels [5-7] and 
increased cortisol levels compared to 
dietary unrestrained women [8-11].  The 
increased cortisol levels in dietary 
restrained women may be secondary to 
the occurrence of psychological stress, 
since dietary restraint is experienced as a 
demanding task [8-11]. However, not all 
studies investigating the association 
between cortisol levels and dietary 
restraint have yielded conclusive results, 
since some studies found a positive 
association in the dietary restrained 
women [8-11], whereas others did not [4-
6]. This inconclusiveness possibly resulted 
from study limitations such as cortisol 
measurements at only one (sometimes 
unspecified) time point during the day or 
several time points during the night. 
Moreover, all cortisol measurements were 
done only under basal conditions. 
However basal cortisol levels also depend 
on cortisol conversion, and therefore 
cortisol measurements under basal 
condition do not reflect 
hypothalamic/pituitary/adrenal (HPA) axis 
functioning. The ability of cortisol to 
suppress its own secretion, mediated by 
the glucocorticoid receptor in both the 
hypothalamus and pituitary (negative 
feedback) is an important determinant of 
the HPA axis functioning [12]. However, 
to our knowledge no studies reported 
adequately on the possible association 
between HPA axis functioning, measuring 
both cortisol exposure and cortisol 
feedback functioning, and dietary 
restraint. Consequently, the objective of 
our study was to investigate the 
relationship between 
hypothalamus/pituitary/adrenal (HPA) 
axis functioning and dietary restraint in 
normal weight (BMI between 20 and 25 
kg/m2) men and women.  
 
Participants and methods 
Participants and protocol 
The study was approved by theMedical 
Ethical Committee of the Maastricht 
University, and a written consent was 
obtained from all participants. Healthy, 
medication-free, non-smoking men (n = 
40) and women (n = 40) aged between 
18 to 45 y and with a BMI between 20 and 
25 kg/m2 were recruited to complete all 
phases of this study. A medical history 
was obtained from each participant before 
entry into the study and exclusion criteria 
were chronic illness, depression, and a 
history of eating disorders or current 
dieting. From 80 participants recruited, 38 
men and 38 women completed the study, 
4 participants dropped out before the 
actual start of the study. 
From each participant we obtained: 5-
hour cortisol exposure, a progressive 
maximal cycling test to volitional 
exhaustion, a dexamethasone (4 mg) 
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suppression test, Three Factor Eating 
Questionnaire (TFEQ) scores, 
anthropometry and body composition.   
 
Measurements 
5-hour cortisol exposure 
At 8 a.m. after an overnight fast an 
intravenous catheter for blood sampling 
was inserted into the forearm vein. 
Directly after insertion of the catheter the 
first blood sample (9 ml) was drawn (0 
minutes), and after 15 minutes the 
participants received their breakfast (20 
% of the participants’ daily energy 
requirement). At 45, 90 and 210 minutes 
the second, third and fourth blood 
samples were drawn. At 225 minutes the 
participants received their lunch (30 % of 
the participants’ daily energy 
requirement) and at 255 and 300 minutes 
the fifth and sixth blood samples were 
drawn. During the test, participants were 
able to drink water ad libitum. Breakfast 
and lunch consisted of typical Dutch 
products, namely brown bread (1.0 MJ per 
100 g; en% C/P/F: 74/15/11) with young 
cheese (1.6 MJ per 100 g; en% C/P/F: 
0/26/74) as well as ab libitum tea or 
water consumption. The daily energy 
requirements were calculated by 
multiplying the basal metabolic rate (BMR) 
by an activity index of 1.75. The BMR 
(MJ/day) was calculated according to the 
equations of Harris-Benedict [13]. 
Participants remained seated during 
sampling and daytime naps were not 
allowed. The participants’ 5-hour cortisol 
exposure was measured by calculating the 
area under the curve (AUC) (0-300 
minutes). 
 
Progressive maximal cycling test to 
volitional exhaustion 
Each subject underwent a progressive 
maximal cycling test to volitional 
exhaustion for quantification of VO2max 
[14]. Subjects cycled on an 
electromagnetically braked bicycle 
ergometer (Lode, Groningen, The 
Netherlands) at 80 rpm, at a workload of 
75 W for women and 100 W for men. 
After 5 minutes, the workload was 
increased every 2.5 minutes with 50 W, 
until subjects were no longer able to 
maintain a pedaling frequency above 80 
rpm. Open-circuit spirometry was 
performed with an Oxycon (Mijnhardt 
Jaeger, Mannheim, Germany), and oxygen 
consumption (VO2) and carbon dioxide 
production (CO2) were measured in the 
breath-by-breath mode and averaged 
over 15 seconds. Heart rate was 
monitored continuously throughout all 
exercise protocols (Polar s610). 
Verification that each subject actually 
achieved VO2max consisted of meeting 
the following criteria: 1) achieving 
predicted maximal heart rate and 2) a 
respiratory exchange ratio of 1.10 or 
more.  
 
Dexamethasone (4 mg) suppression test 
Each participant received 4 mg 
dexamethasone 8 hours before the 
suppression test, all participants 
participated in the treatment, and no 
adverse reactions were reported. 
Participants abstained from alcohol 
consumption and strenuous exercise 15 h 
before testing. At 8 a.m. after an 
overnight fast, an intravenous catheter for 
blood sampling was inserted into the 
forearm vein and a blood sample was 
drawn [12]. 
 
Blood samples 
Blood samples were collected and mixed 
in serum tubes (BD Vacutainer, 9.5 ml). 
Serum was obtained by centrifugation 
(4°C, 3000 rpm, 10 minutes), frozen in 
liquid nitrogen and stored at -80°C until 
analysis of cortisol concentrations. Serum 
cortisol concentrations were measured 
using RIA (Buhlmann Laboratories) and 
detection limits for cortisol concentrations 
were 2.9 ng/ml. Intra-assay coefficient 
variation for cortisol concentrations was 
less than 6 % for all samples. 
 
Attitude towards eating 
Eating behavior was analyzed using a 
validated Dutch translation of the TFEQ 
[2, 15]. The TFEQ consists of 3 factors 
measuring a person’s attitude towards 
eating. Dietary restraint (Factor 1) reflects 
the extent to which individuals attempt to 
cognitively control their food intake. 
Inhibition of restraint (Factor 2 or 
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disinhibition) reflects individual differences 
in the extent to which release from the 
cognitive suppression of eating occurs in 
response to the presence of palatable food 
or other disinhibiting stimuli, such as 
emotional distress. Factor 3 refers to the 
subjective feeling of hunger. Based upon 
the median for the TFEQ scores in the 
South of the Netherlands, participants 
were characterized as unrestrained when 
dietary restraint scores were  < 9, and as 
restrained when scores ≥ 9. Participants 
were characterized as having low 
disinhibition when disinhibition scores 
were  < 5, and as having high 
disinhibition when scores were ≥ 5 [1]. 
 
Anthropometry and body composition  
Measurements were carried out in the 
morning after voiding the bladder and 
before breakfast. Body weight (BW) 
(Sauter D7470, Ebingen, Germany) and 
height (Seca, model 220, Hamburg, 
Germany) were measured to the nearest 
0.01 kg and 0.1 cm respectively. BMI 
(kg/m2) was calculated as body weight 
divided by height (m) squared. The waist 
circumference was measured to the 
nearest 0.1 cm at the site of the smallest 
circumference between the rib cage and 
the ileac crest, whereas the hip 
circumference was measured to the 
nearest 0.1 cm at the level of maximum 
extension of the buttocks. Both 
measurements were done with the 
participants in standing position. 
Body density was determined by hydro 
densitometry with simultaneous 
measurements of residual lung volume 
with the helium dilution technique. Total 
body water (TBW) was determined with 
the deuterium dilution method following 
the Maastricht protocol [16]. Body 
composition was calculated from body 
density and TBW using the three-
compartment model of Siri. Fat free mass 
(FFM) was calculated by dividing TBW by 
the hydration factor 0.73.  Fat mass (FM) 
was determined as BW-FFM. 
 
Statistical analysis 
Differences between two groups were 
determined using unpaired t-tests. 
Differences over time and between 
conditions were determined using two-
factor ANOVA with repeated measures. 
Relationships between dependent and 
independent variables were determined 
using simple linear, or multiple regression 
models. All statistical tests were two-
tailed, differences were considered 
significant at p < 0.05 and values are 
expressed as mean ± standard deviation.  
 
Results 
Table 1 shows the characteristics of all 
participants (n = 76). No significant 
differences were shown between men and 
women in age, BMI, hip circumference 
and feeling of hunger score. The male 
participants showed significantly higher 
height, body weight, waist circumference, 
waist-to-hip ratio, and maximal workload 
during the progressive maximal cycling 
test when compared to the female 
participants. The female participants 
showed significantly higher body fat 
percentage, area under the curve (AUC) 
of 5-hour cortisol exposure, cortisol 
concentrations after a dexamethasone (4 
mg) suppression test, dietary restraint 
score, and disinhibition score when 
compared to male participants. Therefore, 
the results of the male and female 
participants were analyzed separately.  
 
Based upon the median for the TFEQ 
scores in the South of the Netherlands the 
female participants were characterized as 
unrestrained when dietary restraint scores 
were  < 9, and as restrained when score 
≥ 9 [1]. Table 2 shows the characteristics 
of the dietary unrestrained (n = 26) and 
the dietary restrained (n = 12) women. 
The dietary restrained women showed 
significantly higher BMI and body fat 
percentage when compared to the dietary 
unrestrained women. No significant 
differences were shown between dietary 
unrestrained and dietary restrained 
women in age, height, body weight, waist 
circumference, hip circumference, waist-
to-hip ratio, maximal workload during the 
progressive maximal cycling test, 
disinhibition score and feeling of hunger 
score.  
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Table 1. Characteristics of participants (n = 76) 
 Men   
(n = 38) 
Women  
(n = 38)  
P value1 
Age (year) 31.2 ± 5.2 25.9 ± 7.5 0.17 
Height (cm) 183.5 ± 7.3 170.4 ± 6.6 0.01 
Body weight (kg) 75.2 ± 7.9 65.6 ± 7.5 0.01 
Body mass index (kg/m2)  22.3 ± 1.5 22.6 ± 1.9 0.99 
Body fat (%) 11.6 ± 5.2 25.2 ± 5.5 0.01 
Waist circumference (cm) 80.6 ± 5.5 74.4 ± 5.8 0.01 
Hip circumference (cm) 100.8 ± 5.8 99.6 ± 5.7 0.12 
Waist-to-hip ratio 0.80 ± 0.04 0.74 ± 0.06 0.01 
Maximal workload (V) 323 ± 55 216 ± 44 0.01 
AUC2 of 5-hour cortisol 
exposure (nmol/L.min) 
1.1(105) ± 0.2 1.6(105) ± 0.7 0.01 
Cortisol after 
dexamethasone (4 mg) 
(nmol/L) 
33.9 ± 12.6 53.7 ± 28.7 0.01 
Dietary restraint score 4.7 ± 3.5 6.5 ± 3.3 0.08 
Disinhibition score 2.9 ± 1.2 4.2 ± 1.9 0.02 
Feeling of hunger score 3.8 ± 2.5 3.9 ± 2.4 0.84 
1 Differences between men vs. women (t-test) 
2AUC, area under curve 
 
Table 2. Characteristics of dietary unrestrained (score < 
9) and dietary restrained (score ≥ 9) women (n = 38) 
 Dietary 
unrestraint  
(n = 26) 
Dietary 
Restraint  
(n = 12)  
P value1
Age (year) 26.1 ± 6.2 25.9 ± 7.5 0.87 
Height (cm) 171.2 ± 6.2 168.6 ± 7.2 0.26 
Body weight (kg) 64.8 ± 7.8 67.2 ± 6.6 0.35 
Body mass index (kg/m2)  22.1 ± 1.8 23.7 ± 1.6 0.01 
Body fat (%) 24.2± 4.5 28.6 ± 5.6 0.02 
Waist circumference (cm) 74.9 ± 6.8 73.4± 3.7 0.57 
Hip circumference (cm) 98.6± 5.9 101.7± 5.2 0.22 
Waist-to-hip ratio 0.75 ± 0.06 0.72 ± 0.04 0.22 
Maximal workload (V) 214 ± 46 218 ± 41 0.78 
Dietary restraint score 4.7 ± 2.1 10.5 ± 1.5 0.01 
Disinhibition score 4.3 ± 2.1 3.9 ± 1.8 0.58 
Feeling of hunger score 4.0± 2.5 3.8 ± 2.2 0.84 
1 Differences between dietary unrestrained vs. dietary 
restrained women (t-test) 
 
Figure 1 shows the changes in cortisol 
concentrations (nmol/L.min) over a 5-
hour time period in the dietary 
unrestrained and dietary restrained 
women. The cortisol concentrations were 
significantly higher at all time points 
except at 300 minutes in the dietary 
restrained women when compared to the 
dietary unrestrained women. Over time 
there was a significant decrease of cortisol 
in both groups of women, however, the 
decrease was significantly stronger in the 
dietary restrained women. The AUC over a 
5-hour time period of the cortisol 
concentrations was significantly higher in 
the dietary restrained women when 
compared to the dietary unrestrained 
women (136429.8 ± 57665.9 vs. 
193622.5 ± 89322.2 nmol/L.min, p < 
0.02). Additionally, the cortisol 
concentrations after a dexamethasone (4 
mg) suppression test were significantly 
higher in the dietary restrained women 
when compared to the dietary 
unrestrained women (70.7 ± 36.6 vs. 
45.8 ± 20.6 nmol/L, p < 0.01).  
 
Figure 1. Changes in cortisol concentrations (nmol/L) 
over a 5-hour time period in the dietary unrestrained 
(grey, n = 26) and dietary restrained (black, n = 12) 
women. Values are means and error bars indicate SD. 
 
* P < 0.05 for differences in dietary unrestrained 
women compared to dietary restrained women (2- factor 
ANOVA repeated measures) 
# P < 0.05 overall group x time interaction was 
significant 
 
Table 3 shows a positive relationship 
between the cortisol concentrations after 
a dexamethasone (4 mg) suppression test 
and the AUC over a 5-hour time period of 
the cortisol concentrations, the dietary 
restraint score, and the disinhibition 
scores as the independent variables (R2 = 
0.62, p < 0.01) in normal weight women.  
 
Table 4 shows a positive relationship 
between the AUC over a 5-hour time 
period of the cortisol concentrations as the 
dependent variable and the dietary 
restraint scores and the disinhibition 
scores as the independent variables (R2 = 
0.23, p < 0.01) in normal weight women.  
 
Furthermore, in normal weight men no 
relationship was seen between HPA axis 
functioning and eating behavior. Here 
different relationships appeared that were 
not primarily related to HPA axis 
functioning. Dietary restraint scores were  
< 9 in the men, except 3 outliers, who 
were athletes. In these normal weight 
men a linear regression model showed a 
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positive relationship between the dietary 
restraint score as the dependent variable 
and the maximal workload during the 
progressive maximal cycling test as the 
independent variable (R2 = 0.12, p < 
0.03). Additionally, a linear regression 
model showed a negative relationship 
between the AUC over a 5-hour time 
period of the cortisol concentrations as the 
dependent variable and the dietary 
restraint score as the independent 
variable (R2 = 0.13, p < 0.03). 
 
Table 3: Multiple regression model with the cortisol 
concentrations after a dexamethasone (4 mg) 
suppression test (nmol/L) as the dependent variable and 
the area under the curve of cortisol concentrations over 
a 5-hour time period (nmol/L), dietary restraint score 
and disinhibition score as the independent variables in 
normal weight women (n = 38)   
R2 = 0.53, p < 0.01 
 Partial β Std. Error P value 
Intercept 9.8 11.05 0.38 
AUC1 of cortisol concentrations  
over a 5-hour time period 
0.002 0.69 0.001 
Dietary restraint score 1.1 0.1 0.32 
Disinhibition score -1.3 -0.09 0.49 
1 AUC; area under the curve 
 
Table 4: Multiple regression model with the area under 
the curve of cortisol concentrations over a 5-hour time 
period (nmol/L) as the dependent variable and dietary 
restraint score and disinhibition score as the 
independent variables in normal weight women (n = 38) 
R2 = 0.23, p < 0.01 
 Partial β Std. Error P value 
Intercept 49329.5 34584.1 0.16 
Dietary restraint score 8031.7 3273.2 0.01 
Disinhibition score 12605.3 5500.5 0.01 
1 AUC; area under the curve 
 
Discussion 
The objective of our study was to 
investigate the relationship between HPA 
axis functioning and dietary restraint in 
normal weight (BMI between 20 and 25 
kg/m2) men and women. No such 
relationship was found in men. Dietary 
restrained women showed increased 
cortisol concentrations over a 5-hour time 
period, increased cortisol concentrations 
after a dexamethasone (4 mg) 
suppression test, higher BMI, and higher 
body fat percentage. Moreover, a positive 
relationship was found between cortisol 
concentrations over a 5-hour time period 
and dietary restraint alone or in 
combination with the disinhibition score.  
 
Our study contributes to insight in the 
relationship between HPA axis functioning 
and dietary restraint in normal weight 
women [8-11]. Our study is the first to 
analyze HPA axis functioning elaborately, 
since most studies only measured cortisol 
exposure at only one (sometimes 
unspecified) time point during the day or 
the night, and measured no HPA axis 
feedback functioning. In accordance to the 
literature [3, 4] we found that dietary 
restrained women have a higher BMI and 
body fat percentage compared to dietary 
unrestrained women. To determine 
cortisol exposure, we measured cortisol 
concentrations (nmol/L.min) over a 5-
hour time period. We showed that the 
dietary restrained normal weight women 
had a significant higher AUC over a 5-hour 
time period of the cortisol concentrations 
and a stronger decrease in cortisol 
concentrations compared to the dietary 
unrestrained women. This suggests that 
normal weight women, who attempt more 
to restrict food intake through dietary 
restraint, have increased cortisol exposure 
and stronger decline in cortisol levels over 
time.  
 
Additionally, we measured feedback 
functioning through a dexamethasone (4 
mg) suppression test [12], which 
measures the amount of cortisol that 
escaped from dexamethasone 
suppression. When cortisol feedback is 
strong low amount of cortisol will be 
present, and when high amounts of 
cortisol escaped, cortisol feedback is 
decreased [12]. We showed that the 
dietary restrained normal weight women 
had higher cortisol concentrations after 
dexamethasone suppression test, when 
compared to the dietary unrestrained 
women. These results imply that normal 
weight women, who attempt more to 
restrict food intake through dietary 
restraint, have decreased cortisol 
feedback functioning. 
 
Multiple regression analysis showed a 
positive relationship between cortisol 
feedback functioning and cortisol exposure 
as well as dietary restraint score. 
Additionally, we showed a positive 
Thesis_Rutters_v10.pdf   113 2-7-2009   14:50:44
 114 
relationship between cortisol exposure 
and dietary restraint in combination with 
disinhibition score. This suggests that 
especially normal weight women, who 
attempt to restrict food intake through 
dietary restraint but who have high 
inhibition of restraint show increased 
cortisol exposure, and decreased cortisol 
feedback. However, the direction of 
causality cannot be inferred from this 
research.  
 
The lack of a direct relationship between 
HPA axis functioning and dietary restraint 
in normal weight men is consistent with 
the literature [8-11]. Here different 
relationships appeared that were not 
primarily related to HPA axis functioning. 
A possible explanation may be the gender 
difference in stress sensation [12]. In men 
a positive relationship was shown between 
the dietary restraint score and the 
maximal workload during the progressive 
maximal cycling test, which suggests that 
only men who are sincerely engaged in 
sports are dietary restraint. Additionally, a 
negative relationship was shown between 
the maximal workload during the 
progressive maximal cycling test and AUC 
over a 5-hour time period of the cortisol 
concentrations, which suggests that men 
who are sincerely engaged in sports have 
decreased cortisol exposure, as previously 
shown [12]. In general, only men who are 
overweight or who are sincerely engaged 
in sports are dietary restraint. Overweight 
men were not included in our study and 
when the normal weight men who are 
sincerely engaged in sports were omitted 
from the analysis, no relationship between 
HPA axis functioning and dietary restraint 
was found. These results suggest that 
dietary restraint is not perceived as a 
stressor in normal weight men.  
 
Increased cortisol exposure, heightened 
cortisol responsiveness and decreased 
cortisol feedback functioning are 
characteristics of hypercortisolism [12]. 
Hypercortisolism is a state in which the 
HPA axis responsiveness is preserved, 
which is also seen in psychological or 
physiological chronic stressed humans 
[17-19]. It may therefore be hypothesized 
that the association between increased 
cortisol levels and dietary restraint may 
be mediated through psychological stress 
[8-11]. Sustained hypercortisolism 
however may predispose individuals to 
many illnesses, ranging from 
inflammatory diseases to major 
depression, thereby indicating that dietary 
restraint in combination with disinhibition 
is a possible health risk [20].  In 
conclusion, hyperactivity of the HPA-axis 
is related to dietary restraint especially in 
combination with disinhibition, in normal 
weight women. 
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Body weight appears to be regulated with 
remarkable precision in healthy adults, 
and a stable body weight reflects a 
balance between energy intake and 
energy expenditure [1]. Chronic 
deregulation of energy balance with 
energy intake exceeding energy 
expenditure, leads to storage of excessive 
energy as fat, a characteristic of 
overweight and obesity [2]. The first aim 
of the studies presented in this thesis was 
to identify genetic, parental, behavioral, 
and endocrine factors involved in body-
weight development in children, and the 
interaction between these factors. The 
second aim was to assess genetic, 
behavioral, and endocrine factors and 
their interaction in body-weight regulation 
in adults.  
 
Body-weight development during 
childhood and puberty 
 
Genetic factors 
With respect to genetic factors involved in 
body-weight development, we observed 
that in our Dutch children cohort the A 
allele of the fat mass and obesity-
associated gene (FTO) (rs9939609) was 
associated with higher BMI, fat mass 
index (FMI), leptin concentrations, and 
lower activity scores from childhood to 
puberty [3]. In the last decades a large 
number of polymorphisms have been 
related to variation in body weight [4]. For 
our studies, we selected polymorphisms 
with a high allelic frequency distribution 
and a proposed biological function that 
could influence body-weight development. 
The FTO polymorphism is related to 
altered DNA methylation [5, 6], which 
results in altered biological function. 
Studies in humans and rodents have 
suggested a central role for FTO through 
an effect on regulation of food intake, 
such as decreased feelings of satiety [7, 
8], and a peripheral role through an effect 
on lipolytic activity in adipose tissue [6].  
Additionally, we observed in our cohort 
that at age 13y a larger BMI is associated 
to the FTO A allele, larger leptin 
concentrations, and decreased physical 
activity. These results implicate that at 
age 13y genetic, endocrine and 
psychological factors are independent 
predictors for BMI [3]. At age 12, 14, and 
15y BMI was associated to larger leptin 
concentrations, which implicates that 
during puberty BMI is temporarily 
predicted by FTO and predominately 
predicted by endocrine factors [3]. 
Furthermore, in our cohort polymorphisms 
of the ciliary neurotrophic factor (CNTF) 
gene and the peroxisome proliferated-
activated receptor γ2 (PPARγ2) gene did 
not show similar associations during 
puberty [9], although this was expected 
based upon studies in adults [10]. These 
results suggest that especially 
polymorphisms with a strong influence on 
body weight, such as FTO [6], affect body 
weight during puberty, and that the 
influence of polymorphisms, such as CNTF 
and PPARγ2, are stronger during early 
childhood and late adolescence, as 
observed by previous studies [11, 12]. 
Our results implicate that the changes in 
the associations between body-weight 
development and polymorphisms over 
time may be explained by the fact that 
body weight is predominately regulated by 
physiological and endocrine factors during 
puberty.  
 
Parental factors 
With respect to parental factors involved 
in body-weight development, we observed 
that in our cohort a high BMI of the father 
and a high disinhibition score of the 
mother were related to an increased BMI 
in the child [9]. These observations are in 
concordance with previous findings, which 
observed that the childs’ BMI is positively 
related to the parents’ BMI [13, 14]. In 
contrast to previous findings we did not 
show a relationship between mothers 
cognitively restrained eating behavior and 
the body-weight development of the 
children [14]. A possible explanation may 
be that the mothers were successfully 
restraint, so their high restraint scores 
helped them to control their weight 
successfully [15], and only when a high 
disinhibition score was present this 
resulted in a relationship with the weight 
of the child [9]. The parent association is 
due to genetic and environmental factors, 
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such as shared lifestyles (i.e. diets, 
feeding practices and food choices) and 
patterns of activity. For future research, it 
will be of interest to observe whether the 
role of these genetic and parental factors 
in body-weight development will become 
stronger in our cohort as well as in other 
cohorts during late adolescence.  
 
Behavioral factors 
With respect to the behavioral factors 
involved in body-weight development, we 
were the first to show that development of 
BMI during puberty is inversely related to 
change in sleep duration [16]. We focused 
on short sleep duration, as a number of 
cross-sectional and longitudinal studies 
have shown a negative relationship 
between habitual sleep duration and body 
weight in children [17, 18]. None of the 
four longitudinal studies in children 
however investigated whether changes in 
sleep duration were associated with 
changes in body weight [19-22]. Although 
cause and effect cannot be completely 
disentangled from the observed inverse 
relationship between changes in body 
weight and sleep duration, we carefully 
suggest that reduction of sleep duration 
contributes to development of overweight 
during puberty.  
 
Short sleep has been suggested to result 
from psychological distress, and the 
physiological disturbances related to 
psychological distress, such as 
hypercortisolemia [23, 24]. Studies 
investigating the physiological 
mechanisms on how sleep duration affects 
body-weight development in humans are 
however limited. Laboratory based studies 
have observed that short sleep (4 hours) 
lead to lower levels of the anorexigenic 
hormone leptin and higher levels of the 
orexigenic hormone ghrelin [25, 26]. 
Short sleep has also been related to 
reduced insulin sensitivity and increased 
glucose levels [27]. Other physiological 
alterations that result from disturbed 
energy balance are suggested to be 
involved in body-weight development, but 
have not been investigated yet. For future 
research, it will therefore be of interest to 
identify the physiological mechanisms 
behind the relationship between short 
sleep and altered body weight.  
 
Endocrine factors 
With respect to endocrine factors involved 
in body-weight development, leptin is 
suggested to be a permissive factor for 
the start of puberty [28-30], which would 
be mediated through the stimulatory 
effect of leptin on the release of 
gonadotrophic hormones, and 
consequently gonadal hormones. We 
observed that in boys the leptin/fat mass 
ratio decreased from Tanner stage 2 
onwards, while in girls this ratio decreased 
from Tanner stage 2 and increased again 
at Tanner stage 5 [31]. These results 
show that factors independent of fat mass 
become (transiently) more important in 
the regulation of plasma leptin 
concentrations in boys and girls [31]. The 
proposed mechanism behind the temporal 
relationships between leptin, 
gonadotrophic hormones, and gonadal 
hormones during puberty, beholds that 
leptin independently of fat mass acts on 
the hypothalamic luteinizing hormone-
releasing hormone pulse generator [32-
34] Consequently, the release of LH and 
FSH from the pituitary is stimulated. LH 
and FSH in turn stimulate the gonads to 
release testosterone and estradiol, which 
will form a negative feedback loop, which 
will inhibit the secretion of LH and FSH. 
Moreover, testosterone alone will form a 
negative feedback loop, which will inhibit 
leptin secretion from the adipocytes, and 
estradiol will form a positive feedback 
loop, which stimulates leptin secretion 
from the adipocytes [34-36]. As a result, 
the relationship between leptin 
concentrations and body fat is altered 
during puberty.  
 
However, in the literature there is also 
evidence that does not support the role of 
leptin as a permissive factor for the start 
of puberty [37]. A sex specific association 
may explain contradicting findings, as we 
found that in girls a peak in leptin was 
present at the start of puberty followed by 
a peak in the gonadotropic hormone, and 
temporal relationships were observed 
between leptin and gonadotropic 
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hormones during early puberty. In boys, 
however there was no peak in leptin, LH, 
and FSH, and leptin was only related to LH 
and FSH during late puberty [31]. We 
therefore suggested that in girls leptin 
acts as a permissive factor for the onset 
of puberty, while in boys leptin has a 
different function and different timing 
[31]. Why it is more important to have a 
permissive factor for the start of puberty 
in girls than in boys may be explained 
from an evolutionary point of view; girls 
need enough energy reserves in the form 
of body fat for the start of puberty for 
reproduction [38]. The sex differences in 
puberty timing may result from 
differences in expression of genes 
involved in puberty timing [39]. For future 
research, it will therefore be of interest to 
identify the mechanisms behind sex 
differences in puberty timing.  
 
To summarize the previous described 
results, we included a pie chart (figure 1) 
that describes the factors involved in 
body-weight development in overweight 
children, and the interactions between the 
factors in our Dutch children cohort during 
puberty at age 15y. The results from our 
studies implicate that body-weight 
development during puberty is related to 
the FTO polymorphism, as 80 percent of 
overweight children had the A allele [3]. 
Additionally, the behavioral factor sleep 
duration influenced body-weight 
development, as 93 percent of the 
overweight children had short sleep 
duration [16]. Finally, the parental factors 
high BMI of the father and high 
disinhibition score of the mother 
influenced body-weight development in 
overweight children. The effects of the 
genetic, parental and behavioral factors 
are largely combined, as 28% of the 
overweight children have all 4 factors 
related to body-weight development, and 
about 43% of the overweight children 
have 3 out of 4 factors. Only 28% of the 
overweight children have 1 or 2 factors 
related to body-weight development. 
Overall, the model (figure 1) suggests 
that the FTO A allele, short sleep duration, 
and the parental factors interact, and 
together are involved in development of 
overweight during puberty. In contrast, 
most of the normal-weight children still 
appeared to have one or more of these 
factors that are associated with 
overweight.  
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Hypothalamus/pituitary/adrenal 
(HPA) axis and body-weight 
regulation 
The HPA axis is involved in body-weight 
regulation, and alterations in HPA axis 
functioning are suggested to be involved 
in the pathogenesis of obesity, in 
particular obesity characterized by visceral 
fat distribution [40]. Support for the 
involvement of the HPA axis in body-
weight regulation is found in two extremes 
of plasma cortisol levels in humans; 
Addison’s disease (hypocortisolism) that is 
related to weight loss, and Cushing’s 
syndrome (hypercortisolism) that is 
related to rapid weight gain, particularly 
of the trunk and face with sparing of the 
limbs [41]. It however is not completely 
clear to what extent the HPA axis is 
physiologically involved in the regulation 
of body weight [42]. Evidence for a role of 
the HPA axis in body-weight regulation is 
provided via the genetic, behavioral, and 
endocrine factors described in this thesis.  
  
Genetic factors 
With respect to the genetic factors, 
several polymorphisms of the 
glucocorticoid receptor, such as the BclI 
(rs41423247) polymorphism, have been 
related to body-weight regulation, body 
fat distribution and altered HPA axis 
functioning [43].  We observed that the 
BclI G/G genotype is associated with 
increased cortisol exposure as well as 
decreased cortisol feedback sensitivity 
under stress in women but not in men 
[44]. These findings are in concordance 
with the sex specific associations of the 
BclI polymorphism observed in other 
studies, which showed a diminished 
cortisol response to psychosocial stress in 
men with the BclI G/G genotype and an 
increased cortisol response in women 
[45]. The sex specific associations are 
presumably caused by the differences in 
cellular hormonal milieu, which lead to 
differential expressivity of the underlying 
genetic networks [46].  
 
The BclI polymorphism is also involved in 
the efficacy of cortisol signaling and 
thereby influencing the downstream 
biology of peripheral and central cortisol 
responsive systems. Therefore the BclI 
polymorphism is suggested to be one of 
the factors that underlie individual 
susceptibility to stress related disorders, 
such as depression and the metabolic 
syndrome. The associations between the 
BclI G/G genotype and altered body 
weight and body fat distribution were only 
found in a few studies in men, while these 
relationships were always present in 
women [47-49]. Together with the earlier 
discussed sex specific associations on 
altered HPA axis functioning in the BclI 
G/G genotype [44, 45], this suggests that 
women with the BclI G/G genotype are 
more susceptible to disturbed regulation 
of body weight and HPA axis functioning 
compared to men with the same 
genotype. For future research on the role 
of HPA axis related polymorphism in body-
weight regulation and HPA axis 
functioning, it is therefore strongly 
suggested to take possible sex differences 
into account.  
 
Endocrine factors 
With respect to the endocrine factors, we 
observed that low cortisol variability, 
enhanced negative feedback, and 
impaired HPA axis functioning in a 
challenged condition under 4 mg 
dexamethasone were related to visceral 
fat accumulation in both men and women 
[50]. These findings add to evidence from 
previous studies that observed 
associations between visceral fat 
distribution and alterations in HPA axis 
functioning, such as decreased cortisol 
variability [51-53], and increased cortisol 
secretion after physical and psychological 
stressors [51, 52, 54]. Studies on whether 
body fat distribution is related to feedback 
functioning, thereby using dexamethasone 
(a glucocorticoid receptor agonist), have 
however yielded inconclusive results [52, 
53, 55]. Our results are consistent with 
previous work that suggests a 
deregulation of the HPA axis in humans 
with relative more visceral fat [50]. 
 
The disturbed state of low cortisol 
variability related to visceral fat 
distribution possibly results from a 
combination of alterations of the HPA axis. 
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Firstly, as often stated by the literature, 
the alterations result from decreased 
negative feedback mediated through a 
decrease in glucocorticoid receptors of the 
pituitary [52, 56] and through a decrease 
in the mineralocorticoid receptor response 
[57, 58], which leads to higher cortisol 
levels after a stressor [51, 52, 54] and 
after dexamethasone suppression in 
unchallenged conditions [50, 55]. 
Secondly, we suggest that lower cortisol 
levels in a challenged condition under 4 
mg dexamethasone [50] result from 
decreased sensitivity of the adrenal gland 
to ACTH as suggested by Mattsson et al 
2009 [58]. These suggested alterations 
have until now not been directly tested, as 
most studies examine HPA axis 
functioning under basal conditions or via 
dexamethasone, an agonist of the GR 
receptor. For future research it is of 
interest to study the role of the 
mineralocorticoid receptor and the 
decreased sensitivity of the adrenal gland 
in the disturbance of the HPA axis related 
to visceral fat distribution.  
 
Behavioral factors 
With respect to the behavioral factors 
involved in body-weight regulation, we 
observed that acute psychological stress 
results in eating in the absence of hunger 
[60]. In our study, the observed food 
intake in the absence of hunger after 
stress exposure, hardly led to further 
decreases in hunger, underscoring the 
involvement of a non-homeostatic 
regulatory mechanism, such as reward. 
Previous studies on stress-induced eating 
[61-64] proposed the involvement of 
reward, and Dallman et al [65] even 
introduced the term ‘comfort foods’ to 
emphasize the idea that the drive behind 
stress-induced eating is not homeostatic. 
These studies could however not directly 
demonstrate the role of reward, as a role 
for hunger could not be excluded [65, 66]. 
This is possible when using the ‘eating in 
the absence of hunger’ paradigm [60]. 
Stress-induced eating is suggested to be 
caused by disturbance of several neural 
networks related to reward, such as the 
opioid and NPY system [67, 68]. Recently, 
researchers from our lab [69] observed 
that stress prevented a meal-induced 
decrease of wanting and energy intake in 
visceral obese objects and not in normal 
weight objects. Furthermore, Born et al. 
[70] from our lab observed in an fMRI 
study using the ‘eating in absence of 
hunger’ paradigm that activity in reward-
related brain areas were significantly 
reduced under stress. These findings 
further support the role of disturbed 
reward in stress-induced eating.  
 
Large inter-individual differences are 
present in the effect of stress on food 
intake; stress can increase, decrease or 
does not alter food intake. These 
individual differences in response to stress 
were also present in our eating in the 
absence of hunger paradigm [60], and 
may relate to eating behavior 
characteristics [71], as an increase in 
energy intake during stress has been 
found in individuals with high scores on 
dietary restraint and/or emotional eating 
[61-64]. We however observed that stress 
induced an increase in eating in the 
absence of hunger especially in vulnerable 
individuals, which are characterized by 
disinhibited eating behavior and sensitivity 
to chronic stress [60]. High dietary 
cognitive restraint scores did not result in 
stress induced eating in the absence of 
hunger, which is contradictory to previous 
findings [61-64]. The contradicting results 
may be explained by the fact that 
previous studies used the Herman-Polivy 
restraint scale [72], in which high 
restraint score is related to weight 
concern, such as disinhibited eating and 
weight fluctuations, in contrast to the 
TFEQ [71] that we used in our study, in 
which high restraint score is related to 
(successful) control of food intake [15, 
73]. It therefore is suggested that stress-
induced eating is caused by disinhibition, 
which reflects individual differences in the 
extent to which release from the cognitive 
suppression of eating occurs in response 
to the presence of palatable food or other 
disinhibiting stimuli, such as emotional 
distress [71]. 
 
Several studies have suggested that 
dietary restraint can be experienced as a 
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chronic physiological stressor. We 
observed that in normal weight women 
hyperactivity of the HPA-axis is related to 
dietary restraint especially in combination 
with disinhibition [74].  This is in contrast 
to previous studies that have shown that 
only dietary restraint scores were related 
to alterations in HPA axis functioning, 
such as increased cortisol levels [75-77]. 
Our results suggest that dietary restraint 
in combination with disinhibited eating 
behavior can be considered as a chronic 
stressor. Together with the results from 
our study on the relationship between 
stress and eating in the absence of hunger 
[60], our results imply that disinhibition is 
an important mediator in the relationship 
between HPA axis functioning and body-
weight regulation. For future research it 
will be of interest to investigate whether 
disinhibited eaters have a higher cortisol 
response to stress, which in turn may lead 
to larger food intake, and whether these 
differences are related to altered feelings 
of reward.  
 
To summarize, we propose a model 
(figure 2) on how disturbance of the HPA 
axis is involved in body-weight regulation. 
Stress (psychological or physical) results 
via secretion of CRH and ACTH in 
production of cortisol [40]. HPA axis 
activation is larger in women with the BclI 
G/G genotype, which results in higher 
cortisol levels in these women compared 
to men with the same genotype [44, 45]. 
In turn, cortisol interacts with the neuro-
endocrine pathways that control the 
homeostatic regulation of food intake, as 
it potentiates the orexigenic actions of 
NPY [68], induces leptin resistance 
resulting in reduced suppression of food 
intake [78], and interacts with insulin that 
leads to high-fat food choice [79]. Cortisol 
also interacts with the neuro-endocrine 
pathways that control the non-
homeostatic regulation of food intake, 
which results in a decrease in opioid levels 
[67].  
The interaction of cortisol with the 
pathways that control the homeostatic 
and non-homeostatic regulation of food 
intake results in stress-induced eating in 
the absence of hunger [60], especially in 
disinhibited eaters [60]. Stress-induced 
eating results in a positive energy balance 
that leads to visceral fat storage, as 
visceral adipocytes have a four-fold of GR 
receptors that facilitate fat storage in the 
presence of high cortisol levels [80, 81]. 
Visceral fat distribution in turn has been 
related to the disturbance of HPA axis 
functioning in basal and challenged 
conditions [52, 56, 57].  
Moreover, increased fat storage may lead 
to increased weight dissatisfaction, which 
results in altered eating behavior [71], 
such as increased dietary restraint to 
decrease or prevent further weight gain. 
Dietary restraint in combination with 
disinhibited eating behavior is considered 
as a chronic stressor [74], which leads to 
further activation of the HPA axis. 
Therefore, we propose that chronic 
disturbance of the HPA axis initiates a 
viscous circle (figure 2), which puts 
stress as a major risk factor for excessive 
visceral weight gain.  
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Figure 2: a proposed model on how disturbance of the HPA axis is involved in body-weight regulation 
(solid lines represent stimulation and dashed lines represent inhibition).    
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Conclusions 
In children, body-weight development is 
regulated by various factors and 
interactions between these factors, such 
as the A allele of the FTO gene, which was 
associated with higher BMI, FMI, leptin 
concentrations, and lower activity scores 
from childhood to puberty. The influence 
of the FTO polymorphism however 
changed over time, as at age 13y the FTO 
A allele, larger leptin concentrations and 
decreased physical activity were 
independent predictors for a larger BMI, 
while at age 12, 14, and 15y BMI was only 
predicted by larger leptin concentrations. 
Polymorphisms of the CNTF and PPARγ2 
genes did not show an association with 
body-weight development during puberty, 
which implicates that during puberty BMI 
is only temporarily predicted by FTO and 
predominately predicted by endocrine 
factors. Additionally, the behavioral factor 
sleep duration was involved in body-
weight development, as changes in BMI 
during puberty were inversely related to 
changes in sleep duration. Subsequently, 
a higher BMI is associated with an earlier 
leptin peak in girls, and thereby an earlier 
start of puberty, as in girls leptin acts as a 
permissive factor for the onset of puberty. 
In boys leptin however has a different 
function and different timing. After the 
start of puberty factors independent of fat 
mass become (transiently) more 
important in the regulation of plasma 
leptin concentrations in boys and girls. 
 
In adults, stress results in eating in the 
absence of hunger, which demonstrates 
for the first time that non-homeostatic 
mechanisms, such as reward, are involved 
in stress-induced eating. Stress-induced 
eating was present especially in subjects 
with disinhibited eating behavior and 
sensitivity to chronic stress. Disinhibited 
eating behavior in combination with 
dietary restraint is related to hyperactivity 
of the HPA axis. Disturbance of HPA axis 
functioning under basal and challenged 
conditions is related to visceral fat 
accumulation. Therefore, we propose that 
chronic disturbance of the HPA axis 
initiates a viscous circle, which puts stress 
as a major risk factor for excessive 
visceral weight gain. 
 
Future research 
A further follow-up of our Dutch children 
cohort is strongly recommended, since 
this cohort has provided valuable data on 
body-weight development during 
childhood and puberty. It is of interest to 
observe whether the role of endocrine 
factors will diminish once the children are 
in late adolescence, and whether the role 
of genetic factors in body-weight 
development will become stronger during 
this period.  
Furthermore, for future research, it will be 
of interest to identify the physiological 
mechanisms behind the relationship 
between short sleep and altered body 
weight, and to investigate whether weight 
loss or weight stabilization can be 
achieved via sleep duration modification. 
Additionally, future experiments on the 
role of HPA axis functioning in body-
weight regulation should be conducted to 
further disentangle this relationship. It 
remains to be elucidated, whether the 
HPA axis is the primary cause for the 
obese state in the visceral obese, which 
can only be investigated via longitudinal 
studies. Furthermore, the disturbance of 
several neural homeostatic and non-
homeostatic networks involved in energy 
intake by HPA axis activation, such as the 
opioid and NPY system, are thought to be 
involved in stress-induced eating, 
however no direct evidence is found in 
humans yet. For future research it is of 
interest to identify brain regions involved 
in stress-induced eating and to evaluate if 
these regions are involved in homeostatic 
and non-homeostatic regulated food 
intake.  
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Summary 
 
A stable body weight reflects a balance 
between energy intake and energy 
expenditure. Chronic deregulation of 
energy balance leads to storage of 
excessive energy as fat, a characteristic of 
overweight and obesity. The studies 
described in this thesis encompass 
genetic, parental, behavioral, and 
endocrine factors involved in body-weight 
development and regulation during 
childhood, puberty and adulthood.  
The first part elaborates on the factors 
involved in body-weight development 
during childhood and puberty, studied in a 
large cohort of Dutch children, from which 
valuable anthropometrical data from birth 
till age 7y were available. To study body-
weight development during puberty, 
follow-up studies were performed yearly 
between 2004 and 2008, when the 
children had a mean age of 12 to 16y. In 
this cohort the A allele of the FTO gene 
(rs9939609) was associated with higher 
BMI, fat mass index, leptin 
concentrations, and lower activity scores 
from childhood to puberty. The influence 
of the FTO polymorphism however 
changed over time, as at age 13y the FTO 
A allele, larger leptin concentrations and 
decreased physical activity were 
independent predictors for a larger BMI, 
while at age 12, 14, and 15y BMI was only 
predicted by larger leptin concentrations 
(chapter 2).  
In our cohort, polymorphisms of the CNTF 
and PPARγ2 genes did not show an 
association with body-weight development 
during puberty. Our results implicate that 
BMI is only temporarily predicted by the 
FTO A allele and predominately predicted 
by endocrine factors. Next to the genetic 
factors, parental factors were involved in 
body-weight development during puberty, 
as a high BMI of the father and a high 
disinhibition score of the mother were 
related to an increased BMI in the child at 
age 12y (chapter 3).  
To investigate whether changes in sleep 
duration were associated with changes in 
body weight, we measured average sleep 
duration and body weight from Tanner 
stage 1 to 5 in our cohort. We were the 
first to show that development of BMI 
during puberty is inversely related to 
change in sleep duration, and although 
cause and effect cannot be completely 
disentangled from the observed inverse 
relationship, we carefully suggest that 
reduction of sleep duration contributes to 
development of overweight during puberty 
(chapter 4).  
With respect to endocrine factors, we 
studied the hormone leptin, as leptin is 
suggested to be a permissive factor for 
the start of puberty, which would be 
mediated through the stimulatory effect of 
leptin on the release of gonadotrophic 
hormones, and consequently gonadal 
hormones. We observed in our cohort that 
in boys the leptin/fat mass ratio 
decreased from Tanner stage 2 onwards, 
while in girls this ratio decreased from 
Tanner stage 2 and increased again at 
Tanner stage 5, which shows that factors 
independent of fat mass become 
(transiently) more important in the 
regulation of plasma leptin concentrations 
in boys and girls. Additionally, we found 
that in girls a peak in leptin was present 
at the start of puberty followed by a peak 
in LH and FSH, and during early puberty 
temporal relationships were observed 
between leptin and gonadotropic 
hormones. In boys, however there was no 
peak in leptin, LH, and FSH, and leptin 
was only related to gonadotropic 
hormones during late puberty. Leptin is 
therefore suggested to act as a permissive 
factor for the onset of puberty in girls, 
while in boys leptin has a different 
function and different timing (chapter 5). 
To conclude, the data from our cohort 
suggests that the FTO A allele, short sleep 
duration, and the parental factors interact, 
and together are involved in development 
of overweight during puberty.  
 
The second part of this thesis elaborates 
on the role of the neuro-endocrine system 
of the HPA axis in body-weight regulation 
in adults. The HPA axis has been 
suggested to be involved in body-weight 
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regulation, however, to what extent the 
HPA axis is physiologically involved in the 
regulation of body weight is not 
completely clear (chapter 6). The 
physiological role of the HPA axis in body-
weight regulation was studied in a cohort 
of healthy adults, 190 men and women, 
who had a BMI between 20 and 35 kg/m2. 
Evidence for involvement of the HPA axis 
in body-weight regulation is provided by 
genetic factors, such as the BclI 
polymorphism. In our cohort the BclI G/G 
genotype was associated with increased 
cortisol exposure as well as decreased 
cortisol feedback sensitivity under stress 
in women but not in men. Together with 
results on associations between the BclI 
G/G genotype and altered body weight 
and body fat distribution in women, this 
suggests that women with the BclI G/G 
genotype are more susceptible to 
disturbed regulation of body weight and 
HPA axis functioning compared to men 
with the same genotype (chapter 7). 
Additional evidence for involvement of the 
HPA axis in body-weight regulation is 
found in endocrine factors, as we 
observed that low cortisol exposure, 
enhanced negative feedback, and 
impaired HPA axis functioning in a 
challenged condition under 4 mg 
dexamethasone were related to visceral 
fat accumulation in both men and women 
(chapter 8).  
With respect to the behavioral factors 
involved in body-weight regulation, we 
observed that acute psychological stress 
results in eating in the absence of hunger. 
The observed food intake in the absence 
of hunger after stress exposure, hardly led 
to further decreases in hunger, which 
demonstrates for the first time that non-
homeostatic mechanisms, such as reward, 
are involved in stress-induced eating. 
Previous studies on stress-induced eating 
propose the involvement of reward, but 
they could not directly demonstrate the 
role of reward, as a role for hunger could 
not be excluded. Large inter-individual 
differences were present in our eating in 
the absence of hunger paradigm; stress 
could increase, decrease or did not alter 
food intake. These individual differences in 
response to stress relate to eating 
behavior characteristics, as we observed a 
stress-induced increase in eating in the 
absence of hunger especially in vulnerable 
individuals, who are characterized by 
disinhibited eating behavior and sensitivity 
to chronic stress (chapter 9).  
In our cohort disinhibited eating behavior 
in combination with dietary restraint was 
related to hyperactivity of the HPA-axis in 
normal weight women. Our results 
suggest that disinhibition in combination 
with dietary restraint can be considered as 
a chronic stressor. Together with the 
results from our study on the relationship 
between stress and eating in the absence 
of hunger, our results imply that 
disinhibition is an important mediator in 
the relationship between HPA axis 
functioning and body-weight regulation 
(chapter 10). 
To conclude, we propose that in adults 
chronic disturbance of the HPA axis 
initiates a vicious circle, which puts stress 
as a major risk factor for excessive 
visceral weight gain. Stress results in 
eating in the absence of hunger, 
especially in subjects with disinhibited 
eating behavior and sensitivity to chronic 
stress. Disinhibited eating behavior in 
combination with dietary restraint is 
related to hyperactivity of the HPA axis. In 
turn, disturbance of HPA axis functioning 
under basal and challenged conditions is 
related to visceral fat accumulation.  
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Samenvatting 
 
Een stabiel lichaamsgewicht is een 
weerspiegeling van de balans tussen 
energie inname en energiegebruik. Als het 
evenwicht tussen energie inname en 
energie gebruik doorslaat naar een 
positieve balans wordt het teveel aan 
energie opgeslagen als lichaamsvet. 
Wanneer deze disbalans lange tijd 
aanhoudt, ontstaan overgewicht. Dit 
proefschrift richt zich op erfelijke, 
ouderlijke, gedragsmatige en endocriene 
factoren die invloed hebben op de 
ontwikkeling en regulatie van 
lichaamsgewicht bij kinderen en 
volwassenen.  
 
Het eerste deel van dit proefschrift richt 
zich op de ontwikkeling van 
lichaamsgewicht zoals dat tijdens de 
puberteit  gemeten is bij een Nederlands 
kindercohort. Van deze kinderen is vanaf 
de geboorte tot en met de leeftijd van 7 
jaar jaarlijks lengte en gewicht gemeten. 
Om de ontwikkeling van lichaamsgewicht 
tijdens de puberteit te bepalen werden 
tussen 2004 en 2008 vervolgmetingen 
uitgevoerd, toen deze kinderen gemiddeld 
een leeftijd van 12 tot 18  jaar hadden. 
Voor wat betreft genetische invloeden, 
bleek het voorkomen van het A allel van 
het fat mass and obesity-associated (FTO) 
gen (rs9939609) gerelateerd te zijn aan 
een hogere Body Mass Index (BMI), een 
hogere vetmassa, hogere leptine 
concentraties en verlaagde lichamelijke 
activiteit. De invloed van het FTO A allel 
bleek echter niet ieder jaar even sterk, 
want alleen op 13 jarige leeftijd was het 
FTO A allel een voorspeller voor een 
hogere BMI. Op 12, 14 en 15 jarige 
leeftijd waren voornamelijk leptine 
concentraties voorspellend voor een 
hogere BMI (hoofdstuk 2). 
De verschillende genotypen van de ciliary 
neurotrophic factor (CNTF) en peroxisome 
proliferated-activated receptor (PPARγ2) 
genen bleken niet geassocieerd te zijn 
met de ontwikkeling van lichaamsgewicht 
in het kindercohort. Voor wat betreft de 
invloed van de ouders, bleek dat op 12 
jarige leeftijd een hogere BMI van de 
vader en ontremd eetgedrag van de 
moeder gerelateerd te zijn aan de 
ontwikkeling van overgewicht bij het kind 
(hoofdstuk 3).  
De ontwikkeling van het lichaamsgewicht 
tijdens de puberteit werd tevens beïnvloed 
door gedragsmatige factoren zoals het 
aantal uren slaap per nacht. Wij hebben 
met de data van ons cohort als eerste 
aangetoond dat tijdens de puberteit de 
daling van het aantal uren slaap per nacht 
gerelateerd is aan de stijging van het 
lichaamsgewicht. En hoewel het moeilijk is 
om in deze relatie oorzaak en gevolg te 
scheiden, suggereren wij dat een 
verlaging van het aantal uren slaap 
tijdens de puberteit zou kunnen bijdragen 
aan de ontwikkeling van overgewicht 
(hoofdstuk 4).  
Vervolgens werd ingegaan op de rol van 
de endocriene factor leptine in de 
ontwikkeling van lichaamsgewicht. Leptine 
wordt verondersteld een belangrijke rol  
te spelen in de aanzet tot de puberteit, 
omdat leptine mogelijk de productie van 
de gonadotrope hormonen en 
geslachtshormonen stimuleert. In ons 
cohort bleek dat de relatie tussen leptine 
en vetmassa minder sterk werd vanaf 
Tanner stadium 2 bij jongens; bij meisjes 
gebeurde dit ook maar werd de relatie 
weer sterker in Tanner stadium 5. Dat de 
relatie verandert, laat zien dat tijdens de 
puberteit de regulatie van de afgifte van 
leptine (tijdelijk) bepaald wordt door 
factoren die niet gerelateerd zijn aan de 
vetmassa. Verder vond er bij meisjes 
tijdens de start van de puberteit een piek 
in leptine concentraties plaats, welke werd 
gevolgd door een piek in de concentraties 
van de gonadotrope hormonen. Deze 
pieken waren afwezig bij de jongens en de 
relatie tussen leptine en de gonadotrope 
hormonen was alleen aanwezig tijdens de 
late stadia van de puberteit bij de 
jongens. Leptine lijkt dus een belangrijke 
rol te spelen in de aanzet tot de puberteit 
bij meisjes, maar lijkt een andere rol en 
andere timing te hebben bij jongens 
(hoofdstuk 5). 
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Uit de resultaten van ons kindercohort 
beschreven in het eerste deel van het 
proefschrift, kan worden geconcludeerd 
dat het FTO A allel, weinig uren slaap per 
nacht, en ouderlijke factoren samen 
betrokken zijn bij de ontwikkeling van 
overgewicht tijdens de puberteit.  
Het tweede deel van dit proefschrift richt 
zich op de rol van de hypothalamus-
hypofyse-bijnier as (HPA-as) in de 
regulatie van lichaamsgewicht bij 
volwassenen (hoofdstuk 6).  
De fysiologische rol van de HPA-as in de 
regulatie van lichaamsgewicht werd 
onderzocht in een cohort van gezonde 
volwassenen: 190 mannen en vrouwen 
met een BMI tussen de 20 en 35 kg/m2. 
Genetische factoren, zoals het BclI 
polymorfisme, bevestigen de rol van de 
HPA-as in gewichtsregulatie in ons cohort. 
Het BclI G/G genotype bleek namelijk 
gerelateerd te zijn aan verhoogde cortisol 
concentraties en verminderde remming 
van de HPA-as tijdens stress bij vrouwen, 
maar niet bij mannen. Uit de literatuur 
bleek dat het BclI G/G genotype bij 
vrouwen is gerelateerd aan een hoger 
lichaamsgewicht en meer visceraal vet. 
Het totaalbeeld dat ontstaat is dat 
vrouwen met het BclI G/G genotype 
gevoeliger zijn voor verstoorde regulatie 
van lichaamgewicht en van de HPA-as, 
dan mannen met het BclI G/G genotype 
(hoofdstuk 7). 
Ook endocriene factoren ondersteunen de 
rol van de HPA-as bij gewichtsregulatie, 
zoals bleek in ons cohort. Lage exposure 
van cortisol concentraties, sterkere 
remming van de HPA-as en verminderd 
functioneren van de HPA-as bij toediening 
van 4 mg dexamethasone bleken 
gerelateerd te zijn aan viscerale 
vetaccumulatie bij mannen en vrouwen 
(hoofdstuk 8). 
Voorts bevestigen gedragsmatige factoren 
de rol van de HPA-as bij 
gewichtsregulatie, zoals bleek uit het 
verschijnsel dat in ons cohort 
psychologische stress leidde tot 
voedselinname zonder dat iemand honger 
heeft. Bovendien werden de 
hongergevoelens niet verder verlaagd 
door de voedselinname, hetgeen voor het 
eerst aantoont dat niet-homeostatische 
mechanismen zoals de belonende waarde 
van voedsel betrokken zijn bij de regulatie 
van voedselinname tijdens stress. Vorige 
studies suggereerden een rol voor de 
belonende waarde van voedsel bij eten als 
gevolg van stress, maar dit kon niet met 
zekerheid vastgesteld worden omdat het 
effect van stress op hongergevoel niet 
uitgesloten kon worden. Niet iedereen 
verhoogt zijn voedselinname tijdens stress 
en grote verschillen bleken dan ook 
aanwezig te zijn in ons cohort. 
Voornamelijk mensen met ontremd 
eetgedrag en een grote gevoeligheid voor 
chronische stress eten meer tijdens stress 
ongeacht hun hongergevoel (hoofdstuk 
9). 
Ontremd eetgedrag afgewisseld met 
geremd eetgedrag bleek echter weer 
gerelateerd te zijn aan hyperactiviteit van 
de HPA-as bij slanke vrouwen. Dit 
suggereert dat ontremd eetgedrag 
afgewisseld met geremd eetgedrag 
chronische stress veroorzaakt. Samen 
suggereren deze resultaten dat ontremd 
eetgedrag een belangrijke factor is in de 
relatie tussen de HPA-as en 
gewichtsregulatie (hoofdstuk 10).  
Uit de resultaten beschreven in het 
tweede deel van het proefschrift kan 
worden geconcludeerd dat chronische 
activiteit van de HPA-as als gevolg van 
stress een groot risico vormt voor de 
regulatie van lichaamsgewicht. Stress 
veroorzaakt namelijk voedselinname 
zonder dat iemand honger heeft, en wel 
voornamelijk in mensen met ontremd 
eetgedrag en een grote gevoeligheid voor 
chronische stress. Ontremd eetgedrag 
afgewisseld met geremd eetgedrag is 
gerelateerd aan hyperactiviteit van de 
HPA-as. Verstoring van HPA-as leidt weer 
tot opslag van visceraal vet, daarbij een 
vicieuze cirkel vormend. 
Uit de resultaten beschreven in dit 
proefschrift wordt geconcludeerd dat 
erfelijke, ouderlijke, gedragsmatige en 
endocriene factoren invloed hebben op de 
ontwikkeling en regulatie van 
lichaamsgewicht bij kinderen en 
volwassenen. 
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